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ABSTRACT 
Levothyroxine Sodium is one of the most critical drugs for a significant segment of the 
population. The development of HPLC method of analysis for levothyroxine sodium 
revealed that there were significant stability problems associated with this drug. On 
August 141\ 1997, FDA announced that there was evidence which shows significant 
stability and potency problems associated with orally administered levothyroxine sodium 
products. This lack of stability and potency has a potential to cause serious health 
consequence to the public. The literature, on determining the stable formulation of 
levothyroxine sodium is very little. Much of the published work on levothyroxine sodium 
describes the innumerable bioavailability and potency problems with this drug. However, 
little in the literature explored the stability of levothyroxine sodium in presence of 
various excipients. The portion of work in this thesis represents a series of investigations 
we have performed to evaluate the stability of levothyroxine sodium in presence of some 
of the most commonly used excipients at different temperatures and humidities. These 
studies indicated that levothyroxine sodium is unstable in presence of carbohydrates such 
as dextrose, lactose and starch. These excipients have an aldehyde group, which may be 
reacting with the free amino group of levothyroxine sodium leading to a Schiff-base 
reaction along with oxidation reaction. 
In furthe~, series of investigations, the kinetics of degradation reactions were evaluated. 
First order and bi-phasic first order models were evaluated for our studies. Nonlinear 
regression was performed using Sigma Plot and the results suggest a biphasic-first order 
degradation pathway in most of the cases. The shelf life for levothyroxine sodium was 
11 
determined using the k-values obtained from the best fit models. The lower t9o values 
indicated that levothyroxine sodium is highly unstable in presence of moisture and higher 
temperatures and so the tablets should be formulated and stored at or below room 
temperature with 0% humidity. 
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PREFACE 
This body of work represents the series of investigations we have performed to determine 
the stability of levothyroxine sodium in presence of different excipients under various 
conditions. Section I includes the general introduction regarding the solid state stability 
of levothyroxine sodium. The main body of this thesis can be found in Section II and 
Section III. The various chapters in the second and third section can be best envisioned as 
the series of investigation performed to look at the stability of levothyroxine sodium. 
Appendix A contains the statistical output of non-linear regression (Sigma Plot, Version 
4, SPSS Inc., 1997) in modeling the degradation kinetics of levothyroxine sodium. 
Appendix B includes the residual plots which were used in checking the adequacy of a 
fit. At the end of the thesis a bibliography, which sites all the sources used in this 
document, is included. 
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SECTION I: INTRODUCTION 
1 
SOLID STATE STABILITY: AN OVERVIEW 
Background 
Among the different types of drug delivery systems, solid dosage forms are by far the 
most common due to their dose precision, low cost, easy and inexpensive packaging and 
shipping. In addition product identification for these dosage forms is simple when done 
using embossed or monogrammed punch faces; lend themselves to certain special-release 
profiles, such as enteric or delayed released products; having the best combined 
properties of chemical, mechanical and microbiological stability of all oral forms and are 
the lightest and most compact of all oral dosage forms. The advantages of solid dosage 
forms are reflected by widely accepted practice of delivering drugs in this manner during 
initial clinical trials [ 1, 2]. Solid state stability of a drug is one of the most intrinsic and 
vital parts in the formulation of drug substance. One of the primary concerns during 
product development is producing a drug substance that has consistent stability properties 
in the bulk form as well as when formulated [3]. Stability testing provides evidence of 
how the quality of the drug substance or drug product varies over time under the 
influence of a variety of environmental factors such as temperature, humidity and light. A 
systematic approach should be adopted in the testing and evaluation of stability 
information which should cover, as necessary, physical, chemical, biological, and 
microbiological quality characteristics, including unique properties of the dosage form 
(for example, dissolution rate for oral solid dose forms). The design of the stability study 
is to establish, based on testing a minimum of three batches of the drug product, shelf life 
and label storage instructions applicable to all future batches of the dosage form 
manufactured and packed under similar circumstances. The degree of variability of 
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individual batches establishes the confidence that a future production batch will remain 
within specification until the expiration date [ 4]. Stability testing of the drug substances 
and drug products is required to support the defined expiry period for the following 
categories of drug regulatory submissions: Investigational New Drug Applications 
(IND's), New Drug Applications (NDA's) for both the New Molecular Entities (NME's) 
and non-NME's, Abbreviated New Drug Applications (ANDA's), Supplements and 
annual reports, Biologics License Application (BLA's) and product license applications 
(PLA's) [5]. 
The term 'pharmaceutical stability' encompasses a range of parameters. The most 
common interpretation is the chemical stability of the drug substance in a dosage form. 
However, the performance of a drug when given as a tablet, capsule, syrup or injection is 
not only dependent upon the content of the drug substance, but also on its pharmaceutical 
properties (dissolution, disintegration, hardness, friability, content uniformity etc.) [ 1]. 
All of these parameters must, therefore, be a part of the stability program. In 1994 
International Conference on Harmonization (ICH) guidelines for stability testing were 
published and are as follows [ 4]. 
Information on the stability of Active Pharmaceutical Ingredient (API) under defined 
storage conditions is an integral part of the systematic approach to stability evaluation. 
Stability information from accelerated and long-term testing should be provided on at 
least three production batches. Long term stability should cover a minimum of 12 
month's duration on at least three production batches at the time of submission. The 
testing should cover especially those features susceptible to change during storage and 
likely to influence quality, safety and/or efficacy. Stability information should cover as 
I 
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necessary the physical, chemical, biological, and microbiological test characteristics. The 
length of studies and storage conditions should be sufficient to cover storage, shipment, 
and subsequent use. The 6-month accelerated testing should then be carried out at a 
temperature at least 15°C above long term storage temperature (25°C ± 2°C, 6D% ± 5% 
RH. The general guidelines for storage conditions and testing periods for bulk drugs and 
drug product is given in Table 1. 
Table 1. Long-term/accelerated testing conditions 
Conditions Minimum Time Period At 
Submission 
Bulk Drug 
Long Term Testing 25°C ± 2°C, 60% ± 5% RH 12 months 
Accelerated Testing 40°C ± 2°C, 75% ± 5% RH 6 months 
Intermediate Testing 30°C ± 2°C, 60% ± 5% RH 6 months 
Drug Product 
Long Term Testing 25°C ± 2°C, 60% ± 5% RH 12 months 
Accelerated Testing 40°C ± 2°C, 75% ± 5% RH 6 months 
Intermediate Testing 30°C ± 2°C, 60% ± 5% RH 6 months 
If 'significant change' occurs due to accelerated testing, additional testing at an 
intermediate condition e.g., 30°C ± 2°C, 60% ± 5% RH should be conducted. 'Significant 
change' at the accelerated condition is defined as [1]: 
a) A 5 percent potency loss from the initial assay value of the batch; 
b) Any specific degradant exceeding its specification limit; 
c) The product exceeding its pH limits; 
d) Dissolution exceeding the specification limits for 12 capsules or tablets; 
e) Failure to meet specifications for appearance and physical properties e.g., color, 
phase separation, resuspendibility, delivery per actuation, caking, hardness etc. 
4 
Modes of Drug Degradation 
Drug degradation occurs by four main processes [6]: 
Hydrolysis due to H10, H30+, Off, pH 
Oxidation 
Photolysis due to UV, visible light 
. 1 . d +2 +3 +2 +2 Trace metal ion cata ys1s ue to Fe , Fe , Cu , Co , etc. 
The decomposition of drugs are most often classified as either hydrolysis or oxidation. 
Most drugs contain more than one functional group, and hence may be subjected 
simultaneously to oxidation as well as hydrolysis. Other reactions such as epimerization, 
isomerization and photolysis may also affect the stability of drugs. 
Hydrolysis may be caused by reaction of water with amides or esters. Water may also 
react with the ions of salts of weak acids and weak bases. Molecular hydrolysis reactions 
proceed much more slowly then the ionic hydrolysis (protolysis) [7]. In solid dosage 
formulations, free moisture is contributed by various additives or excipients, as well as 
the drug. In tablets a small percentage, typically 2% (w/w) of moisture, is required to 
facilitate good compression. This free water has the ability to act as a vector for chemical 
reactions between the drug and the excipients [6]. Some of the most common examples 
are: the hydrolysis of aspirin above pH 10 and hydrolysis of chloramphenicol which is 
pH independent is catalyzed by general acids and bases [7]. 
Oxidation reactions involve the removal of electrons or loss of hydrogen 
(dehydrogenation) from the molecules. When the reaction involves molecular oxygen, it 
is called auto-oxidation. Oxidation reactions frequently involve free radicals of atoms or 
molecules containing one or more unpaired electrons, or free hydroxy and molecular 
5 
oxygen (0-0). Oxidation may be catalyzed by the presence of trace amounts of heavy 
metals and organic peroxides [7]. The oxidation of unsaturated fats and oils proceeds in 
the presence of atmospheric oxygen, light and trace amounts of catalysts 
according to free radical chain reactions. The hydroperoxide (R'-CHOOH-CH=CH-
R") formed in the reaction may further decompose, and the reaction continues until the 
free radicals formed in the reactions are destroyed by inhibitors or by side reactions 
which will break the chain. Another classic example is the oxidation of ascorbic acid to 
dehydroascorbic acid in the presence of copper ions and oxygen. When the solution of 
ascorbic acid is freed from copper ions, the oxidation of ascorbic acid in alkaline medium 
will cease [7]. 
Oxidation and, to some extent, photolysis may be catalyzed by light. The energy of light 
is inversely related to wavelength (ultravisible > visible > infrared) and is independent of 
temperature. When the molecules are exposed to electromagnetic radiation (EMR), they 
absorb light at characteristic wavelengths, which causes an increase in the energy state of 
. 
the compound. This energy may cause: 
decomposition 
retention or transfer of energy 
conversion to heat 
emission of light at a new wavelength (as fluorescence, phosphorescence). 
Photodegradation is dependent on both the intensity and the wavelength of light and is 
usually mediated by free radicals to produce dark colored substituents [6]. Some of the 







Table 2. Simple strategies for improving drug stability 
(Table reprinted from reference 6) 
De_g_radation Process Method of Protection 
Hydrolysis Remove water, moisture 
e:.9_. Use d_!Y_ desiccant 
Lower water activity 
e:.9_. Add humectants 
Change excipient(s) 
e:.9_. Compatibili!l studies 
Use solid dosage forms 
e.g. Tablets and capsules 
Freeze d_!Y_ injections 
pH Identify pHmin 
e:.9_. Addition of buffers 
Temperature Refrigerate 4 C 
Cool place ~ 15 C 
Oxidation Include antioxidant 
e.g. Ascorbic acid 
Sulphites 
Chelate metal ions 
e:.9_. EDTA 
Remove 02 
e.g. N2, C02 or He 
Photo!Y_sis Protect from l!_g_ht, Packa_g_in_g_ 
7 
Drug-Excipient Compatibility Testing 
What emerges from a drug discovery program is an Active Pharmaceutical Ingredient 
(API) or drug substance. The API is the basis for producing the therapeutic activity 
expected of the drug and becomes a drug product after formulation with various 
excipients to produce a dosage form. Hastening the drug development process and 
optimization of dosage form stability are two major goals of any drug development 
program. The successful formulation of a stable and effective solid dosage form depends 
on the careful selection of the excipients used to facilitate administration, promote 
consistent release, enhance bioavailability of the drug and protect it from degradation. 
Hence, excipients are the integral components of almost all pharmaceutical dosage forms. 
In mixtures of solids, incompatibilities or chemical interactions can occur by following 
mechanisms [ 6]: 
degradation by nucleation via the gaseous phase 
contracting surface due to nucleation with coverage by the breakdown products 
degradation mediated by surface moisture or eutectic films 
oxidation 
photolysis. 
Degradation in the solid state may be affected by several factors, such as the proportion 
of the drug to excipient(s), method of mixing, hygroscopicity of the powder mixture, 
hygroscopicity of the substance involved, temperature, humidity, particle size 
distrib.ution, particle packing, porosity of the powder bed, etc. Hence, in pharmaceutical 
preformu.lation drug-excipient compatibility studies are obligatory. Interestingly, with the 
8 
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importance of drug-excipient compatibility studies, no general method is available for 
these studies. 
Ahlneck et al. [8] studied the three commonly used methods for dn:g-excipient screening: 
the suspension technique, storage of powder mixtures and compacts at specified 
temperatures and stored at specified relative humidities; and evaluated the variables 
influencing drug degradation. They concluded that the suspension technique is a fast-
screening method for detecting chemical stability problems but gives limited information 
on the stability of a drug in solid dosage forms. The solid state techniques, i.e. the powder 
mixtures and compacts, gave a better picture of the stability profile of a solid dosage form 
composition. The solid state procedure took into account a large number of variables such 
as powder mixing, particle size, surface area, moisture adsorption, etc. 
Monkhouse et al. [9] suggested that one should eliminate drug-excipient compatibility 
testing and instead select excipients on the basis of the physical and chemical 
characteristics of the drug substance and the literature data for the excipients. They 
recommended that the final composition should be selected on the basis of the 
accelerated stability testing of one or more target formulations at high temperature and 
humidity. 
In 1999, Serajuddin et al. [10] reported a method that may be used successfully to 
identify the relative influence of different excipients on the stability of the drug. They 
proposed a model which involved storing drug-excipient blends with 20% added water in 
a closed glass vials at 50°C and analyzing at one and three weeks for chemical and 
physical stability. The amount of the drug substance in the blend was determined on the 
basis of the expected drug-to-excipient ratio in the final formulation. The effect of several 
9 
key factors such as the chemical nature of the excipient, drug-to-excipient ratio, moisture, 
micro environmental pH of the drug-excipient mixture, temperature, and light on the 
.. 
dosage form stability could be identified by using this model. They suggested that 
selection of the dosage form composition by using this model at the outset of the drug 
development program would lead to a reduction of surprise problems during long term 
stability testing of drug products. 
Quality and Functionality of The Excipients 
Excipients are better known as promoters of degradation rather than as stabilizers of drug 
substances. Different functional groups or residues present in the excipients may have the 
propensity to interact with labile active ingredients or drugs, causing loss of molecular 
integrity or degradation. The quality of the final product depends not only on the active 
principles and production processes, but also on the performance of the excipients. 
Excipients have undergone an evolution from an 'inert' and cheap vehicle to an essential 
constituent of the formulation that enhances the stability and the bioavailability of the 
drug substance in the drug product and improves its manufacturability on a production 
scale. The studies of interactions between a drug and the excipients shows that 
complexation, hydrogen bonding, ion-dipole, dipole-dipole and van der waals attractions 
can modify the physicochemical, pharmacological or pharmacokinetical behavior of the 
final product especially in the solid dosage forms [11, 12, 13]. 
If excipients have to act as stabilizers they must obviate or alternate the factors that cause 
molecular transformation of drug substances. These factors may be environmental 
components such as water vapor and sunlight. Other factors include stress during the 
10 
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processing of the dosage form such as size reduction, compaction or sterilization, or 
interactions between adjacent molecules of the drug or functional groups on the same 
molecule [11]. 
Moisture Related Degradation 
Water is one of the major factors responsible for causing degradation in pharmaceutical 
formulations. It may be associated with the drug or the excipients, may be incorporated 
during the processing of dosage forms or may be acquired from the environment during 
packaging or storage. Because of its ubiquitous nature and its ability to exist as a vapour, 
water is virtually impossible to avoid and difficult to control. The molecular mass of 
water is low, and so small amounts may be significant in terms of molecular reactivity. 
Water is also capable of diffusing, to some extent, through packaging materials, pack 
seals or through compacted solid dosage forms [ 11]. 
Excipients with a greater affinity for moisture might aid in mitigating moisture 
sensitivity. Thus, formulation with a substance having a greater affinity for water as 
compared to the drug may help in sequestering moisture in the product. Perrier et al. [ 14] 
used nitrogen sorption isotherms to predict the effect of common excipients on the 
stability of nitrazepam. They determined that excipients with higher absorption energies 
caused less degradation, meaning, if the excipient has a higher binding energy for water 
as compared to the drug, the excipient may act as a desiccant and stabilize the drug. 
Along with moisture, residues of lower alcohols (methanol, ethanol, isopropanol) might 
be present in the final formulation, as a result of synthesis, isolation of the drug or the 
process used for manufacturing the dosage form. Nimry et al. [15] and Tobyn et al. [16] 
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showed that materials such as amorphous silica and microcrystalline cellulose may act as 
'scavangers' of volatile residues and help in stabilizing the formulation. 
Degradation by Oxidation 
Loss of drug quality due to oxidation is usually secondary to hydrolytic breakdown. 
These reactions are often complex and caused by factors that are difficult to separate and 
clarify. Oxidation can be catalyzed by exposure to air or light, the presence of trace 
residues (metal ions), by other components in the formulation or the combination of all 
the above mentioned factors. 
Formulation additives have been effective in the stabilizaion of vitamin preparations. The 
antioxidants tocopherol, butylated hydroxy anisole, butylated hydroxy toluene and propyl 
gallate have all be used to stabilize vitamins A and D3 [17, 18]. Reyes [19] showed that 
magnesium, calcium and aluminium stearates helped in the stabilization of ascorbic acid . 
Photodegradation 
Exposure to light may precipitate a plethora of degradation reactions, such as 
polymerization, isomerization, addition reactions in unsaturated systems, substitution 
reactions and photo-oxidation [20]. 
Thoma and Klimek introduced the concept of spectral overlay. This approach involves 
formulating with an excipient whose UV absorption spectrum overlaps (or substantially 
overlaps) that of the compound requiring stabilization. The excipient would thus compete 
with the active compound for photons from a radiation source and hence the impact of 
damaging radiation would be attenuated. They showed that the photolabile calcium 
antagonist nifedipine can be stabilized by the natural food colorant, curcumin, or by 
riboflavin [21]. Sanderson et al. [22] showed that the stability of a 13-lactam BRL42715B 
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can also be enhanced by addition of a 'blocker' such as titanium dioxide and addition of 
soft paraffin with a UV spectrum that provided a partial spectral cover. 
The spectral overlay approach is an elegant way to stabilize a drug. However the list of 
potentially useful materials which are free from pharmaceutical activity and are non-toxic 
is very limited. 
Other Modes of Degradation 
Some degradation reactions like isomerization, dimerization, polymerization and other 
forms of molecular rearrangements do not involve species other than the active 
ingredient. These of reactions are common in drugs of large molecular mass or those of 
biological origin. Hence it might seem that molecules with an intrinsic 'self-destructing' 
capability would be most difficult to stabilize. 
Cyclodextrins are unique compounds, due to their umque, molecular complexation 
capability has been shown to improve the stability of compounds such as clofibrate and 
isosorbide which have tendency to .sublime [23]. Cyclodextrins have also been shown to 
stabilize labile materials such as PGE1 and PGF2 by forming molecular encapsulation 
[24]. 
The use of excipients to stabilize an unstable ingredient is an attractive concept. A 
product can be developed that will retain its quahty while the drug and other formulation 
ingredients are in close association. However, there are few examples, as listed in Table 
3, in which excipients may destabilize or decrease the efficacy of the drug. 
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Table 3. Studies of interactions between APl's and excipients in pharmaceutical 
formulation 
Active Stoichiometry Therapeutic Pharmaceutical Results of References 
Medicament/ (molar ratios activity formulation interaction 
Excipient percentages) 
Acetylsalicylic Different Analgesic Matrix-tablets Poor drug Ref. 25 
acid/Eudragit proportions - antipyretic release 
RS,starch, 5, 10, 15, 25% 
Dextrose 
monhydrate 
Carteolol 22% Carteolol A potent 13- Tablet Type Ref. 26 
hydrochloride/ adrenergic ammonium 




Chloramphenicol Antibiotic Powder · In vitro Ref. 27 





Methods for Studying Interactions between Drug and Excipients in Pharmaceutical 
Formulations 
Presently, infra-red (IR)-spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, 
differential scanning calorimetry (DSC) and X-ray diffraction are the most commonly 
used methods to investigate interactions between drugs and the excipients in 
pharmaceutical formulations. IR spectroscopy is sensitive to crystalline form changes. 
Since it is inherently based on molecular vibrations, IR has an advantage of being 
sensitive to functional group changes in low or non-crystalline materials. IR spectroscopy 
helps in looking at interactions between the drug and the excipient by following 
important characteristics such as the appearance of new IR absorption band(s), the 
broadening of band(s), and alteration in intensity. These comparisons are performed by 
comparing the IR spectra of the drug alone, the excipient alone, the complex and the 
simple physical mixture (prepared in same stoichiometry as a complex from both the 
drug and the excipient(s) [13]. For example, IR was used to determine which excipients 
participate in the salt to free base conversion of delavirdine. The spectra of delavirdine 
mesylate indicated that free base was formed in all· the mixtures except the one where 
croscarmellose sodium was absent. The spectra revealed that croscarmellose sodium in 
the tablet matrix was necessary to prevent conversion of the delavirdine salt to a free 
base [27]. An electronic database is available for comparison and identification of 
absorption and transmission spectra for excipients and the drugs which can be used to 
determine functional groups or degradation products present in the mixtures. This can be 
done by extrapolating the spectra obtained with that present in the database. 
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Solid state NMR can be used to determine inter and intra-molecular interactions and 
crystal packing in the solids at a molecular level; and are, therefore, useful for 
distinguishing between closely related solid forms of the same molecular entity. Rohrs et 
al. (28] used solid state NMR to characterize and quantify the forms of delavirdine in the 
tablet form. Three crystalline forms of delavirdine mesylate have been characterized, and 
the distinct NMR features observed among these and other forms were used for 
diagnostic purposes. The identification of the drug form(s) were used to verify that no 
major interferences occurred from tablet excipients. It was seen that there were no 
interferences from the tablet excipients with the drug forms in the tablet matrix. 
DSC is another important tool which is used to study changes in the melting point of 
compounds and hence determine polymorphic changes in the mixtures. Jain et al. [29] 
used DSC to evaluate the amount of moisture pickup in a drug-moisture-lactose 
interaction. They found that stable solid lactose exists in a- monhydrous, a- anhydrous, 
and ~-anhydrous forms. DSC studies revealed that the a- anhydrous lactose which is 
present in small quatities in ~-lactose is responsible for moisture uptake and hence makes 
the formulation unstable. 
Crystalline materials in powder form exhibit highly characteristic X-ray diffraction 
patterns in which the positions and relative intensities of peaks are well-defined and 
reproducible. The diffraction pattern of a crystalline powder is characteristic for the 
crystal lattices of that particular polymorph. By measuring the rate of disappearance (or 
appearance) of a peak unique to a reactant (or product), the kinetics of a reaction or 
transformation can be determined. This method has been used to follow the desolvation 
reaction of several crystalline hydrates. Since crystals serve as unique micro-reaction 
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vessels, X-ray crystallography can often be used to determine the exact position of atoms 
as they re-orient themselves during a reaction. This can provide valuable information in 
predicting the path followed by atoms throughout the course of a reaction. Because of the 
wealth of information offered by X-ray analysis, it can be expected to play an important 
role in solid state stability studies [30]. 
LEVOTHYROXINE 
INTRODUCTION 
In 1891, G.R.Murray published a paper in the British Medical Journal showing the 
beneficial effects of using sheep thyroid extract in the treatment of hypothyrodism [31]. 
Kendall [32] and Harrington [33] later determined that levothyroxine was the primary 
active component in thyroid extracts. 
Levothyroxine Sodium is a sodium salt of the levo isomer of the endogenous secretion of 
the thyroid gland thyroxine. Thyroid hormones affect protein, lipid, and carbohydrate 
metabolism; growth; and development. Thyroid hormones stimulate oxygen consumption 
by most of the cells in the body, resulting in an increased energy expenditure and heat 
production. It also possesses a cardiostimulatory effect that may result in direct 
stimulation of the heart [34]. Orally administered levothyroxine sodium is used as a 
supplemental or replacement therapy in conditions with diminished or absent thyroid 
function such as cretinism, myxedema, nontoxic goiter or hypothyrodism. It is also used 
as replacement or supplemental therapy in patients with secondary (pituatory) or tertiary 
(hypothalamic) hypothyrodism, making levothyroxine a life long medication [35]. In 
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1997, it was estimated that about 8 million Americans received thyroid replacement 
therapy, which makes it a drug of critical importance for a significant segment of 
population [36]. 
In 1955, Flint laboratories introduced the first orally administered synthetic levothyroxine 
sodium in the United States [37]. In 1982, the FDA, in conjunction with the United States 
Pharmacopeial Convention, took an initiative in organizing a workshop to set the 
standard for the use of High Pressure Liquid Chromatography (HPLC) assay for the 
quality control of levothyroxine sodium. The assay method initially used in the USP was 
based on a titrametric determination of iodine content, was deemed to be neither specific 
nor stability indicating and was unable to distinguish between active drug and the iodine 
containing decomposition products. Moreover, the iodine content method was quite 
insensitive, requiring 3 mg of levothyroxine sodium per assay or 120 tablets of the 25 ug 
dosage form which made the method unsuitable for product quality control, regulatory 
control, content uniformity and routine stability testing [38]. 
In the quest to find a stability indicating method, Smith et al. [39]. In 1981, proposed the 
first HPLC system for the determination of levothyroxine sodium in tablets. They used an 
octadecylsilane reversed phase column, with a mobile phase consisting of potassium 
dihydrogen phosphate, methanol, and water at 44°C and using a UV spectrophotometric 
response at 254 nm. Though this method exhibited accuracy and precision, it was not 
stability indicating, and the quantitation of levothyroxine sodium was complicated by 
interferences observed in aged samples. In 1984, Garnick et al. [38] proposed a HPLC 
system which consisted of a bonded phase cyanopropyl column with a mobile phase 
consisting of acetonitrile : water ( 40 : 60 v/v) and 0.05% phosphoric acid; and used a UV 
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detector at 225 nm. After several modifications to this method the USP published a 
stability indicating assay for levothyroxine sodium and determined that orally 
administered levothyroxine sodium products had significant stability problems [40]. 
In 1990, Gupta et al. [41] analyzed levothyroxine sodium tablets from two different 
manufacturers. The results indicated that one of the brands, contained excipient( s) which 
acted as catalyst(s) to hasten decomposition. Tablets from the same manufacturer but 
from different batches showed an additional long peak in the chromatogram, indicating 
that the excipient(s) may have been changed. In 1992, Won [42], published a most 
interesting paper, which indicated that the kinetics of degradation of levothyroxine in 
aqueous solution and in the solid state are significantly different. It appears that in 
aqueous solution the major degradation pathway involves deiodination while in solid 
state levothyroxine follows a deamidation pathway. 
Between 1987 and 1994, FDA received 58 adverse drug experience reports associated 
with the potency of orally administered levothyroxine sodium products. Out of the 58 
reports, 47 suggested that the products were sub-potent, while 9 suggested super-potency. 
Some of the problems reported were the result o( switching products from different 
manufacturers. However, other adverse events occurred when a patient received a 
prescription refill of a product from the same manufacturer on which they had previously 
been stablized, indicating a lack of consistency, potency and bioavailability between 
different lots of tablets from the same manufacturer. From 1991 to 1997, there had been 
no less than 10 firms initiating recalls of levothyroxine sodium tablets, involving 150 lots 
and more than 100 million tablets. In all but one case, the recalls were initiated because 
the tablets were found to be either sub-potent or potency could not be assured through the 
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expiration date. The remaining recalls were initiated on the products that were found to 
be superpotent. It appears that the stability problem for levothyroxine sodium is quite 
complex and with some products, at least, stability is batch dependent [35]. 
After evaluation of the above mentioned problems, on August 141\ 1997, the FDA stated 
that there was sufficient evidence which showed significant stability and potency 
problems associated with levothyroxine sodium products. Usage of such products is 
believed to cause potentially serious health consequences in the public. In view of the 
stability and potency problems associated with levothyroxine sodium products, FDA 
retrograded all levothyroxine products as new drugs for which approval by NDA or 
ANDA would be required [35]. 
From the literature, it can be seen that very little has been done to successfully develop a 
stable formulation of levothyroxine. There are limited publications exploring the stability 
of levothyroxine sodium in presence of excipients. Investigations to evaluate the stability 
of levothyroxine sodium in presence of some of the most commonly used excipients, 
such as dextrose, dicalcium phosphate dihydrate, calcium sulfate, mannitol, etc at various 
temperatures and humidities would assist in selecting· formulation ingredients, and would 
also provide insight into the nature of degradation typical with levothyroxine sodium. 
Such studies were hoped to provide a better understanding of the formulation parameters 
to be used to optimize formulations and processing for the improvement of the drug 
stability. 
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GENERAL PROPERTIES OF LEVOTHYROXINE (Ref. 43) 
i) Chemical Name: 
ii) 
iii) 
a) Sodium derivative of 3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-
alanine. 
b) L-3,3 ',5,5 '-Tetraiodothyronine, sodium salt, pentahydrate. 
c) 13-[(3,5-diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl]-alanine, sodium salt 
pentahydrate. 
Generic Name: Sodium Levothyroxine 
Trade Names: Synthroid®, Levoxyl®, Eltroxin® etc. 
iv) Empirical Formula and Molecular Weight: 
L-4 Sodium salt pentahydrate 
C1sH1ol4Nna04 • 5H20 
Anhydrous Sodium salt of L-4 
C1sH10l4Nna04 








Figure 1. Structure of levothyroxine sodium 
vi) Organoleptic Properties: 
Color: White to Pale Yellow. 
Odor: Odorless. 
vii) Melting Range: 
235°C - 236°C. 
viii) Stability: 
Levothyroxine is sensitive to irradiation, hydrolysis, oxidation and heat. 
ix) Solubility: 
Table 4. Solubility profile of levothyroxine sodium in presence of different solvents 
Solvent Levot~oxine Solubil!!Y_in _g_m/ 100ml 
HzO 0.14 
95% Ethanol 0.4 
Alkali H_ydroxides Soluble 
Chloroform Almost insoluble 
Et~ Ether Almost insoluble 
Pho~hate buffer _.e.H 7.4 0.022 - 0.044 
22 
SECTION II : EXPERIMENTAL 
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The study of drug-decomposition kinetics, the development of a stable dosage forms, and 
the establishment of expiration dates for drug products should evaluate the parameters 
that are likely to affect the quality, safety, and/or efficacy of the drug product. The 
analytical procedure should be fully validated and the assays should be stability-
indicating. 
During pre-formulation stage, one of the objectives of the stability studies is to establish 
excipient-compatibility information to help the formulator design a stable and efficacious 
formulation. Excipients can affect the stability of drugs by: ( 1) acting as surface catalysts; 
(2) altering the pH of the moisture layer; and (3) undergoing direct chemical reaction 
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with the drug. The above mentioned problems thus require a screening of a large number 
of excipients under several storage conditions such as temperature, humidity, and light. 
This study helps in developing analytical, physical, and chemical data that will facilitate 
formulation studies and manufacturing. These studies also allows the formulator to: (1) 
determine reactivities of the drug substances; (2) establish whether or not special 
handling and storage procedures are required to protect the drug substance; (3) ensure 
that the potency is sufficient and the level of significant degradation products may be 
significant throughout the life of the supplies; (4) develop supporting data for subsequent 
stability studies of the formulated drug; and ( 5) delineate any interaction between 
selected formulation excipients and the drug substance. 
Once the initial screening of the excipients is done, the next step is to perform the 
stability studies on the formulated dosage form(s) under several storage conditions of 
temperature and humidity. In case of tablets, stability studies should also include 
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evaluation of characteristics such as: appearance, friability, strength, hardness, color, 
disintegration and dissolution. 
I) STABILITY INDICATING ASSAY FOR LEVOTHYROXINE SODIUM: 
The selected HPLC method was selected to provide high sensitivity for levothyroxine 
sodium along with its reference standard liothyronine sodium at very low concentrations, 
as well as to be highly reliable and simple to use within the constraint of these studies. 
REAGENTS I EQUIPMENTS USED: 
Equipments 
Metler AE 240 Weighing balance 
Ultrasonifier (Fisher Scientific) 
Magnetic Stirrer (Thermix® Model 120 MR) 
HPLC System consisting of: 
Automated Gradient Controller (Waters®) 
HPLC Pumps (Waters® Model 515) 
Auto Sampler (Waters® Model 717 plus) 
LC Spectrophotometer (Waters® Model 480) 
Data Module (Waters® Model 746) 
L-10 column (Zorbax®) 
Column Temperature Controller (Fiatron Systems Inc, Model TC-50) 
Reagents 
Levothyroxine Sodium (Biochemie Labs, Lot# 78459003) 
Liothronine Sodium (Sigma Labs, Lot# 98Hl 1681) 
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Sodium Hydroxide (Fisher Scientific, Lot # S318-500) 
Methanol (HPLC Grade, Fisher Scientific, Lot# A452-4) 
Acetonitrile (HPLC Grade, Fisher Scientific, Lot# A998-4) 
a-Phosphoric Acid (Fisher Scientific, Lot # A260-500) 
Deionized water. 
STANDARD PROCEDURE: 
If the HPLC system has not been used for a week or more, the system should be purged 
and primed as described in the instruction manual. 
PREPARATION OF MOBILE PHASE: 
Prepare a mixture of water and acetonitrile (70 : 30) containing 1 ml of a-phosphoric acid 
in each 1000 ml of the mixture. While making the mobile phase water and a-phosphoric 
acid should be mixed prior to the addition of acetonitrile. Mix the mobile phase for 5 
minutes with magnetic stirrer. Filter the mobile phase using vacuum pump. Degas the 
mobile phase in ultra-sonifier for 5 minutes. 
PREPARATION OF HPLC SYSTEM: 
Connect the L-10 column to the system and make sure that the connections are tight. 
Turn on the system and set the following parameters: 
The column thermostat temperature should be set to 30°C. 
The absorbance of the spectrophotometer should be set to 225 nm. 
The flow rate should be set to 1 ml/minute. 
The run time should be set to 20 minutes. 
Injection volume should be set to 25 µl. 
Number of injections from each vial should be set to 5. 
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Allow the system to stabilize for at least 2 hours. 
PREPARATION OF STANDARDS: 
o.OlM METHANOLIC NaOH: Approximately 400mg of NaOH was weighed and 
dissolved in 500ml of water in 1 OOOml volumetric flask. To it 500ml of methanol was 
added to make up the volume. 
STOCK SOLUTION (500µg/ml) OF L-4: Approximately 0.025g of L-4 was weighed 
and transferred to 50 ml volumetric flask. The volume was made up with O.OIM 
methanolic NaOH. 
STANDARD SOLUTION (5µg/ml) OF L-4: lml of above stock solution was taken in 
IOOml volumetric flask and the volume was made up with O.OIM methanolic NaOH. 
L-4 SOLUTION (10 µg/ml): lml of above stock solution was taken in 50 ml volumetric 
flask and the volume was made up with O.OIM methanolic NaOH. 
Following the above procedure, L-3 solutions were prepared. 
SERIAL DILUTIONS: 
L-4 (0.2 µg/ml) and L-3 (0.2 µg/ml): 2ml of L-4 (10 µg/ml) + 2ml of L-3 (10 µg/ml) in 
lOOml volumetric flask and volume made up with O.OIM methanolic NaOH. 
L-4 (0.4 µg/ml) and L-3 (0.4 µg/ml): 4ml of L-4 (10 µg/ml) + 4ml of L-3 (10 µg/ml) in 
lOOml volumetric flask and volume made up with O.OIM methanolic NaOH. 
L-4 (0.6 µg/ml) and L-3 (0.6 µg/ml) : 60 µL of L-4 stock + 60 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OIM methanolic NaOH. 
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L-4 (.8 µg/ml) and L-3 (.8 µg/ml): 80 µL of L-4 stock + 80 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OlM methanolic NaOH. 
L-4 (1 µg/ml) and L-3 (1 µg/ml): 100 µL of L-4 stock + 100 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OlM methanolic NaOH. 
L-4 (2 µg/ml) and L-3 (2 µg/ml): 200 µL of L-4 stock + 200 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OlM methanolic NaOH. 
L-4 ( 4 µg/ml) and L-3 ( 4 µg/ml): 400 µL of L-4 stock + 400 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OlM methanolic NaOH. 
L-4 (6 µg/ml) and L-3 (6 µg/ml): 600 µL of L-4 stock+ 600 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OlM methanolic NaOH. 
L-4 (8 µg/ml) and L-3 (8 µg/ml): 800 µL of L-4 stock + 800 µL of L-3 stock in 50ml 
volumetric flask and volume made up with O.OlM methanolic NaOH. 
L-4 (10 µg/ml) and L-3 (10 µg/ml): 1000 µL of L-4 stock + 1000 µL of L-3 stock in 
50ml volumetric flask and volume made up with O.OlM methanolic NaOH. 
RECOMMENDATIONS: 
Confirming to the standard procedure described above, together with the following 
recommendations allowed the assay of levothyroxine sodium in a consistent and 
reproducible manner. 
Prepare fresh standards everyday. 
Wait for the HPLC system to stabilize. 
The mobile phase should be properly degassed and the pump should be free of air 
bubbles. If there are erratic changes in the pump pressures, it might be due to entrapment 
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of air in the pump heads. The pumps should be primed to remove the entrapped air. If the 
problem still persists, inlet and outlet check valves of the pump should be checked. 
Always mount the magnetic stirrer in the mobile phase. 
Any problem with the assay may be due to pumps, column, standard, sample, technique 
and should be isolated by checking each in turn. 
A)VALIDATION OF ASSAY: 
Investigations into the validity of the method have been undertaken. Using suitable 
standards, all containing liothyronine, the slope, measuring range and linearity of the 
calibration curve were determined for levothyroxine sodium. Additional studies were also 
completed to determine the validity of the typical analytical parameters used in the assay 
such as precision, accuracy, linearity, selectivity etc. In a further series of investigations, 
the storage of levothroxine sodium in .01 M methanolic NaOH at room temperature over 
a period of 2 days was also investigated. This was performed to make sure that 
levothyroxine sodium does not degrade during the analysis, which takes 35 hours. 
PRECISION: The precision of an analytical method is the closeness of the test results 
when the procedure is applied repeatedly to multiple aliquots from a single homogenous 
sample. Thus, it is a measure of the degree of reproducibility of the analytical method 
under normal operating circumstances. Precision is determined by repeatedly assaying 
multiple samples removed from the homogenous sample. 
ACCURACY: The accuracy of an analytical method is the closeness of test results 
obtained by the method to the true value. It is a measure of the exactness of the analytical 
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method. Accuracy is determined by usmg the calibration curve to determine the 
concentration of a sample (with known concentration). The accuracy of our assay 
method, expressed as percent recovery was found to be greater than 95% throughout the 
linear range used. 
LINEARITY: The linearity of an analytical method is its ability to elicit test results that . 
are directly, or by a well defined mathematical transformation, proportional to the 
concentration of analyte in samples within a given range. Linearity expressed in terms of 
the variance around the slope of the regression line. 
ACCURACY SELECTIVITY I INTERFERENCES: Placebo analysis was performed 
to check for interference or junk peaks due to excipients. No interfering peaks were 
observed with all nine excipients. 
REPRODUCIBILITY: Reproducibility IS limited by factors such as temperature, 
fluctuations and noise. The reproducibility was found to be independent of concentration 
and temperature, as the temperature of the column was controlled by a thermostat. 
LIMIT OF DETECTION (LOD): Determination of the signal-to-noise ratio IS 
performed by comparing measured signals from samples with known low concentrations 
of analyte with those of blank samples and establishing the minimum concentration at 
which the analyte can be readily detected. A signal-to-noise ratio between 3 or 2: 1 is 
generally considered acceptable for estimating the detection limit. In our assay method 
LOD was found to be 0.4µg/ml, with a signal-to-noise ratio of 3: 1. 
LIMIT OF QUANTITATION (LOQ): Determination of the signal-to-noise ratio is 
performed by comparing measured signals from samples with known low concentrations 
of analyte with those of blank samples and establishing the minimum concentration at 
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which the analyte can be readily quantified. A typical signal-to-noise ratio is 10: 1. In our 
assay method LOQ came out to be 0.6µg/ml, with a signal-to-noise ratio of 10: 1. 
No significant differences were found in the concentrations of the samples stored for 2 
days at room temperature. Placebo analysis were performed for all excipients to be used 
to make sure that the excipient peaks do not interfere with the levothyroxine peaks. No 
additional peak were seen which confirmed that the excipients did not interfere with 
levothyroxine peaks. Tables 5 and 6 shows the mean values of the data generated out of 
five days of validation studies for ten separate and distinct samples for series of 
levothyroxine sodium and liothyronine sodium concentrations ranging from 0.2 to 10 
µg/ml. Figures 2 and 3 illustrate the complete as well as linear protion of the calibration 
curve for these samples. The correlation coefficient was found to be 0.9999 and 0.9997 
for levothyroxine sodium and liothyronine sodium respectively. 
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Table 5. Reproducibility of levothyroxine sodium from standard solutions over 5 
days of validation studies 
DAY 1 ,2,3,4&5 AVERAGE Std Dev %CV 
0.2 23155.8 1692.483 7.30911 
0.4 51158.36 2037.795 3.983307 
0.6 84070.32 3589.236 4.269326 
0.8 112283.96 5918.373 5.270898 
1 139962.48 4930.562 3.522774 
2 293628.6 6953.736 2.368208 
4 600607.8 12771.75 2.126471 
6 904545.04 27886.95 3.082981 
8 1215639.2 30161.43 2.481117 
10 1496429.92 43786.46 2.926062 
Standard curve for Levothyroxine Sodium 
1600000 --..--- --- - --------.. 
y = 151358x - 6665.3 
R2 = 0.9999 
~ 1000000 
_J 0 800000 
:::::> 
<( 600000 +---- -~-----------------< 
200000 .+-------#-----------------< 
o------~-------l 




Figure 2. Representative calibration curve from the validation study for 
levothyroxine sodium assay 
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Table 6. Reproducibility of liothyronine sodium from standard solutions over 5 days 
of validation studies 























22956.28 1132.168 4.931844 
52606.12 3601.949 6.847016 
64867.24 7805.121 12.03245 
102057.24 7582.398 7.429554 
137360.4 7228.503 5.262436 
302628.04 4502.396 1.487766 
622099.6 4146.621 0.666553 
937045.56 9922.515 1.058915 
1241169.04 17554.86 1.414381 
1573166.8 13105.93 0.833092 
Standard curve for Liothyronine Sodium 
y = 158219x - 15026 
R2 = 0.9997 
0 1 2 3 4 5 6 7 8 9 10 11 12 
Cone. (ug/ml) 
Figure 3. Representative calibration curve from the validation study for 
liothyronine sodium assay 
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B) NORMALIZATION OF LEVOTHYROXINE SODIUM 
Levothyroxine sodium obtained from Biochemie, Inc. was compared for purity with the 
standard levothyroxine sodium obtained from Sigma Chemical Company (Lot # 
088H 1318) which had a purity of 99 .1 % using our validated HPLC method. 
Three samples each containing 5 µg/ml of levothyroxine sodium obtained from Sigma 
Chemical Company and Biochemie, Inc. were prepared using the standard method. The 
samples were analyzed by HPLC and the results compared using a two sided t-test with 
95% confidence interval as shown in Table 7 and Table 8. It was seen that there was no · 
significant difference between the levothyroxine sodium obtained from Sigma Chemical 
Company and that obtained from Biochemie, Inc. 
Table 7. Normalization data for levothyroxine sodium obtained from Sigma 
chemical company (Standard) and Biochemie, Inc. (Sample) 
Standard#1 (5uq/ml) Standard#2 (5ua/ml) Standard#3 (5ua/ml) 
AUG Retention Time AUG RetentionTim__e AUG Retention Time 
708356 15.16 727869 14.96 744958 14.93 
725036 15.12 742935 14.96 747136 14.91 
734825 15.06 749291 14.94 739102 14.94 
737402 15.04 746485 14.94 745375 14.96 
MEAN MEAN MEAN 
AUG 726404.75 AUG 741645 AUG 744142.75 
RT 15.095 RT 14.95 RT 14.935 
Samole#1 (5uq/ml) Samole#2 (5ua/ml) Samole#3 (5ua/ml) 
AUG Retention Time AUG Retention Time AUG Retention Time 
736790 15.02 745838 14.94 716068 14.96 
750280 15.01 754013 14.94 741785 14.97 
742310 15 768462 14.94 748421 14.96 
759268 14.96 746411 14.92 754361 14.96 
MEAN MEAN MEAN 
AUG 747162 AUG 753681 AUG 740158.75 
RT 14.9975 RT 14.935 RT 14.9625 
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Table 8. t-Test: two-sample assuming equal variances for Sigma and Biochemie. 
Si.g_ma Bioch~mi!i_ 
Mean 737397.50 747000.58 
Variance 92190103.00 45732353.00 
Observations 3.00 3.00 
Pooled Variance 68961228.00 
Hypothesized Mean Difference 0.00 
df 4.00 
t Stat -1.42 
P(T<=t) one-tail 0.11 
t Critical one-tail 2.13 
P(T<=t) two-tail 0.23 
t Critical two-tail 2.78 
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II) STABILITY STUDIES FOR LEVOTHYROXINE SODIUM 
Evaluation of a stable solid dosage formulation often begins with drug-excipient 
compatibility studies. The present study was designed to investigate the stability of 
levothyroxine as a pure drug as well as in the presence of different excipients at different 
temperatures and humidities. From results of these investigations, excipients as well as 
optimal formulation and processing conditions were identified that would yield a more 
stable and reliable dosage form of levothyroxine. Of the many excipients available in the 
market, selection for this study was based on the physical and chemical properties. Nine 
excipients were selected for inclusion in the study. The studies were divided into four 
sections: 
1) Use of saturated salt solutions to achieve specified relative humidities. 
2) Stability testing of 900 µg of levothyroxine sodium (pure drug). 
3) Drug-Excipient compatibility studies. 
4) Stability studies for levothyroxine sodium tablets. 
Samples were placed under different conditions in dessicators to maintain different 
conditions such as 25°C ± 2°C, 25°C ± 2°C and 60% ± 5%RH, 40°C ± 2°C and 75% ± 
5%RH, 50°C with 20% w/w moisture and 50°C (without addition of moisture) and 
samples were removed at various intervals and analyzed. 
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METHODS AND MATERIALS: 
MATERIALS: 
Plastic dessicators ( Fisher Scientific), HPLC System(Waters, Inc.), Magnetic Stirrer 
(Thermix® Model 120 MR), Weighing balance (Metler, Model# AE 240), Temperature 
and Humidity Logger (Dickson, Model # TL120), Sodium Chloride (AR Grade, Fisher 
Scientific, Lot # S640-3), Sodium Bromide (AR Grade, Sigma Labs, Lot # S45-47), 
Dextrose (AR Grade, Fisher Scientific, Lot # S640-3), Sodium Hydroxide (Fisher 
Scientific, Lot # S318-500), Methanol (HPLC Grade, Fisher Scientific, Lot # A452-4), 
Acetonitrile (HPLC Grade, Fisher Scientific, Lot# A998-4), 0-Phosphoric Acid (Fisher 
Scientific, Lot # A260-500), Lactose Monohydrate (Quest International, Lot # 
MRP867682), Lactose Anhydrous (Quest International, Lot# M018151), Ferric Oxide 
(Fluka Chemicals, Lot# 44955), Mannitol (SPI Polyols, Inc. Lot# 3127G9), Starch 1500 
(National Starch and Chemical Company, Lot# CB7137), Calcium Sulfate (Mendell, Lot 
# 8072CX), Di Calcium Sulfate Dihydrate (Mendell, Lot # X26AX), Talc (Cyprus 
Industrial Minerals Co., ID# ACM-189-7-03) and Deionized water. 
PREPARATION OF SATURATED SALT SOLUTIONS FOR MAINTAINING 
SPECIFIED RELATIVE HUMIDITIES: 
Saturated salt solutions are used to maintain specified relative humidities in closed 
chambers. Different salts are used to prepare saturated salt solutions, which can be used 
to obtain a wide range of relative humidities within the different temperature intervals 
suitable for stability studies of pharmaceuticals [ 44]. 
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Saturated salt solutions ofNaBr and NaCl were prepared to provide the relative humidity 
levels of 60% ± 5%RH and 75% ± 5%RH in storage dessicators at 25°C ± 2°C and 40°C 
± 2°c respectively. 
Experimental Design: To obtain the humidity of 60% ± 5%RH at 25°C ± 2°C and 75% ± 
5%RH at 40°C ± 2°C, saturated salt solutions of NaBr and NaCl were prepared by 
dissolving the salts at 60°C. The slush of NaBr was kept at 25°C ± 2°C and that of NaCl 
was kept at 40°C ± 2°C in the dessicators. A dessicator with silica as a dessicant was also 
kept at 25°C ± 2°C and vacuum was applied to this dessicator. The dessicators were 
allowed to equilibrate for 48 hours. A temperature humidity logger was kept in each 
dessicator for two days to record the temperature and humidity. The data obtained from 
these studies is shown in Figures 4, 5 and 6. Measurements were repeated monthly to 
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Figure 4. Showing 25°C ± 2°C and 0% humidity in the dessicator 
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STABILITY TESTING OF 900 µg OF LEVOTHYROXINE SODIUM (PURE 
DRUG) 
Experimental Design: For these studies, 0.0009 gm (900 µg) of levothyroxine was 
carefully weighed and transferred to 4 ml HPLC vials. The vials were placed under 
different conditions in the dessicators. Three samples were withdrawn randomly from 
each dessicators at predetermined time intervals. HPLC analysis of these samples was 
performed to determine the percent of pure levothyroxine sodium left un-degraded. The 
studies were conducted for a period of 10 weeks. 
Recovery Procedure: To a 4 ml HPLC vial containing 0.0009gm of a drug, 4ml of .01 M 
methanolic NaOH was added. The vials were shaken and kept in sonifier bath for 5 
minutes, such that the drug dissolves in 4 ml of 0.01 M methanolic NaOH, to give an 
approximate concentration of 225 µg/ml. One ml of this solution was withdrawn and 
diluted in a 25 ml volumetric flask with 0.01 M methanolic NaOH, to get a concentration 
of 9 µg/ml. The samples were then analyzed by the HPLC method discussed earlier. 
Note: The concentration of 9 µg /ml was selected to ensure that the sample concentration 
falls within the validated range of our HPLC method. Also, if the drug degrades over a 
period of time it would still be within the detection limits of the HPLC method. 
RESULTS AND DISCUSSION: 
The data presented in Table 9 shows the amount of drug remaining over a period of 1 O 
weeks. Figure 7 shows a graphical presentation of the data. As can be seen from the plot, 
the drug appeared to be relatively stable at the different conditions evaluated except at 
50°C. This is further corroborated by the fact that none of the kinetic models designed to 
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measure degradation fitted to the stability profiles of pure drug at the different conditions 
tested. It is believed that any trend in the degradation behavior of pure drug would have 
been accentuated and revealed by these models evaluated. Absence of any such trend 
within the limits of experimental variability coupled with the high values of percent drug 
left support this conclusion. Temperature induced degradation appeared to be significant 
at 50°c, as compared to the lower temperatures (see 25°C, 40°C and 50°C curves in 
Figure 7). These findings are supported by Won's study indicating a threshold 
temperature between 50°C and 60°C where levothyroxine sodium degrades rapidly [ 42]. 
Won, studied the kinetics of degradation of levothyroxine sodium in aqueous solution 
and in the solid state. The author concluded that levothyroxine sodium followed simple 
first-order degradation by the process of deiodination in aqueous solution. In contrast to 
solution degradation, levothyroxine sodium did not deiodinate in the solid state. Instead, 
the isolated degradation products 
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Table 9. Percentage of drug remaining after each time period under different 
conditions. 





















25°C/60%RH 40°C!75%RH so°C/20%moisture so0c (dry) 
100.00 100.00 100.00 100.00 
97.37 98.00 121.02 104.00 
95.02 102.57 105.10 106.54 
102.63 90.01 92.96 
114.32 114.04 102.80 84.26 
·--------·------··· ------~ 
4 6 8 
time in weeks 
10 12 
--+-- 25 degrees 
--25 degrees/ 60% RH 
- -40 degrees/ 75% RH 
~ 50 degrees I 20 % moisture 
-lf- 50 degrees 
Figure 7. Percent levothyroxine remaining after storage for a period of 10 weeks. 
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indicated a deamination reaction. Furthermore, the solid-state degradation profiles 
showed biphasic first order degradation profiles, indicating the possibility of additional 
and complex degradation pathways [42]. 
As stated earlier, the drug exhibited stability at the different conditions monitored in this 
study. Studies at rather adverse conditions might have provided more insight into the 
degradation pathways. However, these are outside the scope of this study considering the 
FDA stipulated guidelines. 
While the possibility of multiple complex degradation pathways may be indicated, what 
becomes important in context of predicting a model are those mechanisms that contribute 
significantly to that degradation. First order and biphasic first order models were 
evaluated to find the best fit for degradation kinetics of levothyroxine sodium under 
various conditions. 
Statistical analysis of the data was performed using a non-linear curve fitting procedure 
from Sigma Plot for Windows (SPSS Inc., 1997). The raw data generated following the 
experimental procedures described earlier was evaluated using nonlinear regression. The 
goodness of fit of the experimental data for first-order and biphasic first-order model was 
evaluated using residual plots, adjusted r2 values, normality testing etc. The equations 
used for first order and biphasic first order are shown below: 
First-Order Equation C =Co* e-kt 
Biphasic First-Order Equation 
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Attempts to fit a model to understand the nature of degradation in this regime were 
unrewarding considering the stable behavior of pure drug. Inherent variability in the data 
arising as a result of the complex sample preparation (refer to page 40) and storage 
conditions involved further complicated the prediction of model. While no particular 
trend in the degradation profile of pure drug is seen at various conditions tested, it can be 
stated that the drug's stability seems unaffected at these conditions for short period of 
testing. An understanding of the stability behavior of pure levothyroxine sodium at the 
FDA stipulated conditions will form a basis for later studies which are expected to 
involve more complex multiple interactions. 
III) DRUG-EXCIPIENT COMPATIBILITY TESTING 
Drug-Excipient compatibility studies were conducted to determine the formulation 
ingredients and conditions that might provide a stable formulation of levothyroxine 
sodium. 
Experimental Design: For these studies, nine commonly used excipients were selected. 
These excipients were dextrose, dicalcium phosphate dihydrate, calcium sulfate, 
mannitol, lactose anhydrous, lactose monohydrate, starch 1500, talc and ferric-oxide. The 
maximum strength of levothyroxine sodium tablets available in the market is 300 µg. 
According to FDA c-GMP guidelines, the sampling from the mixture should not be more 
than 3 times the maximum dose concentration available. Thus, it was decided to work at 
three times 900 µg. The levothyroxine sodium-excipient ratio was kept at 1: 10. 
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Levothyroxine sodium and the excipients were mixed usmg a Crescent Wtg-L-Bug 
mixer. 0.0099gm of the mixture was carefully weighed out in separate 4 ml HPLC vials 
and recovery analysis was performed using the method described earlier. The vials were 
pla.ced in the dessicators under the different conditions previously described. At defined 
time intervals, three samples for each drug-excipient mixture were analyzed. The studies 
were conducted for a period of 20 weeks. 
RESULTS AND DISCUSSION: 
The data presented in Tables 10 to 18 shows the amount of drug degraded in presence of 
different excipients over a period of 20 weeks. Figures 8 to 16 provide a graphical 
presentation of the data along with standard errors. 
From the data obtained, it can be seen that levothyroxine sodium seems to be most stable 
in the presence of mannitol, starch 1500 and talc at 25°C, 25°C 160% RH and 40°C 175% 
RH. Drug degradation seems to be significant in the presence of some of the excipients 
containing carbohydrate. However, among this similar chemical class of excipients, wide 
differences in the degradation patterns were seen between dextrose and mannitol. While 
as little as 14% drug degradation was seen after 20 weeks in the presence of mannltol 
(40°C/75%RH condition), drug degradation was as large as 94% under similar 
experimental conditions in presence of the dextrose. In the order of increasing 
compatibility and stability of drug at 25°C, the various excipients evaluated can be ranked 
as: mannitol, starch 1500, ferric-oxide, talc, lactose hydrous, dicalcium phosphate 
dihydrate, dextrose, lactose anhydrous and calcium sulfate. 
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Table 10. Levothyroxine remammg in the presence of dextrose after each time 
period under different conditions. 
Timeiweeksl 25°C 25°C/60%RH 40°C/75%RH 50°Ct20%moisture 50°C_i<!n1_ 
Day 0 100.00 100.00 100.00 100.00 100.00 
1 91.80 86.43 10.07 9.96 92.06 
2 94.24 85.96 8.03 10.08 89.45 
4 86.31 62.76 6.51 6.74 67.54 
7 87.38 45.63 7.70 7.07 58.04 
10 80.90 68.55 6.13 8.88 55.48 
20 82.42 62.40 6.16 7.39 41 .64 
Dextrose 
120.00 -······----·--·-········-·-----·------ -----------~ 




-+-- 25 degrees 
·c: 
·o; 
--25 degrees/60%RH E 
" 60.00 - -40 degrees/75%RH a: 
Cl -~ 50 degrees/20%moisture 2 
0 
--50 degrees ;f. 
40.00 
20.00 +----'f--- ----------------------1 
Lk3- -~-i,_-;---_._---- -_ __ ···~_._··--::_-·-·-~·-_-·---__. -~---t.:'4 
0.00 +-- -----.-----,------.,..-------.------1 
0.00 5.00 10.00 15.00 20.00 25.00 
Time in weeks 
Figure 8. Levothyroxine remaining in the presence of dextrose over a period of 20 
weeks. 
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T ble 11. Levothyroxine remaining in the presence of dicalcium phosphate dihydrate 
a after each time period under different conditions. 
Time(week~ 25°C 25°C/60%RH 40°C/75%RH 50°C/20%moisture 50°C J_dry}_ 
DayO 100.00 100.00 100.00 100.00 100.00 
1 95.65 70.89 76.94 92.90 66.97 
2 78.56 84.03 71.82 93.12 77.15 
3 121 .70 74.15 98.00 103.12 57.96 
4 78.53 78.06 87.40 91.35 78.81 
7 65.81 78.11 67.55 70.38 59.33 
10 93.03 72.84 68.22 67.38 44.61 
20 87.00 125.68 62.91 56.59 43.44 
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Figure 9. Levothyroxine remammg in the presence of dicalcium phosphate 
dihydrate over a period of 20 weeks. 
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Table 12. Levothyroxine remaining in the presence of calcium sulfate after each 
time period under different conditions. 
Time_iweeksl 25°C 25°C/60%RH 40°Ct75%RH so°C/20%moisture 50°CJ_dJYl 
Day 0 100.00 100.00 100.00 100.00 100.00 
1 91.92 88.39 86.92 74.72 84.16 
2 90.09 86.84 84.26 82.37 83.91 
3 91.00 89.35 87.23 76.19 81.98 
4 83.74 87.87 85.57 78.41 72.51 
7 83.69 88.73 78.27 89.02 60.83 
10 82.41 90.89 85.30 68.50 60.80 
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Figure 10. Levothyroxine remaining in the presence of calcium sulfate over a period 
of 20 weeks. 
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Table 13. Levothyroxine remammg in the presence of mannitol after each time 
period under different conditions. 
Timelweeksl_ 25°C 25°C/60%RH 40°C/75%RH so°C/20%moisture 50°C ld_!Yl 
Day 0 100.00 100.00 100.00 100.00 100.00 
1 99.62 96.91 96.84 100.78 95.69 
2 101.32 100.96 97.75 95.21 96.09 
3 99.32 97.14 92.61 90.57 91.04 
4 96.46 91.51 94.59 91 .03 89.51 
7 94.71 92.11 92.13 87.26 59.09 
10 89.22 94.78 98.23 92.47 75.06 
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Figure 11. Levothyroxine remaining in the presence of mannitol over a period of 
20 weeks. 
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Table 14. Levothyroxine remaining in the presence of lactose anhydrous after each 
time period under different conditions. 
TimeLweeksl 25°C 25°C/60%RH 40°C/75%RH 50°C/20%moisture 50°C_id_ryl 
Day 0 100.00 100.00 100.00 100.00 100.00 
1 91.87 89.59 78.30 75.98 88.87 
2 91 .61 91 .36 76.57 61 .55 66.12 
3 88.27 82.51 76.78 58.09 64.97 
4 84.40 81.11 70.83 54.74 81.79 
7 74.94 69.22 63.14 58.91 43.14 
10 73.66 69.21 63.51 53.14 45.48 
20 66.07 61 .79 56.62 50.94 43.87 
Lactose Anhydrous 
--+-- 25 degrees 
--- 25 degrees/60%RH 
- -40 degrees/75%RH 
-X-· 50 degrees/20%moisture 
--- 50 degrees 
0 +-~~~~~~~~~~~~~~~~~~~~~-----1 
0.00 5.00 10.00 15.00 20.00 25.00 
Time in Weeks 
Figure 12. Levothyroxine remaining in the presence of lactose anhydrous over a 
period of 20 weeks. 
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Table 15. Levothyroxine remaining in the presence of lactose hydrous after each 
time period under different conditions. 
Timelweeks_l 25°C 25°C/60%RH 40°C/75%RH 50°C/20%moisture 50°C (d_ry}_ 
I"'"" 100.00 100.00 100.00 100.00 100.00 Day 0 
1 96.86 93.86 83.35 75.17 96.77 
2 98.54 97.16 79.34 61 .08 85.06 
3 101.98 86.79 77.71 59.80 75.39 
4 84.23 83.68 80.61 65.94 67.96 
7 86.59 85.21 69.87 53.29 65.11 
10 83.88 69.05 71.35 60.15 56.60 
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Figure 13. Levothyroxine remaining in the presence of lactose hydrous over a period 
of20 weeks. 
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Table 16. Levothyroxine remaining in the presence of starch 1500 after each time 


























40°C/75%RH so°C/20%moisture 50°CJ_<!n1_ 
100.00 100.00 100.00 
100.85 97.26 94.65 
103.37 90.47 89.57 
99.91 86.07 87.21 
101.55 80.36 76.05 
98.80 64.39 63.08 
102.38 68.50 59.58 
100.66 72.1 9 53.85 
99.50 73.78 41 .01 
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Figure 14. Levothyroxine remaining in the presence of starch 1500 over a period of 
20 weeks. 
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Table 17. Levothyroxine remammg in the presence of talc after each time period 
under different conditions. 
Time(weeks_l 25°C 25°C/60%RH 40°C/75%RH so°C/20%moisture so0c J_d_.!Y}_ 
Day 0 100.00 100.00 100.00 100.00 100.00 
1 103.49 102.67 99.12 87.19 100.14 
2 103.05 99.86 100.06 79.11 87.20 
3 97.36 98.22 97.43 66.64 79.61 
4 95.07 101.49 104.43 73.49 77.79 
6 96.59 101.99 100.10 64.01 68.88 
8 88.43 98.32 108.48 68.72 64.40 
10 89.71 94.77 98.60 58.90 60.01 
20 80.15 94.11 99.70 59.92 39.45 
Talc 
120.00 .,------- ----------- --------.., 
80.00 
"' c: --+-- 25 degrees 
·c: 
·n; 
_._ 25 degrees/60%RH E 
E 60.00 ~~- - -40 degrees/75%RH 
"' 2 x • 50 degrees/20%moisture ,, 
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40.00 
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Time in weeks 
Figure 15. Levothyroxine remaining in the presence of talc over a period of 20 
weeks. 
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Table 18. Levothyroxine remaining in the presence of ferric-oxide after each time 
Period under different conditions. 
Time(week!il_ 25°C 25°C/60%RH 40°C/75%RH 50°C/20%moisture 
Day 0 100.00 100.00 100.00 100.00 
1 90.09 93.16 94.61 85.05 
2 97.45 96.88 97.73 91.40 
3 93.80 91.54 99.21 97.04 
4 93.10 89.95 97.38 88.44 
6 91.25 94.38 93.34 84.27 
8 85.47 88.63 88.69 84.95 
10 84.21 89.28 88.46 85.17 
20 86.16 91.71 94.17 85.21 
Ferric Oxide 
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Figure 16. Levothyroxine remaining in the presence of ferric-oxide over a period of 
20 weeks. 
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Considering that a Schiff-base reaction and an oxidation reaction may be the predominant 
pathways [43, 46], first-order and biphasic first-order models were evaluated to find the 
best fit for degradation kinetics of levothyroxine sodium in the presence of different 
excipients under various conditions. Significant degradation involving any single 
pathway is best explained by simple first order kinetics as seen with dextrose, where 
Schiff-Base reaction is seemingly predominant. On the other hand, degradation following 
two different mechanisms (Schiff-base reaction plus oxidation) that are regulated by 
different rate kinetics seems to be best explained by bi-phasic first order models. The 
majority of the drug-excipient mixtures that were evaluated exhibited dual mechanism as 
reflected in the number of successfully fitted biphasic first order models. A non-linear 
regression analysis similar to the one used for the pure drug data was performed on the 
experimental data obtained from drug-excipient compatibility studies. The complete 
output of this statistical analysis along with the model parameters and constraints are 
shown in detail in Appendix A. Residual plots are generated from this statistical output 
using suitable graphing procedure (Microsoft® Excel 97) and are shown in Appendix B. 
After selecting the model that fits the data following the above analysis, expiration dates 
(t90) for levothyroxine sodium in the presence of different excipients were calculated. For 
all conditions, the k-values for first order reactions and ai, a2, k1 and k2 for biphasic first 
order reactions were calculated from the models and used to calculate t90 values. The 
summary of the various results obtained is presented in Table 19. 
It was noticed that levothyroxine degraded to a higher extent at 50°C in presence of all 
the excipients. These findings further support the fact that 50°C- 60°C is the threshold 
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Table 19. T90 values for different drug-excipient mixtures at different conditions. 
t-90 in V\eel<s 
ExciJierts 25C 25000%ffl 40075%RH 50 c / 20% rmistl.re soc 
~ 2.77 0.76 0.001 5.296-00 1.23 
llCalc:illTI Phosphate llhyd"ate 2.00 <1 0.54 3.18 2.38 
Calc:illTI ~ 1.89 16.4 0.56 0.023 0.94 
M:rritol 24.22 153.6 19.44 6.26 2.29 
Lactose Anhyd"ous 2.13 1.55 0.29 0.29 0.68 
Lactose Hyct"ot.IS 7.29 5.1 2.38 0.22 0.45 
5ta"ch 18.1 28.37 >20 1.61 1.67 
Talc 9.24 26.92 >20 0.68 1.67 
Ferric Oxide 14 153.6 ~7.2 2.74 1.26 
temperature for the degradation of levothyroxine sodium. Among all of the different 
types of excipients used, degradation of levothyroxine sodium occurs most quickly in the 
presence of carbohydrates such as dextrose, lactose hydrous, lactose anhydrous and 
starch. At higher temperatures, it is theorized that the ring structure of the carbohydrates 
breaks to open up a free aldehyde group. This leads to a Schiff-base reaction between a 
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free aldehyde group of the carbohydrates and the highly reactive ammo group of 
levothyroxine sodium. The general Schiff-base reaction is shown in Figure 17. 
I 
































!mine (Schiff - base) 
Figure 17. Reaction mechanism for Schiff-base reaction 
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The availability of the free aldehyde group varies among the carbohydrates. For example, 
dextrose which is composed of only one ring structure, can easily break open to give a 
free aldehyde group, and so by this mechanisn the drug would degrade very quickly in 
presence of dextrose. Lactose, which is composed of a two-ring structure, would be more 
stable with the drug as compared to dextrose but less stable as compared to starch. 
Levothyroxine sodium was found to be much more stable in presence of mannitol. This 
could be attributed to the absence of the ring structure and the free aldehyde group in 
mannitol. 
The literature also indicates that levothyroxine has a tendency to undergo oxidation 
reaction [43]. Accordingly, in the presence of various components capable of oxidizing 
the pure drug, the degradation can be expected to be rather severe. It was seen that the 
mixture of levothyroxine with carbohydrates had turned brown, and this may be 
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Figure 18. Reaction mechanism for Oxidation 
58 
The overall results showed that the drug was most stable at 25°C and 25°C I 60% RH. 
One of the most interesting findings observed was in the case of talc and starch, where 
levothyroxine sodium was much more stable at 25°C I 60% RH and 40°C I 75% RH in 
. presence of these excipients (Figure 14 and 15) than at the same temperatures with added 
humidity. This behavior may be due to a higher moisture uptake ability of starch and talc 
as compared to other excipients [ 4 7]. A higher affinity of these excipients towards 
moisture might have sequestered the free moisture, thereby reducing the availability of 
water for reaction with pure drug. 
Overall for this group of excipie.nts the lowest t-90 values of levothyroxine sodium were 
observed in the presence of dextrose, dicalcium phosphate dihydrate and calcium sulfate 
at 25°C, 25°C I 60% RH and 40°C I 75% RH (Table 19) with stability well below usable 
levels. 
Interestingly, the stability of the mixtures of levothyroxine sodium and lactose anhydrous 
were much lower as compared to that of levothyroxine sodium and lactose monohydrate 
as seen in Table 19 (Figures 23 and 24). HPLC analysis demonstrated that at higher 
humidity/temperature, the mixture containing lactose anhydrous exhibited relatively 
greater degradation of the drug than that containing lactose monohydrate. This type of 
degradation was reported by Jain et al. [29], who studied the stability of a proprietary 
hydrophobic drug in the presence of hydrous and anhydrous lactose. The authors 
concluded that, lactose anhydrous becomes hydrated on exposure to high 
humidity/temperature condition and that the transition state of the lactose, not its stable 
state may be responsible for its greater interaction and subsequent degradation of the 
drug. They also concluded that in certain cases, lactose anhydrous may absorb a 
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significant amount of moisture, which can affect its inherent properties and may directly 
come in contact with the drug. For a moisture sensitive drug like levothyroxine sodium, 
this behavior may drastically affect its stability. Therefore, the general belief that lactose 
anhydrous, which has less than 0.5% moisture, should provide greater stability as 
compared to lactose hydrous needs to be properly evaluated. 
The comparative effects of the different storage conditions on the stability of each of the 
drug-excipient mixtures are presented in Figures 19 to 27. 
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Figure 20. Effect of storage conditions on drug+DCPD mixture 
25C 25C/60%RH ooc 
Conditions 
Figure 21. Effect of storage conditions on drug+calcium sulfate mixture 
61 






Figure 22. Effect of storage conditions on drug+mannitol mixture 
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Figure 24. Effect of storage conditions on drug+lac.hydrous mixture 
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Conditions 
Figure 25. Effect of storage conditions on drug+starch 1500 mixture 
25C 25Cl80%RH 50C/20%moisture 50C 
Conditions 
Figure 26. Effect of storage conditions on drug+talc mixture 
Conditions 
Figure 27. Effect of storage conditions on drug+ferric-oxide mixture 
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JV) LEVOTHYROXINE SODIUM TABLETS AND PHYSICAL TESTS 
A) FORMULATION OF LEVOTHYROXINE SODIUM TABLETS 
After the completion of drug-excipient compatibility studies, evaluation of the stability of 
tablet formulations proceeds in two consecutive steps; the first is the formulation of 
tablets that meet USP criterions and second is to monitor stability under various 
conditions. The present study is designed to formulate and evaluate the properties of 
levothyroxine tablets. 
METHODS AND MATERIALS: 
Materials: 
Sodium Hydroxide (Fisher Scientific, Lot # S318-500), Methanol (HPLC Grade, Fisher 
Scientific, Lot # A452-4), Acetonitrile (HPLC Grade, Fisher Scientific, Lot # A998-4), 
0-Phosphoric Acid (Fisher Scientific, Lot # A260-500), Mannitol (SPI Polyols, Inc. Lot 
# 312709), Starch 1500 (National Starch and Chemical Company, Lot# CB7137), Talc 
(Cyprus Industrial Minerals Co., ID# ACM-189-7-03), Deionized water, pH/mv meter 
(model 420A, Orion Research, Inc.), Stokes Single Punch Tablet Press, Turbula mixer, 
Tablet Hardness Tester, USP Dissolution Apparatus, USP Disintegration Apparatus, 
HPLC System(Waters, Inc.), Magnetic Stirrer (Thermix® Model 120 MR), Weighing 
balance (Metler, Model # AE 240) and Sieve # 40. 
EXPERIMENTAL PROCEDURE: 
Based on the results obtained from drug-excipient compatibility studies, the more stable 
excipients, mannitol(diluent), starch 1500(disintegrant and binder) and talc(lubricant) 
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were selected for use in formulating the tablets. Due to the low concentration of the 
levothyroxine sodium in the tablets drug-to-excipient ratios of the excipients slightly 
different from those studied in the compatibility studies were used to obtain tablets of 
consistent weight and hardness. The total weight of the tablets was fixed at 115mg. Table 
20 indicates the selected formulation. 
Table 20. Composition of levothyroxine sodium tablet formulation 
Ingredients Composition Composition Batch of 30,000 tablets 
1°/tl _i m_g_/table!}_ jg_msl 
Levothyroxine Sodium 0.299 0.345 0.9 
Mannitol 93.718 108.1 282 
Starch 1500 4.985 5.75 15 
Talc 0.997 1.15 3 
Tabletting Procedure 
Ingredients for the batch of 30,000 tablets, each weighing 115mg and containing 345 µg 
of levothyroxine sodium were weighed as shown in Table 20. 
All the excipients as well as the drug were passed through a #40 sieve to get uniform 
particle size distribution. 282 gm of mannitol, 15 gm of starch 1500 and 3 gm of talc 
were weighed into a jar and mixed for 5 minutes using Turbula® mixer. Levothyroxine 
sodium was added to the remaining ingredients using geometric dilution while mixing. 
The overall optimum mixing time was estimated to be 20 minutes. This was determined 
by addition of a red dye to the excipient mixture and observation of the homogeneity of 
the dye dispersed in the mixture at various time intervals. Further to confirm the 
homogeneity of the mixture, a 1 OOmg sample of the powder was taken from 6 different 
points in the container and compared with standard L-4 (6mcg/ml). Results of 
homogeneity testing are shown in Table 21. The amount of drug recovered expressed as 
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mean (% CV) of six random samples was found to be 98.6% (7.00). Accordingly, the 
homogeneity of the drug mixture passes the USP specified limits (85% - 115% ). 
Table 21. Homogeneity check for lOOmg of powder mixture as compared to 
standard (6 ug/ml) after 20 minutes of mixing. 
Sample 1 103.78 
Sample 2 96.32 
Sample 3 109.03 
Sample 4 98.36 
Sample 5 94.51 
ml 6 . 1 
Mean 98.6 
Std. Dev 6.9 
0 v 7 
An ANOV A was applied to the data and the p-value of .07 obtained indicated no 
significant difference between these samples. The mixture was considered acceptable and 
tablets were compressed using a Stokes® single punch tabletting machine. The following 
tests were performed to check the general properties of the tablets: 
1) Weight Variation: Twenty tablets were selected at random and weighed. The 
weight of these tablets are s_hown in Table 22. 
USP limits: For tablet weights below 130mg, percentage difference accepted is 
±10% which allows weight limits for these tablets of 105mg to 125mg. 
Average weight of 20 tablets= 116.05mg 
Allowable deviation is 10% 
Number of tablets in sample exceeding limits was 0 tablets 
Result: Therefore the batch passes the weight variation test 
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Table 22. Weight of 20 tablets for weight variation test 
Tablet Weight Tablet Weight 
_{g_ml _{g_ml 
Tablet 1 0.123 Tablet 11 0.122 
Tablet 2 0.114 Tablet 12 0.113 
Tablet 3 0.114 Tablet 13 0.107 
Tablet 4 0.119 Tablet 14 0.110 
Tablet 5 0.117 Tablet 15 0.113 
Tablet 6 0.115 Tablet 16 0.122 
Tablet 7 0.111 Tablet 17 0.123 
Tablet 8 0.120 Tablet 18 0.120 
Tablet 9 0.107 Tablet 19 0.118 
Tablet 10 0.121 Tablet 20 0.112 
2) Content Uniformity: 30 Tablets were selected at random, out of which 10 tablets 
were randomly chosen for the content uniformity test. The data for content 
uniformity test is presented in Table 23. 
USP Limits: The concentration of the drug should lie in the range of 85% to 
115% and the %CV should be less than or equal to 6.0%. 
Results: The tablets passed the USP content uniformity test. 
3) Tablet Hardness: Hardness ·of 10 tablets was determined using the Erweka® tablet 
hardness tester and the data is shown in Table 24. The average hardness of the 
tablets was 7.125kg. 
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Table 23. Data for content uniformity test for llSmg tablets 
Tablet 1 96.03 
Tablet 2 109.3 
Tablet 3 105.82 
Tablet 4 107.07 
Tablet 5 101.21 
Tablet 6 99.89 
Tablet 7 97.87 
Tablet 8 93.28 
Tablet 9 103.04 
Tablet 10 9 .95 
Mean % Recovery 100.45 
Std. Dev 6.02 
0 v .87 
Table 24. Data for hardness test for levothyroxine tablets 
Hardness in ~ 
Tablet 1 7.00 
Tablet .2 6.50 
Tablet 3 7.50 
Tablet 4 7.00 
Tablet 5 7.50 
Tablet 6 - 7.25 
Tablet 7 6.75 
Tablet 8 7.50 
Tablet 9 7.50 
Tablet 10 6.75 
Mean 7.13 
Std. Dev 0.38 
%CV 5.30 
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4) Friability Test: 
Weight of 10 tablets = 1.161 gms 
Weight of 10 tablets after 150 revolutions (5minutes) = 1.153gms 
Percentage weight loss of 10 tablets = 0.69%. 
USP Limits: A maximum weight loss of not more than 1 % of the weight of tablets 
being tested is considered acceptable for most products. 
Results: The tablets passed USP friability test. 
5) Disintegration Test: The USP (Vanderkamp) disintegration tester was used for 
these studies. 1000 ml of distilled water was placed in a glass beaker and was kept 
in the water bath maintained at the temperature 3 7 ± 2°C. Six tablets were 
selected and the disintegration time noted. All tablets disintegrated within 5 
minutes. 
USP Limits: All six tablets should disintegrate within 30 minutes. 
Results: The tablets passed the USP disintegration test. 
6) Dissolution Test: USP apparatus 2 was used. The apparatus was set to 100 rpm. 
The temperature of water bath was set to 37 ±_i°C. 
Dissolution media: .05M phosphate buffer with pH 7.4; 500ml. 
Dissolution Studies: 500 ml of pH 7.4, .05M phosphate buffer was filled in the 
dissolution flasks and the system was allowed to equilibrate for 30 minutes. Six 
tablets weighing 105mg were selected and placed in each of the six dissolution 
flasks. Sampling was performed at predetermined time points, namely 10, 20, 30, 
45, 60, 80 and 100 minutes. At each time interval, 5 ml of the sample was 
withdrawn from the dissolution flask and 1 drop of phosphoric acid was added to 
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the sample. The media was not replaced because the volume of dissolution media 
after sampling was still adequate to maintain sink conditions (solubility of L-4 in 
phosphate buffer pH 7.4 is .022 - .044 gm/lOOml) [43]. A correction factor was 
used to correct for the volume of the media not replaced, and hence to calculate 
the percent of drug dissolved. The samples were directly analyzed by HPLC. 
Table 25 shows the data obtained. Figure 28 shows the dissolution profile of 
levothyroxine sodium from its tablets over the 100 minutes of run time. 
Results: USP limits state that not less than 55% (Q) of the labeled amount of 
Levothyroxine sodium is dissolved in 80 minutes. Hence the tablets passed the 
dissolution test. 
Table 25. Dissolution of levothyroxine sodium tablets 
Time (minutes) Mean % Dissolved Standard Deviation 
n=6 
0 0 0 
10 79.32 11.05 
20 82.22 4.99 
30 74.83 2.79 
45 79.82 8.83 
60 76.87 4.1 
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Figure 28. Dissolution profile of levothyroxine sodium in tablet formulation 
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B) EVALUATION OF THE STABILITY OF LEVOTHYROXINE SODIUM 
TABLETS 
Evaluation of the stability of formulation is an integral part of the development process. 
A complete understanding of the stability of the formulation can only be obtained after 
the underlying component interactions are studied. This also helps the formulator in 
selecting the tabletting excipients that should offer optimum stability. The importance of 
such studies is exemplified by cases like the marketed levothyroxine sodium formulations 
where the potency could not be assured through the expiration date. The many problems 
and issues associated with levothyroxine sodium formulations have been discussed in the 
earlier section (Chapter 1 ). 
In view of the above facts, studies were performed to evaluate the stability of pure drug 
and excipient compatibility. Based on these results an optimum formulation components 
were selected. Further tablet testing was performed on the selected formulation and the 
tablets produced were found to conform to the USP standards. This portion of work deals 
with the stability testing of these tablets. 
Experimental Design: 
The previously formulated and manufactured levothyroxine sodium tablets were stored in 
stability chambers under same conditions as excipients. The stability of the tablets was 
evaluated over a period of 10 weeks. Tablets were sampled at predetermined time points 
and drug content was determined after extraction using the previously discussed HPLC 
method. At the end of 1 O weeks, dissolution studies were also conducted on these tablets, 
that had been stored at 25°C I 60%RH and at 40°C I 75%RH to determine if dissolution 
was affected by moisture. 
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RESULTS AND DISCUSSION: From the results obtained from the drug-excipient 
compatibility studies, it was decided to use mannitol (diluent), starch 1500 (binder and 
disintegrant) and talc (lubricant) as the excipients in the formulation of the levothyroxine 
sodium tablets. Immediately after manufacture, the tablets were characterized by good 
mechanical strength and a shorter disintegration time than the limits specified in the USP. 
Further dissolution studies indicated that 80% of levothyroxine sodium was released 
within 30 minutes. The data for stability studies after 10 weeks is shown in table 26 and 
Figure 29. 
From the data (Table 26) it can be seen that the drug degraded to less than 90% in less 
than a week, at all conditions studied. The stability of tablets was found to be much worse 
than the stability of levothyroxine sodium determined in presence of individual excipients 
(refer to Figure 29 versus Figures 11, 14 and 15). It appears that the rate of degradation of 
levothyroxine sodium contained in the tablets was the synergistic effect of the individual 
excipients used. This is reflected in the shape of the degradation curves for the tablets 
when compared to those of individual excipients. A general trend showing an initial 
faster degradation rate followed by a relatively sfower phase is apparent for all the 
conditions studied. 
The results of the dissolution studies of the tablets stored for 10 weeks are presented in 
Table 27 and 28 and Figures 30 and 31. The amount of drug released was corrected 
basing on the percentage of drug left undegraded under respective conditions. Dissolution 
profiles were found to be identical when compared to the freshly manufactured tablets. 
Basing on these findings it could be stated that the physical stability of the formulation 
did not change at the end of 1 O weeks. Dissolution testing of tablets is considered as a 
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quality-indicating tool in ensuring batch to batch uniformity [2]. For our purposes, it is 
therefore believed that any minor changes in the physical stability of the formulation 
would have been accentuated and reflected in the dissolution behavior of tablets. 
Table 26. Evaluation of the stability of levothyroxine sodium tablets. 
Time_{_weeks_l 25°C 25°C/60%RH 40°C/75%RH so0c _id_!Y}_ 
Day 0 100.00 100.00 100.00 100.00 
1 83.25 83.46 91.45 73.73 
2 74.83 82.42 82.64 75.25 
7 81.68 94.57 72.52 54.66 
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Figure 29. Stability profile of levothyroxine sodium tablets 
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Table 27. Dissolution studies of levothyroxine sodium tablets after 10 weeks at 25°C 
/60%RH. 









Table 28. Dissolution studies of levothyroxine sodium tablets after 10 weeks at 40°C 
/75%RH. 
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Figure 30. Dissolution profile of levothyroxine sodium tablets stored at 25°C I 
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Figure 31. Dissolution profile for levothyroxine sodium tablets stored at 40°C I 
75%RH after 10 weeks 
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To better define the rate of degradation of the tablets as compared to the excipients, first-
order and biphasic first-order models were evaluated using Sigma Plot. Details of the 
modeling procedure have been discussed earlier (refer to page 43). Results of the 
statistical analysis and goodness of fit calculations are compiled in appendices A and B. 
T 90 values at the different storage conditions studied were derived from the kinetic 
parameters obtained from best fit models. In few cases of excipient/conditions (DCPD 
and levothyroxine sodium tablets at 25°C/60%RH and starch and talc at 40°C/75%RH) 
limited success was seen in fitting a kinetic model for degradation. A combination of 
factors such as the complexity in degradation, variability in the data etc., restricted 
selection of the best kinetic model. 
For comparative purposes, the effect of series of storage conditions on t9o values of 
levothyroxine in tablets are shown together with those of single excipient mixtures in 
Figures 32 to 35. As can be seen from Figures 32 to 35, the t9o values of levothyroxine 
sodium tablets are significantly lower when compared to those determined in the 
presence of individual excipients. As discussed earlier the excipients that offered the best 
t9o values and those exhibiting the highest compatibility on an individual basis were 
selected for the final formulation. However, it can be seen that in combination, the 
incompatibility caused by these excipients was more seemingly complex. For example, 
the t9o values of levothyroxine sodium at 25°C in tablets dropped · by 98.55% when 
compared to that in presence of pure mannitol. As a result of the rapid degradation seen 
m presence of the tablet formulation at all storage conditions studied no particular trend 
was observed. The rapid rate of degradation is believed to mask the effect of temperature 
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Figure 32. T 90 of levothyroxine sodium in presence of different excipients and as a 
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Figure 33. T 90 of levothyroxine sodium in presence of different excipients and as a 
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Figure 34. T 90 of levothyroxine sodium in presence of different excipients and as a 
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Figure 35. T 90 of levothyroxine sodium in presence of different excipients and as a 
tablet when stored at 50°C 
81 
figure 36 shows that estimated t9o values for the tablet formulation under all storage 
conditions studied were found to be less than one week. The loss of potency often 
observed in the marketed levothyroxine sodium formulations was confirmed by these 
results. 
It remains to be seen why levothyroxine sodium in tablets exhibited a complex and rapid 
degradation as compared to pure levothyroxine sodium and levothyroxine sodium in 
presence of single excipients. Compatibility studies involving multiple excipients and 
evaluation of the effect of environmental conditions during manufacture may help in 
understanding this behavior. To this objective, our studies are believed to form a firm 
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Figure 36. Effect of storage conditions on levothyroxine sodium tablets 
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V) SUMMARY AND CONCLUSIONS 
The proposed testing program was designed to evaluate excipient compatibility studies 
with levothyroxine sodium as a pre-formulation tool. The results provided an insight on 
the stability of the drug in the presence of single as well as multiple excipients under the 
FDA stipulated conditions of temperature and humidity. 
The acquired results indicated that the pure drug was relatively stable for up to 10 weeks 
under different conditions evaluated except at 50°C. Won CM [42] had observed rapid 
degradation of the pure drug above 50°C. A similar trend was observed in our studies, 
which indicates that there might be additional and complex degradation pathways at 
higher temperatures. 
Nine commonly used excipients were selected for the compatibility studies. These 
excipients were dextrose, dicalcium phosphate dihydrate, calcium sulfate, mannitol, 
lactose anhydrous, lactose monohydrate, starch 1500, talc and ferric-oxide. In the 
presence of these excipients the stability of the drug decreased as compared to that of 
pure drug with the extent of degradation dependant on the chemical properties of the 
excipients. The lowest drug degradation of the investigated drug-excipient mixtures was 
observed in the drug mixtures with mannitol, starch 1500 and talc. Considerable 
degradation of the drug was noted in the presence of carbohydrates having an aldehyde 
group. This behavior of the drug in presence of carbohydrates was attributed to Schiff-
base and oxidation reactions. The lowest t-90 values for the drug was observed in the 
presence of dextrose, dicalcium phosphate dihydrate and calcium sulfate at 25°C, 25°C I 
60% RH and 40°C I 75% RH (Table 19) with stability well below usable levels. 
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The results of the compatibility studies led to the selection of mannitol, starch 1500 and 
talc for use in formulating levothyroxine sodium tablets. The formulated tablets were 
found to conform to USP standards. The data on the stability of tablets revealed that the 
drug degraded to less than 90% in less than a week at all the conditions studied. These 
results indicate that in the presence of multiple excipients, the stability of the drug 
appeared to be much less. No particular trend was observed in the degradation profile as a 
function of temperature and humidity on the final formulation. It appears that the rapid 
degradation of the drug in tablets may be due to the synergistic effect of the individual 
excipients used or the processing variables such as mixing techniques, compaction 
pressures etc. 
from the overall results obtained it can be concluded that levothyroxine sodium has very 
little stability at 50°C. It is also recommended that dextrose, lactose hydrous, lactose 
anhydrous, calcium sulfate and dicalcium phosphate dihydrate should not be used as 
excipients along with levothyroxine due to the very low stability in presence of these 
excipients. 
VI) RECOMMENDATIONS FOR FUTURE WORK 
The future work on the stability studies of levothyroxine sodium should focus on the 
following: 
• Increase the drug concentration and study the degradation pattern using IR, NMR 
or DSC for better understanding of the degradation pathways. 
• Investigate the stability of the drug in presence of different formulation 
environments like adjusting micro-environmental pH or addition of anti-oxidants 
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or coating the drug particles with inert polymers and thereby reducing the contact 
of the drug with excipients. 
• Stability of the drug in presence of different mini-formulations (multiple 
excipients) consisting of different compositions and ratios. 
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This appendix includes the statistical output of non-linear regression for first-order and 
biphasic first-order reactions. Sigma plot for Windows (Version 4, SPSS Inc., 1997) was 
used to perform the curve fitting procedures for both the models. First section gives the 
definition of the variables, constraints and model parameters. This is followed by tests to 
validate the equal variance and normality assumptions for model errors. The final section 
gives the residuals and other diagnostics. Salient parameters basing on which out 
conclusions are made, include adjusted r2 values, normality tests and residual plots 










reciprocal _y= 1 / abs(y) 
reciprocal_ysquare= 1/y/\2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a::::: yatxnearO(y,x) Auto { {prev10us: 94.074}} 
b::::: -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.00908564}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





stepsize= 1 00 
iterations= 100 
R = 0.79403850 Rsqr = 0.63049713 Adj Rsqr = 0.55659656 






Analysis of Variance: 
DF SS 
Regression! 173.3889 
Residual 5 1O1. 6146 
Total 6 275.0034 
PRESS= 385.8371 

















Normality Test: Passed (P = 0.7083) 
Constant Variance Test: Passed (P = 0. 7810) 
Power of performed test with alpha= 0.0500: 0.5810 
The power of the performed te~t (0.58~0) is bet.ow the desired power of 0.8000. 
You should interpret the negative findmgs cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 94.0740 5.9260 
2 93.2232 -1.4185 
3 92.3800 1.8564 
4 90.7165 -4.4046 
5 88.2772 -0.9019 
6 85.9036 -5.0004 
7 78.4427 3.9775 
Influence Diagnostics: 
Row Cook'sDist 
1 0.5119 0.2947 
2 0.0214 0.2459 
3 0.0279 0.2072 
4 0.1064 0.1580 
5 0.0041 0.1479 
6 0.1980 0.2040 
7 4.3516 0.7423 
95% Confidence: 
Row Predicted Regr. 5% 
1 94.0740 87.7828 
2 93.2232 87.4765 
3 92.3800 87.1052 
4 90.7165 86.1103 
5 88.2772 83.8206 
6 85.9036 80.6701 





































































10 15 20 25 
-Col11vCol12 
• Time, weeks v % Drug [Dextrose, 25C) 
************************************************************************ 
DEXTROSE (First-order reaction) 
25°C /60 %RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 85.5238}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0276726}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 






iterations= 1 OO 
R = 0.63120454 Rsqr = 0.39841917 Adj Rsqr = 0.27810301 
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Normality Test: Passed (P = 0.0576) 










The power of the performed test (0.3181) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
l 85.5238 14.4762 
2 83.1896 3.2403 
3 80.9191 5.0445 
4 76.5623 -13.8018 
5 70.4629 -24.8293 
6 64.8494 3.6990 
7 49 .1729 13 .2297 
Influence Diagnostics: 
Row Cook'sDist 
l 0.3138 0.3319 
2 0.0101 0.2605 
3 0.0171 0.2088 
4 0.0828 0.1543 
5 0.2885 0.1628 
6 0.0114 0.2398 




































RoW Predicted Regr. 5% 
1 85.5238 62.1921 
2 83.1896 62.5191 
3 80.9191 62.4128 
4 76.5623 60.6541 
5 70.4629 54.1204 
6 64.8494 45.0165 
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DEXTROSE (First-order reaction) 
40°C /75 %RH 
Nonlinear Regression 
[Vari ab 1 es] 
x = col(l) 
y = col(2) 
reciprocal_y= 1 I abs(y) 
reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 99.9044}} 




fit f to Y . . 
"fit fto y with we~ght rec~procal_y 





stepsize= 1 00 
iterations= 100 
R == 0.98465494 Rsqr = 0.96954536 Adj Rsqr = 0.96345443 














PRESS = 282946.1962 








Normality Test: Failed (P = 0.0025) 






Power of performed test with alpha= 0.0500: 0.9981 
Regression Diagnostics: 
Row Predicted Residual 
1 99.9044 0.0956 
2 11.6744 -1.6080 
3 1.3642 6.6708 
4 0.0186 6.4913 
5 0.0000 7.7013 
6 0.0000 6.1283 





























1 fluence Diagnostics: 
now Cook'sDist Leverage DFFITS f 3143.8469 0.9998 80.6421 
2 10.0185 0.9478 -4.5360 
3 0.0290 0.0524 0.2422 
4 0.0000 0.0000 0.0061 
5 0.0000 0.0000 0.0000 
6 0.0000 0.0000 0.0000 
7 0.0000 0.0000 0.0000 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 99.9044 82.6993 117.1095 75.5716 124.2372 
2 11.6744 -5.0767 28.4255 -12.3395 35.6883 
3 1.3642 -2.5741 5.3025 -16.2874 19.0158 
4 0.0186 -0.0901 0.1274 -17.1883 17.2256 
5 0.0000 -0.0003 0.0003 -17.2066 17.2067 
6 0.0000 -0.0000 0.0000 -17.2066 17.2066 





"' 60 8 
>- 40 
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10 15 20 25 
- Col 21 v Col22 
• Time, weeks v % Drug [Dextrose. 40Cn5%RHJ 
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Y = col(2) 
rec~procal_y= 1 I abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
100 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO{ q,r )=xatymax( q,xnearO( r)) 
[Parameters] . 
a= yatxnearO{y,x) "Auto { {prev10us: 99.8667}} 
b = -ln(.5)/{x50(x,y)-min(x)) "Auto {{previous: 2.10922}} 
[Equation] 
f=a*exp(-b*x) 
fit f to Y 
"fit f toy with weight reciprocal_y 







R = 0.97845723 Rsqr = 0.95737856 Adj Rsqr = 0.94885427 






Analysis of Variance: 
DF SS 
Regression 1 6903.0535 
Residual 5 307 .3163 
Total 6 7210.3698 
PRESS = 400202.4543 








Normality Test: Failed (P = 0.0112) 









Power of performed test with alpha= 0.0500: 0.9948 
Regression Diagnostics: 
Row Predicted Residual 
l 99.8667 0.1333 
2 12.1171 -2.1559 










4 0.0216 6.7143 0.8564 0.8565 0.8293 
5 0.0000 7.0723 0.9021 0.9021 0.8818 
6 0.0000 8.8752 1.1321 1.1321 1.1741 
7 0.0000 7.3872 0.9423 0.9423 0.9293 
Influence Diagnostics: 
Leverage DFFITS Row Cook'sDist 
1 3240.5340 0.9998 84.4919 
2 11.1981 0.9436 -4.9472 
3 0.0384 0.0566 0.2873 
4 0.0000 0.0001 0.0059 
5 0.0000 0.0000 0.0000 
6 0.0000 0.0000 0.0000 
7 0.0000 0.0000 0.0000 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 99.8667 79.7159 120.0176 71.3676 128.3658 
2 12.1171 -7.4589 31.6931 -15.9785 40.2127 
3 1.4702 -3.3245 6.2649 -19.2453 22.1857 
4 0.0216 -0.1220 0.1653 -20.1318 20.1751 
5 0.0000 -0.0004 0.0005 -20.1529 20.1530 
6 0.0000 -0.0000 0.0000 -20.1530 20.1530 
7 0.0000 -0.0000 0.0000 -20.1530 20.1530 










• • • • • 
10 15 20 25 
- Col 26vCol 27 
• Time, weeks v % Drug (Dextrose, 50Cl20%RHJ 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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y == col(2) 
reciprocal y= 1 I abs(y) 
reciprocal_ysquare= 1/y"2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO(q)=max(abs(q))-abs(q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] ,, . 
a== yatxnearO(y,x) Auto {{previous: 95.1795}} 
b == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0531936}} 
[Equation] 
f=:a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocaly 







R = 0.95335268 Rsqr = 0.90888134 Adj Rsqr = 0.89065761 






Analysis of Variance: 
DF SS 
Regressionl 2636.4745 
Residual 5 264.3162 
Total 6 2900.7906 
PRESS= 595.5611 


















Constant Variance Test: Passed (P = 0.6019) 
power of performed test with alpha= 0.0500: 0.9620 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 95.1795 4.8205 0.6630 0.8452 0.8165 
2 90.2489 1.8105 0.2490 0.2926 0.2640 
3 85.5737 3.8791 0.5335 0.5993 0.5564 
4 76.9373 -9.3995 -1 .2928 -1.4073 -1.6197 
5 65.5891 -7.5493 -1.0383 -1.1601 -1.2137 
6 55.9148 -0.4379 -0.0602 -0.0716 -0.0641 
7 32.8480 8.7874 1.2086 1.6836 2.2881 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.2233 0.3847 0.6456 
2 0.0163 0.2759 0.1630 
3 0.0470 0.2075 0.2847 
4 0.1831 0.1561 -0.6966 
5 0.1671 0.1989 -0.6048 
6 0.0011 0.2923 -0.0412 
7 1.3327 0.4846 2.2189 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 95.1795 83.5879 106.7712 73.1868 117.1723 
2 90.2489 80.4312 100.0665 69.1373 111.3605 
3 85.5737 77.0603 94.0870 65.0361 106.1112 
4 76.9373 69.5534 84.3211 56:8416 97.0329 
5 65.5891 57.2538 . 73.9244 45.1247 86.0535 
6 55.9148 45.8099 66.0196 34.6680 77.1615 
7 32.8480 19.8368 45.8593 10.0751 55.6210 
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************************************************************************ 





y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1 /y'''2 
'Automatic Initial Parameter Estimate Functions 
xnearO(q)=max(abs(q))-abs(q) 
yatxnearO( q,r )=xatyrnax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto { {previ~us: 0.168671}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.267513}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.819683}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 4.2155e-012}} 
[Equation] · 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
· iterations= 1 OO 
105 
R == 0.94079403 Rsqr = 0.88509342 Adj Rsqr = 0.77018683 
Standard Error of Estimate = 0.0325 
Coefficient 
0.1687 0.1299 a 
b 0.2675 0.3250 
c 0.8197 0.1373 
d 0.0000 0.0090 



















Normality Test: Passed (P = 0.6858) 








Power of performed test with alpha= 0.0500: 0.9370 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9884 0.0116 
2 0.9488 -0.0307 
3 0.9185 0.0239 
4 0.8775 -0.0144 
5 0.8456 0.0281 
6 0.8313 -0.0223 
7 0.8205 0.0037 
Influence Diagnostics: 
Row Cook'sDist 
1 1.1398 0.8455 
2 0.1591 0.3244 
3 0.1680 0.4187 
4 0.0563 0.4046 
5 0.1986 0.3914 
6 0.5163 0.6231 







































Row Predicted Regr. 5% 
1 0.9884 0.8934 
2 0.9488 0.8899 
3 0.9185 0.8516 
4 0.8775 0.8118 
5 0.8456 0.7810 
6 0.8313 0.7498 
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DEXTROSE ( Biphasic First-order reaction) 




y = col(2) 
reciprocal _y= 1/abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatx.nearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.433192}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.421275} } 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.586266}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 1.86902e-010}} 
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[Equation] * * [=:::a*exp(-b*x)+c exp(-d x) 
fit f to Y . . 
"fit f toy with we~ght rec~procal_y 





tolerance= 1 e-6 
stepsize=O. 1 
iterations= 100 
R = 0.89024727 Rsqr = 0.79254021 Adj Rsqr = 0.58508042 
Standard Error of Estimate = 0.1194 
Coefficient 
a 0.4332 0.2466 
b 0.4213 0.4753 
c 0.5863 0.2447 
d 0.0000 0.0270 
Analysis of Variance: 
DF SS 
Regression3 0.1635 
Residual 3 0.0428 
Total 6 0.2063 
PRESS= 3.5557 










Nonnality Test: Passed (P = 0.6032) 








Power of performed test with alpha= 0.0500: 0.8123 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0195 -0.0195 
2 0.8705 -0.0062 
3 0.7728 0.0868 
4 0.6666 -0.0390 
























0.0928 0.7769 1.0849 1.1363 
7 0.5864 
0.0377 0.3153 2.2021 (+inf) 
Influence E>iagnostics: 
Leverage DFFITS Row Cook'sDist 
1 0.7373 0.9095 -1.4762 
2 0.0007 0.3830 -0.0428 
3 0.2192 0.4686 0.9352 
4 0.0209 0.3408 -0.2427 
5 0.5447 0.4314 -5.8228 
6 0.2794 0.4871 1.1073 
7 57.9123 0.9795 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0195 0.6569 1.3820 0.4942 1.5448 
2 0.8705 0.6353 1.1058 0.4235 1.3176 
3 0.7728 0.5126 1.0330 0.3121 1.2335 
4 0.6666 0.4447 0.8885 0.2264 1.1068 
5 0.6090 0.3593 0.8586 0.1542 1.0638 
6 0.5927 0.3274 0.8580 0.1291 1.0562 
7 0.5864 0.2101 0.9626 0.0515 1.1212 
20 Graph 2 
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0.5 
• 
10 15 20 25 
- Col15vCol16 
• Time, weeks v D!Do, [Dextrose, 25C/60%RHJ 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
109 
DEXTROSE ( Biphasic First-order reaction) 
40°C I 75 %RH . 
Nonlinear Regress10n 
[Variables] 
x == col(l) 
y == col(2) 
reciprocal _y== 1/abs(y) 
reciprocal _ysquare= lly'' 2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a== yatxnearO(y,x)/2 Auto {{previous: 0.912799}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 93.796}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.0872007}} 
d == -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0233318}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit fto y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.99961260 Rsqr = 0.99922535 Adj Rsqr = 0.99845071 
Standard Error of Estimate= 0.0138 
Coefficient Std. Error t p 
a 0.9128 0.0167 54.5026 <0.0001 
b 93.7960 685683.1062 0.0001 0.9999 
c 0.0872 0.0095 9.1641 0.0027 
d 0.0233 0.0139 1.6780 0.1919 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.7350 0.2450 1289.9098 <0.0001 
Residual 3 0.0006 0.0002 
Total 6 0.7356 0.1226 
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pRESS = 1898897780025.0015 
Durbin-Watson Statistic= 2.3452 
Nonnality Test: Passed (P = 0.7511) 
Constant Variance Test: Passed (P = 0.6019) 
Power of performed test with alpha = 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0000 -0.0000 
2 0.0852 0.0155 
3 0.0832 -0.0029 
4 0.0794 -0.0143 
5 0.0741 0.0030 
6 0.0691 -0.0078 










Row Cook'sDist Leverage 
1 2499270892732516.5000 1.0000 
2 0.3082 0.3782 1.5920 
3 0.0067 0.3017 -0.1354 
4 0.0880 0.2055 -0.6555 
5 0.0029 0.1720 0.0884 
6 0.0311 0.2312 -0.3101 
7 0.5354 0.7114 1.4177 
95% Confidence: 
Row Predicted Regr. 5% 
1 1.0000 0.9561 
2 0.0852 0.0582 
3 0.0832 0.0591 
4 0.0794 0.0595 
5 0.0741 0.0559 
6 0.0691 0.0480 












































20 Graph 3 
~ L 0 >- • • • • 
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• Time. weeks v O/Oo, {Dextrose, 40Cn5%RH] 
************************************************************************ 
DEXTROSE ( Biphasic First-order reaction) 
50°C I 20%moisture 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y= 11 abs(y) 
reciprocal _ysquare= 1 /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.908409}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) . "Auto {{previous: 22045.5}} 
c = yatxnearO(y ,x )/2 "Auto { {previous: 0. 0915 914} } 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0130566}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 









R == 0.99941069 Rsqr = 0.99882173 Adj Rsqr = 0.99764346 
Standard Error of Estimate= 0.0168 
Coefficient 
0.9084 0.0201 a 22045.4822 b 
0.0916 0.0111 c 
d 0.0131 0.0140 



















Normality Test: Passed (P = 0.3935) 








Power of performed test with alpha = 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0000 -0.0000 
2 0.0904 0.0092 
3 0.0892 0.0116 
4 0.0869 -0.0196 
5 0.0836 -0.0129 
6 0.0804 0.0084 










Row Cook'sDist Leverage 
1 -51475181805011992.0000 
2 0.0643 0.3561 0.4505 
3 0.0700 0.2934 0.4908 
4 0.1124 0.2083 -0.8344 
5 0.0355 0.1680 -0.3514 
~ 0.0213 0.2131 0.2519 


























R Predicted Regr. 5% ow 
1 1.0000 0.9464 
2 0.0904 0.0584 
3 0.0892 0.0602 
4 0.0869 0.0625 
5 0.0836 0.0616 
6 0.0804 0.0557 
7 0.0705 0.0238 







































y = col(2) 
reciprocal_y=l/abs(y) 
reciprocal_ysquare= 1 /y"2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.507061}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.198221}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.509762}} 




fit f to Y . . 
"fit f toy with we~ght rec~procal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.98931299 Rsqr = 0.97874020 Adj Rsqr = 0.95748039 
Standard Error of Estimate = 0.0453 
Coefficient 
a 0.5071 0.4358 
b 0.1982 0.1900 
c 0.5098 0.4515 
d 0.0108 0.0412 
Analysis of Variance: 
DF SS 
Regression3 0.2839 
Residual 3 0.0062 
Total 6 0.2901 
PRESS = 0.6980 










Nonnality Test: Passed (P = 0.4222) 








Power of performed test with alpha = 0.0500: 0.9995 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0168 -0.0168 
2 0.9202 0.0004 
3 0.8400 0.0545 
4 0.7177 -0.0423 























0.5275 0.0273 0.6011 1.0595 .1.0935 6 0.4205 -0.0042 -0.0915 -1.2847 -1.5638 7 
Influence Diagnostics: 
Leverage DFFITS ow Cook'sDist ~ 0.8006 0.8130 -1.6821 
2 0.0000 0.3109 0.0060 
3 0.3798 0.3903 2.2011 
4 0.2951 0.4339 -1.2716 
5 0.0427 0.3788 -0.3544 
6 0.5911 0.6781 1.5870 
7 80.8563 0.9949 -21.8923 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0168 0.8867 1.1469 0.8225 1.2111 
2 0.9202 0.8397 1.0006 0.7550 1.0854 
3 0.8400 0.7498 0.9301 0.6699 1.0101 
4 0.7177 0.6227 0.8128 0.5449 0.8905 
5 0.5993 0.5105 0.6881 0.4299 0.7687 
6 0.5275 0.4087 0.6463 0.3406 0.7144 
7 0.4205 0.2766 0.5644 0.2167 0.6243 
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reciprocal _y= 1/abs(y) 
reciprocal _ysquare= 1 /y/\2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 




a:::: yatxnearO(y,x) Auto {{previous: 93.5638}} 




"fit f toy with weight reciprocal_y 







R = 0.22215643 Rsqr = 0.04935348 Adj Rsqr = 0.00000000 






Analysis of Variance: 
DF SS 
Regressionl 98.8417 
Residual 6 1903.8879 
Total 7 2002.7295 
PRESS = 3042.9073 

















Normality Test: Passed (P = 0.2724) 
Constant Variance Test: Passed (P = 0.8849) 
Power of performed test with alpha= 0.0500: 0.0729 
The power of the performed te~t (0.07~9) is bel.ow the desired power of 0.8000. 
You should interpret the negative findmgs caut10usly. 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 93.5638 6.4362 0.3613 0.4174 0.3867 
2 92.9397 2.7105 0.1522 0.1711 0.1566 
3 92.3198 -13.7590 -0.7724 -0.8509 -0.8283 
4 91.7040 29.9978 1.6840 1.8281 2.5074 
5 91.0924 -12.5671 -0.7055 -0.7586 -0.7283 
6 89.2818 -23.4710 -1.3176 -1.4143 -1.5813 
7 87.5071 5.5220 0.3100 0.3448 0.3179 
8 81.8426 5.1597 0.2897 0.5839 0.5489 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0292 0.2508 0.2237 
2 0.0039 0.2090 0.0805 
3 0.0773 0.1760 -0.3828 
4 0.2983 0.1515 1.0594 
5 0.0450 0.1351 -0.2879 
6 0.1522 0.1320 -0.6168 
7 0.0141 0.1917 0.1549 
8 0.5224 0.7539 0.9608 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 93.5638 71.7371 115.3905 . 44.8166 142.3109 
2 92.9397 73.0151 112.8643 45.0140 140.8654 
3 92.3198 74.0355 110.6041 45.0525 139.5871 
4 91.7040 74.7404 108.6677 44.9317 138.4763 
5 91.0924 75.0696 107.1151 44.6531 137.5317 
6 89.2818 73.4427 105.1208 42.9055 135.6580 
7 87.5071 68.4207 106.5936 39.9238 135.0905 
8 81.8426 43.9956 119.6896 24.1167 139.5685 
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************************************************************************ 








x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 88.6789}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0208095}} 
[Equation] 
f==a*exp(-b*x) 
fit f toy 
"fit f to Y with weight reciprocal v 
"fit ft . _./ 








R==0.68153155 Rsqr = 0.46448525 Adj Rsqr = 0.37523279 























Nonnality Test: Passed (P = 0.5252) 










The power of the performed test (0.4603) is below the. desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 88.6789 11.3211 
2 86.8526 -9.9140 
3 85.0639 -13.2474 
4 83.3120 14.6881 
5 81.5963 5.7987 
6 76.6581 -9.1053 
7 72.0187 -3.7947 
8 58.4886 4.4182 
Influence Diagnostics: 





































4 0.1740 0.1494 0.6580 
5 0.0232 0.1328 0.2017 
6 0.0626 0.1423 -0.3456 
7 0.0200 0.2180 -0.1850 
8 0.5128 0.6817 0.9638 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 88.6789 74.0939 103.2638 57.3859 119.9718 
2 86.8526 73.8590 99.8461 56.2689 117.4362 
3 85.0639 73.3804 96.7473 55.0134 115.1143 
4 83.3120 72.6105 94.0136 53.6296 112.9945 
5 81.5963 71.5077 91.6849 52.1292 111.0633 
6 76.6581 66.2136 87.1025 47.0673 106.2488 
7 72.0187 59.0921 84.9453 41.4635 102.5740 
8 58.4886 35.6301 81.3470 22.5854 94.3917 
20 Graph 2 
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DiCaicium Phosphate Dihydrate (First-order reaction) 
SOoC/ 20 %moist~re 
Nonlinear Regression 
[Variables] 
x ==col( I) 
y == col(2) 
reciprocal __y= 1/abs(y) 
reciprocal__ysquare= 1/y/\2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a:::: yatxnearO(y,x) Auto {{previous: 100.426}} 
b == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0329605}} 
(Equation] 
f==a*exp(-b*x) 
fit f toy 
"fit f to y with weight reciprocal__y 







R == 0.92115552 Rsqr = 0.84852748 Adj Rsqr = 0.82328207 






Analysis of Variance: 
DF SS 
Regressionl 1739.5926 
Residual 6 310.5385 
Total 7 2050.1312 
PRESS= 556.3837 

















Normality Test: Passed (P = 0.7068) 
Constant Variance Test: Passed (P = 0.1196) 
power of performed test with alpha= 0.0500: 0.9463 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 100.4257 -0.4257 -0.0592 -0.0708 -0.0647 
2 97.1696 -4.2745 -0.5942 -0.6769 -0.6429 
3 94.0190 -0.9002 -0.1251 -0.1381 -0.1263 
4 90.9706 12.1472 1.6885 1.8288 2.5095 
5 88.0211 3.3287 0.4627 0.4967 0.4630 
6 79.7339 -9.3572 -1.3007 -1.4154 -1.5832 
7 72.2270 -4.8509 -0.6743 -0.7750 -0.7458 
8 51.9462 4.6423 0.6453 1.0346 1.0419 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0011 0.3023 -0.0426 
2 0.0682 0.2294 -0.3508 
3 0.0021 0.1790 -0.0590 
4 0.2895 0.1476 1.0442 
5 0.0188 0.1321 0.1806 
6 0.1846 0.1556 -0.6796 
7 0.0964 0.2430 -0.4226 
8 0.8404 0.6110 1.3057 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 100.4257 90.7466 110.1048 80.3367 120.5148 
2 97.1696 88.7379 105.6013 77.6509 116.6883 
3 94.0190 86.5712 101.4669 74.9048 113.1333 
4 90.9706 84.2080 97.7333 72.1128 109.8285 
5 88.0211 81.6236 94.4186 . 69.2911 106.7511 
6 79.7339 72.7900 86.6779 60.8103 98.6575 
· 7 72.2270 63.5486 80.9053 52.6005 91.8535 
8 51 .9462 38.1866 65.7058 29.6031 74.2893 
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x = col(l) 
y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y"2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 82.5879}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0440508}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





stepsize= 1 00 
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iterations== 100 
R == o.79944607 Rsqr = 0.63911401 Adj Rsqr = 0.57896635 























Nonnality Test: Passed (P = 0.6617) 










The power of the performed test (0.6891) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 82.5879 17.4121 
2 79.0288 -12.0604 
3 75.6231 1.5303 
4 72.3641 -14.4028 
5 69.2456 9.5619 
6 60.6735 -1.3395 
7 53.1626 -8.5527 
8 34.2213 9.2182 
Influence Diagnostics: 
Row Cook'sDist 
1 0.7179 0.3261 
2 0.1954 0.2371 
3 0.0021 0.1792 
















































Row Predicted Regr. 5% 
1 82.5879 65.3819 
2 79.0288 64.3568 
3 75.6231 62.8686 
4 72.3641 60.8447 
5 69.2456 58.2635 
6 60.6735 48.2226 
7 53.1626 37.6282 





































x = col(l) 
Y = col(2) 
rec~procal_y= 1/ abs(y) 
reciprocal_ysquare= 1 /yl\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
126 
[parameters] 
_ txnearO(y,x)/2 "Auto {{previous: 0.166203}} 
: : ::o(.5)/(0.5*(x50(x,y)-min(x))). "Auto {{previous: 0.327697}} 
== atxnearO(y,x)/2 "Auto {{previous: 0.837541_}} ~ == :ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 7.31869e-011}} 
[Equation] 
f:::a*exp(-b*x)+c*exp(-d*x) 
fitftoy . . 
"fit fto y with weight rec~procal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R == 0.34643013 Rsqr = 0.12001384 Adj Rsqr = 0.00000000 
Standard Error of Estimate = 0.2099 
Coefficient 
a 0.1662 0.6081 
b 0.3277 1.9321 
c 0.8375 0.6331 
d 0.0000 0.0440 
Analysis of Variance: 
DF SS 
Regression3 0.0240 
Residual 4 0.1762 
Total 7 0.2003 
PRESS = 8.8045 










Nonnality Test: Passed (P = 0.6135) 












~e power of the performed test (0.1247) is below the desired power of 0.8000. 
ou should interpret the negative findings cautiously. 
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R gression Diagnostics: 
Std. Res. Stud. Res. e Predicted Residual Stud. Del. Res. 
Row 1.0037 -0.0037 -0.0178 -0.0466 -0.0404 
2 0.9573 -0.0008 -0.0038 -0.0045 -0.0039 ! 0.9238 -0.1382 -0.6586 -0.7957 -0.7511 
5 0.8997 0.3173 1.5116 1.8178 3.7747 
6 0.8824 -0.0971 -0.4626 -0.5427 -0.4883 
7 0.8543 -0.1962 -0.9347 -1.2012 -1.3011 
8 0.8438 0.0865 0.4120 0.6309 0.5758 
9 0.8378 0.0322 0.1536 1.4559 1.8390 
Influence Diagnostics: 
Leverage Row Cook'sDist DFFITS 
2 0.0032 0.8534 -0.0974 
3 0.0000 0.2928 -0.0025 
4 0.0728 0.3149 -0.5092 
5 0.3685 0.3085 2.5211 
6 0.0277 0.2735 -0.2996 
7 0.2350 0.3945 -1.0502 
8 0.1339 0.5736 0.6678 
9 47.0686 0.9889 17.3316 
95% Confidence: 
Row Predicted Regr. 5 % Regr. 95% Pop. 5% Pop. 95% 
2 1.0037 0.4654 1.5421 0.2103 1.7971 
3 0.9573 0.6420 1.2727 0.2947 1.6199 
4 0.9238 0.5968 1.2509 0.2556 1.5921 
5 0.8997 0.5760 1.2234 0.2331 1.5664 
6 0.8824 0.5776 1.1871 0.2247 1.5400 
7 0.8543 0.4883 1.2203 0.1661 1.5425 
8 0.8438 0.4024 1.2852 0,1128 1.5749 












10 15 20 25 
- Col1 0vCol11 
e Time, weeks v D/Oo, [OCPO, 25C] 
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••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• DiC;l~l~.;; Phosphate Dihydrate ( Biphasic First-order reaction) 
lSoC/60 %RH 
NO OUTP!!! •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• I 
••••••••• 




x = col(l) 
y = col(2) 
reciprocal _y= 1/abs(y) 
reciprocal _ysquare= 1 /y"2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
(Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.333646}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.113982}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.586469}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 1.50132e-010}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.70718831 Rsqr = 0.50011531 Adj Rsqr = 0.12520180 
Standard Error of Estimate = 0.1339 
Coefficient Std. Error t p 
a 0.3336 3.9740 0.0840 0.9371 
b 0.1140 1.1744 0.0971 0.9274 
c 0.5865 4.0325 0.1454 0.8914 d 0.0000 0.2444 0.0000 1.0000 
129 
Analysis of Variance: 
DF SS 
Regression3 0.0717 
Residual 4 0.0717 
Total 7 0.1434 





Durbin-Watson Statistic= 2.1035 
Normality Test: Passed (P = 0.7263) 
Constant Variance Test: Failed (P = 0.0212) 
F 
1.3339 
Power of performed test with alpha = 0.0500: 0.5045 
p 
0.3811 
The power of the performed test (0.5045) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
l 0.9201 0.0799 
2 0.8842 -0.1148 
3 0.8521 -0.1339 
4 0.8235 0.1565 
5 0.7980 0.0760 
6 0.7367 -0.0612 
7 0.6932 -0.0110 
8 0.6206 0.0085 
Influence Diagnostics: 
Row Cook'sDist 
l 1.1254 0.7556 
2 0.0941 0.2716 
3 0.1113 0.2501 
4 0.2196 0.3079 
5 0.0587 0.3284 
6 0.0404 0.3386 
7 0.0200 0.7495 
8 315.4957 0.9982 
95% Confidence: 
Row Predicted Regr. 5% 
1 0.9201 0.5970 
















































0.8521 0.6662 1.0380 0.4365 1.2677 3 0.8235 0.6172 1.0297 0.3984 1.2486 4 0.7980 0.5849 1.0110 0.3695 1.2264 5 0.7367 0.5204 0.9530 0.3066 1.1668 6 0.6932 0.3714 1.0150 0.2015 1.1849 7 
8 0.6206 0.2492 0.9920 0.0951 1.1461 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
DiCalcium Phosphate Dihydrate ( Biphasic First-order reaction) 




y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= l/y1' 2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.630224}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0706267}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.393708}} • 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 6.l 8862e-01 O}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
131 
"fit f toy with we~ght rec~procal_y 





tolerance== 1 e-6 
stepsize==O .1 
iterations== 100 
R == 0.92794829 Rsqr == 0.86108803 Adj Rsqr == 0.75690405 
Standard Error of Estimate== 0.0844 
Coefficient 
a 0.6302 9.4315 
b 0.0706 0.7448 
c 0.3937 9.4717 
d 0.0000 0.6242 
Analysis of Variance: 
DF SS 
Regression3 0.1765 
Residual 4 0.0285 
Total 7 0.2050 
PRESS== 309.8853 










Nonnality Test: Passed (P == 0.5092) 








Power of performed test with alpha == 0.0500: 0.9568 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0239 -0.0239 
2 0.9810 -0.0520 
3 0.9409 -0.0097 
4 0.9036 0.1276 
5 0.8688 0.0447 
6 0.7781 -0.0743 
7 0.7047 -0.0310 
































fl ence Diagnostics: 
In ; Cook'sDist Leverage DFFITS ~o o.2061 0.7326 -0.8177 
2 0.0489 0.2724 -0.4106 
3 0.0014 0.2389 -0.0642 
4 0.3539 0.3018 2.4196 
5 0.0538 0.3373 0.4249 
6 0.1477 0.3358 -0.7912 
7 0.5552 0.7823 -1.4036 
8 10866.7651 0.9989 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0239 0.8234 1.2245 0.7156 1.3323 
2 0.9810 0.8587 1.1032 0.7167 1.2452 
3 0.9409 0.8264 1.0554 0.6802 1.2017 
4 0.9036 0.7749 1.0323 0.6363 1.1709 
5 0.8688 0.7328 1.0049 0.5979 1.1397 
6 0.7781 0.6424 0.9139 0.5073 1.0489 
7 0.7047 0.4975 0.9119 0.3920 1.0175 
8 0.5472 0.3130 0.7813 0.2160 0.8784 
20 Graph 8 
1 . 1 ~----------~ 
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x == col(l) 
y == col(2) 
reciprocal __y= 1 I abs(y) 
reciprocal __ysquare= 1 /y/\2 . . 
'Automatic Initial Parameter Estimate Funct10ns 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • • 
a= yatxnearO(y,x)/2 Auto { {prev10us: 0.257223}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 356066}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.742777}} 
d = -ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0315182}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal__y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R= 0.90478094 Rsqr = 0.81862855 Adj Rsqr = 0.68259996 










Analysis of Variance: 
DF SS 
Regression3 0.2064 
Residual 4 0.0457 
Total 7 0.2521 
















pR£SS == 12930026640575624.0000 
Durbin-Watson Statistic = 3 .1687 
Normality Test: Passed (P = 0. 7820) 
Constant Variance Test: Passed (P = 0.6194) 
Power of performed test with alpha= 0.0500: 0.9177 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0000 0.0000 
2 0.7197 -0.0500 
3 0.6974 0.0741 
4 0.6758 -0.0961 
5 0.6548 0.1333 
6 0.5957 -0.0024 
7 0.5420 -0.0959 











Row Cook'sDist Leverage 
1 282793880062915520.0000 
2 0.0389 0.3242 -0.3563 
3 0.0529 0.2486 0.4348 
4 0.0616 0.1966 -0.4969 
5 0.0917 0.1646 0.7169 
6 0.0000 0.1591 -0.0091 
7 0.0838 0.2404 -0.5846 











Predicted Regr. 5% 






























































x = col(l) 
y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 93.7223}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0127838}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





stepsize= 1 oo 
iterations= 1 oo 
R == 0.89831165 Rsqr = 0.80696382 Adj Rsqr = 0.77479112 
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Nonnality Test: Passed (P = 0.6907) 






Power of performed test with alpha= 0.0500: 0.9053 
Regression Diagnostics: 
Row Predicted Residual 
1 93.7223 6.2777 
2 92.5318 -0.6072 
3 91.3564 -1.2651 
4 90.1960 0.8058 
5 89.0502 -5.3088 
6 85.6997 -2.0053 
7 82.4752 -0.0686 
8 72.5779 2.2181 
Influence Diagnostics: 
Row Cook'sDist 
1 0.7189 0.2621 
2 0.0048 0.2139 
3 0.0159 0.1770 
4 0.0051 0.1506 
5 0.1908 0.1339 
6 0.0277 0.1358 
7 0.0001 0.2026 











































Row predicted Regr. 5% 
Regr. 95% Pop. 5% Pop. 95% 
93.7223 89.1723 98.2723 83.7377 103.7069 1 92.5318 88.4210 96.6426 82.7395 102.3241 2 91.3564 87.6170 95.0958 81.7141 100.9987 3 90.1960 86.7468 93.6451 80.6625 99.7294 4 89.0502 85.7974 92.3030 79.5860 98.5144 5 
6 85.6997 82.4245 88.9749 76.2278 95.1716 
7 82.4752 78.4749 86.4756 72.7288 92.2217 













10 15 20 25 
- Col10vCol11 
• Time, weeks v % Drug [Ca Sulfate, 25C) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CALCIUM SULFATE (First-order reaction) 
2s0c I 60 %RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y= 1/ abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 92.3787}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.00639435}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f to Y with weight reciprocal_y 
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R::::: 0.67039550 Rsqr = 0.44943012 Adj Rsqr = 0.35766848 























Normality Test: Passed (P == 0.2602) 










The power of the performed test (0.4422) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 92.3787 7.6213 
2 91.7898 -3.3997 
3 91.2048 -4.3680 
4 90.6234 -1.2764 
5 90.0458 -2.1758 
6 88.3349 0.3927 
7 86.6565 4.2343 






























Leverage DFFITS w Cook'sDist ~o o.6794 0.2503 1.8760 
2 0.1012 0.2087 -0.4398 
3 0.1298 0.1759 -0.5209 
4 0.0090 0.1515 -0.1235 
5 0.0225 0.1352 -0.1983 
6 0.0007 0.1319 0.0344 
7 0.1378 0.1913 0.5338 
8 0.3500 0.7551 -0.7787 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 92.3787 87.0372 97.7201 80.4406 104.3168 
2 91.7898 86.9119 96.6678 80.0518 103.5279 
3 91.2048 86.7268 95.6828 79.6272 102.7823 
4 90.6234 86.4679 94.7790 79.1667 102.0802 
5 90.0458 86.1204 93.9712 78.6706 101.4211 
6 88.3349 84.4572 92.2127 76.9760 99.6938 
7 86.6565 81.9866 91.3265 75.0034 98.3097 
8 81.2889 72.0113 90.5664 67.1446 95.4331 










10 15 20 25 
- Col 15vCol 16 
• Time. weeks v % Drug (Ca Sulfate, 25Cl60%RHJ 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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CALCIUM SULFATE (First-order reaction) 
4ooc I 15 %RH . 
Nonlinear Regression 
[Variables] 
x == col(l) 
y == col{2) 
reciprocal __y= 1 /abs(y) 
reciprocal__ysquare= 1/y/\2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max{ abs{ q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a== yatxnearO(y,x) Auto {{previous: 89.0732}} 
b == -ln(.5)/(x50{x,y)-min(x)) "Auto {{previous: 0.0053762}} 
(Equation] 
f==a*exp(-b*x) 
fit f toy 
"fit fto y with weight reciprocal__y 







R = 0.47385900 Rsqr = 0.22454235 Adj Rsqr = 0.09529941 






Analysis of Variance: 
DF SS 
Regression 1 60.2402 
Residual 6 208.0396 
Total 7 268.2798 
PRESS= 505.4006 

















Normality Test: Passed (P = 0.5123) 
Constant Variance Test: Passed (P = 0.4228) 
power of performed test with alpha= 0.0500: 0.2095 
The power of the performed te~t (0.20?5) is bet.ow the desired power of 0.8000. 
You should interpret the negative findmgs cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 89.0732 10.9268 
2 88.5956 -1.6784 
3 88.1206 -3.8642 
4 87.6481 -0.4213 
5 87.1781 -1.6130 
6 85.7833 -7.5173 
7 84.4109 0.8923 
8 79.9926 3.2879 
Influence Diagnostics: 
Row Cook'sDist 
1 0.7570 0.2484 
2 0.0135 0.2079 
3 0.0557 0.1757 
4 0.0005 0.1516 
5 0.0068 0.1354 
6 0.1419 0.1314 
7 0.0033 0.1896 
8 2.0578 0.7600 
95% Confidence: 
Row Predicted Regr. 5% 
1 89.0732 81.8923 
2 88.5956 82.0263 
3 88.1206 82.0808 
4 87.6481 82.0374 
5 87.1781 81.8762 
6 85.7833 80.5607 
7 . 84.4109 78.1378 













































































10 15 20 25 
- Col20vCol 21 
• Time, weeks v % Drug [Ca Sulfate, 40Cf75%RHJ 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CALCIUM SULFATE (First-order reaction) 
50°C I 20 %moisture 
Nonlinear Regression 
(Variables] 
x == col(l) 
y == col(2) 
reciprocal _y== 1 I abs(y) 
reciprocal _ysquare= 1/y"'2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)==max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x) "Auto {{previous: 89.2674} } 
b == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0271455}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





stepsize== l 00 
iterations= 1 oo 
R == 0.81445053 Rsqr = 0.66332967 Adj Rsqr = 0.60721794 
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Analysis of Variance: 
DF SS 
Regression 1 1102.6058 
Residual 6 559.6232 
Total 7 1662.2290 
PRESS= 1019.5279 








Nonnality Test: Passed (P = 0.2449) 










The power of the performed test (0.7222) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 89.2674 10.7326 
2 86.8768 -12.1566 
3 84.5502 -2.1805 
4 82.2860 -6.0993 
5 80.0823 -1.6722 
6 73.8192 15.2045 
7 68.0459 0.4526 
8 51.8693 -4.5297 
Influence Diagnostics: 
Row Cook'sDist 
1 0.3560 0.2903 
2 0.2971 0.2251 
3 0.0068 0.1787 
4 0.0408 0.1484 
5 0.0026 0.1322 
6 0.2545 0.1488 






































0.5647 0.6454 -1.0245 8 
95% Confidence: Regr. 95% Pop. 5% Predicted Regr. 5% ROW 102.0006 62.4239 1 89.2674 76.5343 
2 86.8768 75.6639 98.0897 60.7201 
3 84.5502 74.5615 94.5389 58.8944 
4 82.2860 73.1815 91.3904 56.9613 
5 80.0823 71.4892 88.6754 54.9370 
6 73.8192 64.7037 82.9347 48.4906 
7 68.0459 56.6884 79.4034 41.8268 
8 51.8693 32.8841 70.8545 21.5562 

































x = col(l) 
y= col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 89.2447}} 




fit f to Y . . 
"fit fto y with we~ght rec~procal_y 







R == 0.88984785 Rsqr = 0.79182919 Adj Rsqr == 0.75713406 






Analysis of Variance: 
DF SS 
Regression 1 1305.1093 
Residual 6 343.1114 
Total 7 1648.2207 
PRESS= 991 .9402 








Normality Test: Passed (P = 0.5061) 






Power of performed test with alpha= 0.0500: 0.8884 
Regression Diagnostics: 
Row Predicted Residual 
1 89.2447 10.7553 
2 86.3151 -2.1575 
3 83.4817 0.4318 
4 80.7413 1.2402 
5 78.0909 -5.5809 
6 70.6503 -9.8174 
7 63.9186 -3.1203 
































Jnf1 ence Diagnostics: u . Leverage DFFITS w Cook'sD1st 
Ro 0.6298 0.3027 1.4257 
~ 0.0157 0.2296 -0.1634 
3 0.0004 0.1790 0.0269 
4 0.0027 0.1476 0.0676 
5 0.0477 0.1321 -0.2981 
6 0.1843 0.1559 -0.6785 
7 0.0362 0.2435 -0.2504 
8 2.9330 0.6097 3.6141 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 89.2447 79.0635 99.4259 68.1249 110.3645 
2 86.3151 77.4494 95.1809 65.7971 106.8332 
3 83.4817 75.6528 91.3107 63.3899 103.5736 
4 80.7413 73.6336 87.8491 60.9194 100.5633 
5 78.0909 71.3662 84.8156 58.4031 97.7787 
6 70.6503 63.3453 77.9553 50.7568 90.5438 
7 63.9186 54.7886 73 .0487 43 .2850 84.5523 
8 45.7797 31.3309 60.2285 22.3029 69.2564 
2D Graph 9 












10 15 20 25 
- Col 30v Col 31 
• Time, weeks v % Drug (Ca Sulfate, 50C/Ory] 
************************************************************************ 
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x = col(l) 
y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y"2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a= yatxnearO(y,x)/2 Auto {{previous: 0.10396}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.831913}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.893294}} 
d == -ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0088255}} 
[Equation] 
f=:a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit fto y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.97516606 Rsqr = 0.95094885 Adj Rsqi = 0.91416049 
Standard Error of Estimate= 0.0224 
Coefficient Std. Error t p 
a 0.1040 0.0334 3.1144 0.0357 
b 0.8319 0.6029 1.3798 0.2398 
c 0.8933 0.0274 32.6200 <0.0001 
d 0.0088 0.0026 3.4236 0.0267 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.0390 0.0130 25.8492 0.0044 
Residual 4 0.0020 0.0005 
Total 7 0.0410 0.0059 
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pR£SS === 0.0191 
purbin-Watson Statistic= 2.7875 
Normality Test: Passed (P = 0.2261) 
Constant Variance Test: Passed (P = 0.6194) 
power of performed test with alpha= 0.0500: 0.9983 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 0.9973 0.0027 0.1224 0.8138 0.7716 
2 0.9307 -0.0114 -0.5104 -0.7925 -0.7475 
3 0.8974 0.0036 0.1586 0.1970 0.1715 
4 . 0.8785 0.0315 1.4044 1.6131 2.3632 
5 0.8660 -0.0286 -1.2765 -1.5233 -2.0360 
6 0.8401 -0.0031 -0.1401 -0.1744 -0.1516 
7 0.8179 0.0062 0.2767 0.3262 0.2863 
8 0.7488 -0.0008 -0.0353 -0.1181 -0.1025 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 7.1494 0.9774 5.0700 
2 0.2215 0.5852 -0.8879 
3 0.0053 0.3520 0.1264 
4 0.2077 0.2420 1.3353 
5 0.2461 0.2978 -1.3260 
6 0.0042 0.3546 -0.1123 
7 0.0104 0.2804 0.1788 
8 0.0355 0.9107 -0.3271 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9973 0.9357 1.0588 0.9097 1.0848 
2 0.9307 0.8831 0.9783 0.8523 1.0091 
3 0.8974 0.8604 0.9343 0.8250 0.9697 
4 0.8785 0.8479 0.9092 0.8091 0.9479 
5 0.8660 0.8321 0.9000 0.7951 0.9370 
6 0.8401 0.8030 0.8772 0.7676 0.9125 
7 0.8179 0.7849 0.8508 0.7474 0.8883 
8 0.7488 0.6893 0.8082 0.6627 0.8348 
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10 15 20 25 
- Col10vCol11 
• Time, weeks v D/Do (Cal Sulfate, 25CJ 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 




x = col(l) 
y= col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] · 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.409319}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00642529}} 
c.= yatxnearO(y,x)/2 "Auto {{previous: 0.514467}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00636928}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f to y with weight reciprocal_y 









R:::: 0.67039549 Rsqr = 0.44943012 Adj Rsqr = 0.03650270 
Standard Error of Estimate= 0.0534 
Coefficient 
0.4093 2.7704 a 
0.0064 0.8393 b 
0.5145 2.7704 c 
d 0.0064 0.6629 



















Nonnality Test: Passed (P = 0.2601) 












The power of the performed test (0.4422) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously.· 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9238 0.0762 
2 0.9179 -0.0340 
3 0.9120 -0.0437 
4 0.9062 -0.0128 
5 0.9005 -0.0218 
6 0.8834 0.0039 
7 0.8666 0.0423 
8 0.8129 -0.0103 
Influence Diagnostics: 
Row Cook'sDist 















































Row Predicted Regr. 5% 
1 0.9238 0.8480 
2 0.9179 0.8496 
3 0.9120 0.8496 
4 0.9062 0.8478 
5 0.9005 0.8439 
6 0.8834 0.8196 
7 0.8666 0.7835 










































10 15 20 25 
- Col15vCol16 
















Y = col(2) 
reciprocal_y= 1/abs(y) 
152 
reciprocal _ysquare= 1/y"2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
:::: yatxnearO(y,x)/2 Auto {{previous: 0.15346}} 
: :::: -ln(.5)/(0.5*(x50(;,y)-min(x))). "Auto {{previous: 1.84686}} 
:::: yatxnearO(y,x)/2 Auto { {prev10us: 0.846437}} 
~:::: -ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00115251}} 
[Equation] 
f=:a*exp(-b*x)+c*exp(-d*x) 
fit f to Y 
"fit fto y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.91149456 Rsqr = 0.83082234 Adj Rsqr = 0.70393910 
Standard Error of Estimate= 0.0337 
Coefficient 
a 0.1535 0.0418 
b 1.8469 1.6895 
c 0.8464 0.0253 
d 0.0012 0.0029 
Analysis of Variance: 
DF SS 
Regression3 0.0223 
Residual 4 0.0045 
Total 7 0.0268 
PRESS == 0.0727 










Nonnality Test: Passed (P = 0.0534) 












power of performed test with alpha= 0.0500: 0.9299 
R gression Diagnostics: 
a:w Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 0.9999 0.0001 0.0031 0.1511 0.1313 
2 0.8697 -0.0005 -0.0147 -0.0569 -0.0493 
3 0.8483 -0.0057 -0.1705 -0.1954 -0.1700 
4 0.8441 0.0282 0.8357 0.9882 0.9843 
5 0.8426 0.0130 0.3863 0.4554 0.4050 
6 0.8396 -0.0570 -1.6914 -1.8922 -5.0595 
7 0.8367 0.0163 0.4837 0.5417 0.4874 
8 0.8271 0.0057 0.1679 0.4485 0.3986 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
I 14.0117 0.9996 6.5020 
2 0.0113 0.9330 -0.1840 
3 0.0030 0.2387 -0.0952 
4 0.0972 0.2848 0.6212 
5 0.0202 0.2804 0.2529 
6 0.2251 0.2010 -2.5373 
7 0.0186 0.2026 0.2457 
8 0.3086 0.8599 0.9873 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95%' 
1 0.9999 0.9064 1.0934 0.8676 1.1321 
2 0.8697 0.7793 0.9600 0.7396 0.9997 
3 0.8483 0.8026 0.8940 0.7442 0.9524 
4 0.8441 0.7942 0.8940 0.7381 0.9501 
5 0.8426 0.7931 0.8922 0:7368 0.9485 
6 0.8396 0.7977 0.8816 0.7371 0.9421 
7 0.8367 0.7946 0.8788 0.7342 0.9393 
8 0.8271 0.7404 0.9139 0.6996 0.9547 
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10 15 20 25 
- Col 25 v Col 26 
• Time.weeks v 0/00 (Cat Sulfate, 40Cfl5%RH] 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
CALCIUM SULFATE (Biphasic First-order reaction) 
S0°C I 20%moisture 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y"2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.148785}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 46.9667}} 
c=yatxnearO(y,x)/2 "Auto {{previous: 0.851214}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0225145}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 









R == o.87160383 Rsqr = 0.75969324 Adj Rsqr = 0.57946318 
Standard Error of Estimate= 0.0999 
Coefficient Std. Error 
0.1488 0.1178 1.2625 a 
46.9667 4971732.3006 0.0000 b 
0.8512 0.0625 c 
d 0.0225 0.0100 















Durbin-Watson Statistic= 1.8740 
Nonnality Test: Failed (P = 0.0154) 








Power of performed test with alpha= 0.0500: 0.8498 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0000 0.0000 
2 0.8323 -0.0851 
3 0.8137 0.0100 
4 0.7956 -0.0338 
5 0.7779 0.0062 
6 0.7271 0.1631 
7 0.6796 0.0054 
8 0.5426 -0.0692 
Influence Diagnostics: 
Row Cook'sDist 
1 (+inf) 1.0000 
2 0.1157 0.3069 
3 0.0011 0.2430 
4 0.0087 0.1967 
5 0.0002 0.1663 















































R Predicted Regr. 5% ow 
1 1.0000 0. 7225 
2 0.8323 0.6786 
3 0.8137 0.6770 
4 0.7956 0.6726 
5 0.7779 0.6648 
6 0.7271 0.6190 
7 0.6796 0.5490 
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x = col(l) 
Y = col(2) 
reciprocal_y= 1/abs(y) 
~eciprocal_ysquare= 1/y/\2 
Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
YatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.437725}} 
157 
b == -ln(.5)/{0.5*(x50{~,y)-min(x))). "Auto {{previous: 0.211931}} 
_ atxnearO(y,x)/2 Auto {{previous: 0.54193}} ~: :ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 2.18758e-011}} 
[Equation] * * 
f::::a*exp(-b*x)+c exp(-d x) 
fit f to Y . . 
"fit fto y with we~ght rec~procal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.97882582 Rsqr = 0.95809999 Adj Rsqr = 0.92667497 
Standard Error of Estimate= 0.0416 
Coefficient 
a 0.4377 0.2591 
b 0:2119 0.1610 
c 0.5419 0.2714 
d 0.0000 0.0245 
Analysis of Variance: 
DF SS 
Regression3 0.1579 
Residual 4 0.0069 
Total 7 0.1648 
PRESS == 0.0772 










Normality Test: Passed (P = 0.4467) 








Power of performed test with alpha = 0.0500: 0.9991 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9797 0.0203 











Stud. Del. Res. 
1.1543 
-2.0912 
0.8284 0.0107 0.2577 0.3037 0.2661 3 0.7737 0.0461 1.1096 1.3399 1.5630 4 0.7294 -0.0043 -0.1046 -0.1253 -0.1087 5 0.6412 -0.0329 -0.7916 -0.9896 -0.9863 6 
7 0.5945 0.0135 0.3243 0.5626 0.5077 
8 0.5482 0.0011 0.0262 0.3785 0.3338 
Influence Diagnostics: 
Leverage DFFITS Row Cook'sDist 
1 1.2704 0.8051 2.3460 
2 0.2253 0.2753 -1.2890 
3 0.0090 0.2798 0.1659 
4 0.2057 0.3143 1.0582 
5 0.0017 0.3025 -0.0716 
6 0.1378 0.3601 -0.7399 
7 0.1589 0.6676 0.7195 
8 7.4290 0.9952 4.8078 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9797 0.8761 1.0832 0.8247 1.1347 
2 0.8961 0.8355 0.9566 0.7658 1.0263 
3 0.8284 0.7674 0.8895 0.6979 0.9589 
4 0.7737 0.7090 0.8384 0.6415 0.9060 
5 0.7294 0.6660 0.7929 0.5978 0.8611 
6 0.6412 0.5720 0.7105 0.5067 0.7758 
7 0.5945 0.5002 0.6888 0.4455 0.7435 
8 0.5482 0.4332 0.6633 0.3853 0.7112 
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• Time.weeks v D/Do [Cal Sulfate, SOC/Dry) 
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x === col(l) 
y == col(2) 
reciprocal _y= 1/abs(y) 
reciprocal_ys~~are= 11Y'''2 . . 
'Automatic Imtial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a== yatxnearO(y,x) Auto {{previous: 99.7941}} 




"fit fto y with weight reciprocal_y 







R=0.81183641 Rsqr == 0.65907835 Adj Rsqr == 0.60225808 






Analysis of Variance: 
DF SS 
Regression I 86.2916 
Residual 6 44.6361 
Total 7 130.9276 
PRESS== 191.7129 


















Constant Variance Test: Failed (P = 0.0212) 
power of performed test with alpha= 0.0500: 0.7164 
The power of the performed te~t (0.71?4) is bel.ow the desired power of 0.8000. 
You should interpret the negative findmgs cautiously. 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 99.7941 0.2059 0.0755 0.0871 0.0796 
2 99.2258 0.3929 0.1441 0.1619 0.1481 
3 98.6608 2.6544 0.9732 1.0720 1.0883 
4 98.0989 1.2187 0.4468 0.4851 0.4518 
5 97.5403 -1 .0840 -0.3974 -0.4274 -0.3962 
6 95.8833 -1.1694 -0.4287 -0.4601 -0.4276 
7 94.2546 -5.0372 -1.8468 -2.0522 -3.4314 
8 89.0225 2.8270 1.0365 2.1085 3.7821 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0013 0.2490 0.0458 
2 0.0034 0.2082 0.0759 
3 0.1225 0.1758 0.5026 
4 0.0210 0.1516 0.1910 
5 0.0143 0.1353 -0.1568 
6 0.0160 0.1316 -0.1664 
7 0.4944 0.1902 -1.6627 
8 6.9770 0.7584 6.7004 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 99.7941 96.4636 103.1247 92.3352 107.2530 
2 99.2258 96.1807 102.2709 91.8900 106.5617 
3 98.6608 95.8626 101.4589 91.4239 105.8976 
4 98.0989 95.5004 100.6974 90.9369 105.2609 
5 97.5403 95.0851 99.9954 90.4290 104.6515 
6 95.8833 93.4626 98.3041 88.7839 102.9828 
7 94.2546 91.3443 97.1649 86.9736 101.5355 
8 89.0225 83.2105 94.8346 80.1726 97.8725 
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10 15 20 25 
- Col 10 v Col 11 
• Time, weeks v % Drug [Mannitol, 25C) 
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x = col(l) 
y= col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y" 2 · 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 96.8219} } 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.000606115}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





stepsize= 1 00 
iterations= 1 oo 
162 
R == 0.10972658 Rsqr = 0.01203992 Adj Rsqr = 0.00000000 























Normality Test: Passed (P = 0.6426) 










The power of the performed test (0.0433) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
l 96.8219 3.1781 
2 96.7632 0.1484 
3 96.7046 4.2603 
4 96.6460 0.4894 
5 96.5874 -5.0795 
6 96.4119 -4.3008 
7 96.2368 -1.4615 
8 95.6553 2.7657 
Influence Diagnostics: 
Row Cook'sDist 
l 0.1524 0.2400 
2 0.0003 0.2040 
3 0.1691 0.1747 
4 0.0018 0.1522 
5 0.1715 0.1365 





































0.0211 0.1821 -0.1906 7 4.5310 0.7811 3.6182 8 
95% Confidence: 
Regr. 95% Pop. 5% Pop. 95% Row Predicted Regr. 5% 
1 96.8219 92.3741 101.2696 86.7123 106.9315 
2 96.7632 92.6630 100.8634 86.8016 106.7248 
3 96.7046 92.9098 100.4993 86.8647 106.5444 
4 96.6460 93.1039 100.1881 86.9008 106.3912 
5 96.5874 93.2336 99.9412 86.9091 106.2657 
6 96.4119 93.1463 99.6776 86.7638 106.0601 
7 96.2368 92.3628 100.1108 86.3661 106.1075 
8 95.6553 87.6313 103.6792 83.5389 107.7716 











10 15 20 25 
- Col15vCol16 
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x = col(l) 
Y = col(2) 
reciprocal_y= 1/ abs(y) 
~eciprocal_ysquare= 1 /y"2 
Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 97.8276}} 
164 
b == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.00540918}} 
[Equation] 
f::::a*exp(-b*x) 
fit fto Y . . 
"fit fto y with we~ght rec~procal_y 







R = 0. 75578351 Rsqr = 0.57120871 Adj Rsqr = 0.49974349 






Analysis of Variance: 
DF SS 
Regression 1 76.5729 
Residual 6 57.4812 
Total 7 134.0541 
PRESS= 116.2583 








Normality Test: Passed (P = D.4876) 










The power of the performed test (0.5970) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 97.8276 2.1724 
2 97.2999 -0.4606 
3 96.7750 0.9734 

















95.7337 -1.1414 -0.3688 -0.3966 -0.3669 5 94.1927 -2.0666 -0.6677 -0.7164 -0.6839 6 92.6765 5.5524 1.7939 1.9928 3.1284 7 87.7966 -1.3882 -0.4485 -0.9149 -0.9004 8 
Influence Diagnostics: 
Leverage DFFITS Row Cook'sDist 
1 0.1084 0.2485 0.4503 
2 0.0037 0.2079 -0.0784 
3 0.0128 0.1757 0.1475 
4 0.1459 0.1516 -0.5781 
5 0.0123 0.1354 -0.1452 
6 0.0388 0.1314 -0.2660 
7 0.4648 0.1897 1.5136 
8 1.3232 0.7597 -1.6009 
95% Confidence: 
Row Predicted Regr. 5 % Regr. 95% Pop. 5% Pop. 95% 
1 97.8276 94.0520 101.6032 89.3650 106.2902 
2 97.2999 93.8463 100.7535 88.9759 105.6238 
3 96.7750 93.6001 99.9498 88.5628 104.9872 
4 96.2529 93.3038 99.2021 88.1253 104.3805 
5 95.7337 92.9469 98.5204 87.6636 103.8038 
6 94.1927 91.4471 96.9383 86.1367 102.2487 
7 92.6765 89.3780 95.9750 84.4157 100.9373 
8 87.7966 81.1954 94.3979 77.7499 97.8434 
20 Graph 13 
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10 15 20 25 
- Col 25 v Col 26 




l\fANNITOL (First-order reaction) 
50oc I 20 %moist~re 
Nonlinear Regression 
[Variables] 
x == col(l) 
y == col(2) 
reciprocal _y= 1/abs(y) 
reciprocal_ysquare= 1/y/\2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a== yatxnearO(y,x) Auto {{previous: 97 .1413}} 




"fit fto y with weight reciprocal_y 







R = 0.82013595 Rsqr = 0.67262297 Adj Rsqr = 0.61806013 






Analysis of Variance: 
DF SS 
Regressionl 171.3449 
Residual 6 83.3965 
Total 7 254.7413 
PRESS= 139.4052 


















Constant Variance Test: Passed (P = 0.8393) 
power of performed test with alpha= 0.0500: 0.7349 
The power of the performed te~t (0.73~9) is bel.ow the desired power of 0.8000. 
You should interpret the negative findmgs cautiously. 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 97.1413 2.8587 0.7668 0.8878 0.8696 
2 96.3210 4.4557 1.1951 1.3450 1.4691 
3 95.5076 -0.3017 -0.0809 -0.0892 -0.0814 
4 94.7011 -4.1309 -1.1080 -1.2027 -1.2603 
5 93.9014 -2.8757 -0.7714 -0.8292 -0.8045 
6 91.5426 -4.2865 -1.1498 -1.2348 -1.3052 
7 89.2430 3.2310 0.8666 0.9658 0.9594 
8 81.9869 1.0640 0.2854 0.5655 0.5306 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.1342 0.2541 0.5075 
2 0.2411 0.2104 0.7584 
3 0.0009 0.1763 -0.0377 
4 0.1288 0.1512 -0.5319 
5 0.0535 0.1348 -0.3175 
6 0.1170 0.1330 -0.5113 
7 0.1129 0.1949 0.4720 
8 0.4680 0.7453 0.9077 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 97.1413 92.5431 101.7395 86.9254 107.3572 
2 96.3210 92.1362 100.5058 86.2844 106.3576 
3 95.5076 91.6772 99.3380 85.6135 105.4017 
4 94.7011 91.1536 98.2486 84.9131 104.4891 
5 93.9014 90.5526 97.2502 84.1836 103.6192 
6 91.5426 88.2151 94.8701 81.8321 101.2531 
7 89.2430 85.2161 93.2699 79.2712 99.2148 
8 81.9869 74.1112 89.8626 69.9350 94.0388 
168 
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10 15 20 25 
- Col30vCot31 
• Time, weeks v % Drug [Mannitol, SOC/20%RHJ 
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x = col(l) 
y= col(2) 
reciprocal _y= 1 / abs(y) 
reciprocal_ysquare= 1/y-''2 
'Automatic Initial Parameter Estimate Functions 
xnearO(q)=max(abs(q))-abs(q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 95.6578}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0224532}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 







R==0.74699016 Rsqr = 0.55799429 Adj Rsqr = 0.48432668 
169 























Normality Test: Failed (P = 0.0176) 










The power of the performed test (0.5794) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 95.6578 4.3422 
2 93.5339 2.1604 
3 91.4572 4.6360 
4 89.4266 1.6171 
5 87.4410 2.0683 
6 81.7450 -22.6505 
7 76.4201 -1.3635 
8 61.0513 9.6455 
Influence Diagnostics: 
Row Cook'sDist 
1 0.0465 0.2806 
2 0.0078 0.2215 
3 0.0258 0.1782 
4 0.0024 0.1492 
5 0.0034 0.1326 
6 0.4575 0.1438 






































2.6637 0.6731 2.7939 8 
95% Confidence: 
Regr. 95% Pop. 5% Pop. 95% Row Predicted Regr. 5% 
1 95:6578 82.0656 109.2500 66.6198 124.6958 
2 93.5339 81.4584 105.6095 65.1741 121.8937 
3 91.4572 80.6237 102.2907 63.6036 119.3108 
4 89.4266 79.5159 99.3373 61.9187 116.9344 
5 87.4410 78.0965 96.7856 60.1321 114.7500 
6 81.7450 72.0150 91.4751 54.3018 109.1883 
7 76.4201 64.3544 88.4858 48.0645 104.7757 
8 61.0513 39.9992 82.1034 27.8601 94.2424 













10 15 20 25 
- Col35vCol 36 
• Time. weeks v % Drug !Mannitol, SOC/Ory) 
************************************************************************ 




x = col(l) 
Y = col(2) 
reciprocal_y= l/abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a=yatxnearO(y,x)/2 "Auto {{previous: 0.121814}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.133524}} 
171 
I I i 
I 
=== atxnearO(y,x)/2 "Auto {{previous: 0.895236}} ~ === :ln(.5)/(l.5*(x50(x,y)-rnin(x))) "Auto {{previous: 3.93015e-010}} 
[Equation] 
f::::a*exp(-b*x)+c*exp(-d*x) 
fit f to Y . . 
"fit f toy with we~ght rec~procal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R=0.89221155 Rsqr = 0.79604144 Adj Rsqr = 0.64307252 
Standard Error of Estimate = 0.0258 
Coefficient 
a 0.1218 0.5065 
b 0.1335 0.5219 
c 0.8952 0.5172 
d 0.0000 0.0224 
Analysis of Variance: 
DF SS 
Regression3 0.0104 
Residual 4 0.0027 
Total 7 0.0131 
PRESS= 45.5486 










Normality Test: Passed (P = 0.7148) 








Power of performed test with alpha = 0.0500: 0.8932 
Regression Diagnostics: 
Row Predicted Residual 
I 1.0170 -0.0170 
2 1.0018 -0.0056 


















0.0163 0.6321 0.7610 0.7126 
5 0.9666 
-0.0021 -0.0805 -0.0979 -0.0849 
6 0.9431 
0.0041 0.1573 0.1939 0.1687 
7 0.9273 
-0.0351 -1.3589 -2.6360 (+int) 
8 0.9037 0.0148 
0.5739 12.2416 (+int) 
Influence Diagnostics: 
Leverage DFFITS Row Cook'sDist 
1 1.5161 0.7655 -2.9139 
2 0.0061 0.2717 -0.1363 
3 0.1049 0.2555 0.6733 
4 0.0650 0.3100 0.4776 
5 0.0011 0.3239 -0.0588 
6 0.0049 0.3414 0.1215 
7 4.7995 0.7342 (+int) 
8 17010.3237 0.9978 (+int) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0170 0.9543 1.0798 0.9217 1.1124 
2 1.0018 0.9644 1.0392 0.9209 1.0827 
3 0.9885 0.9522 1.0248 0.9081 1.0689 
4 0.9768 0.9369 1.0168 0.8947 1.0589 
5 0.9666 0.9258 1.0075 0.8841 1.0492 
6 0.9431 0.9012 0.9850 0.8600 1.0262 
7 0.9273 0.8658 0.9888 0.8328 1.0218 
8 0.9037 0.8320 0.9753 0.8023 1.0051 














10 15 25 
- Col10 v Col 11 
• Time, weeks v DIDo, (Mannitol, 25C] 
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••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• ;fANNiTOL ( BiPhasic First-order reactfon) 
2soc I 60 %RH . 
Nonlinear Regression 
[Variables] 
x == col{l) 
y == col{2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y"2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a== yatxnearO(y,x)/2 Auto {{previous: 0.0547482}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.487789}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.948324}} 
d = -ln{.5)/(1.5*(x50{x,y)-min(x))) "Auto {{previous: l .26353e-O 11}} 
(Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit fto y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.55878062 Rsqr = 0.31223578 Adj Rsqr = 0.00000000 
Standard Error of Estimate = 0.0379 
Coefficient Std. Error t p 
a 0.0547 0.0695 0.7882 0.4746 
b 0.4878 1.2185 0.4003 0.7094 
c 0.9483 0.0662 14.3342 0.0001 
d 0.0000 0.0048 0.0000 1.0000 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.0026 0.0009 0.6053 0.6455 
Residual 4 0.0057 0.0014 
Total 7 0.0084 0.0012 
174 
pR.ESS == 1.6045 
ourbin-Watson Statistic= 1.5317 
Normality Test: Passed (P = 0.7430) 
Constant Variance Test: Passed (P = 0.7053) 
Power of performed test with alpha= 0.0500: 0.2915 
The power of the performed test (0.2915) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Std. Res. Row Predicted Residual Stud. Res. Stud. Del. Res. 
1 1.0031 -0.0031 -0.0810 -0.2768 -0.2420 
2 0.9819 -0.0128 -0.3382 -0.4224 -0.3742 
3 0.9690 0.0407 1.0731 1.3410 1.5653 
4 0.9610 0.0104 0.2732 0.3218 0.2824 
5 0.9561 -0.0410 -1.0821 -1.2497 -1.3862 
6 0.9501 -0.0290 -0.7652 -1.0112 -1.0151 
7 0.9487 -0.0010 -0.0261 -0.0348 -0.0301 
8 0.9483 0.0359 0.9464 5.6130 (+inf) 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.2043 0.9143 -0.7905 
2 0.0250 0.3589 -0.2800 
3 0.2525 0.3596 1.1731 
4 0.0100 0.2792 0.1757 
5 0.1303 0.2503 -0.8009 
6 0.1908 0.4273 -0.8769 
7 0.0002 0.4387 -0.0266 
8 269.1707 0.9716 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0031 0.9024 1.1037 0.8574 1.1487 
2 0.9819 0.9189 1.0450 0.8592 1.1047 
3 0.9690 0.9058 1.0321 0.8462 1.0917 
4 0.9610 0.9054 1.0166 0.8419 1.0801 
5 0.9561 0.9034 1.0088 0.8384 1.0738 
6 0.9501 0.8813 1.0189 0.8244 1.0759 
7 0.9487 0.8790 1.0185 0.8225 1.0750 
8 0.9483 0.8446 1.0521 0.8005 1.0961 
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10 15 20 25 
- Col 15vCol 16 
• Time, weeks v D/Oo, (Mannitol, 25Cf60% RH) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 




x = col(l) 
y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1 /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatyrnax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.323691}} 
b = -ln(.5)/(0.5*(x50(x,y)-rnin(x))) "Auto { {previqus: 0.00543067}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.654584}} 
d = -ln(.5)/(1 .5*(x50(x,y)-min(x))) "Auto {{previous: 0.00539824}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 









R:::::: o.75578349 Rsqr = 0.57120869 Adj Rsqr = 0.24961521 
Standard Error of Estimate= 0.0379 
Coefficient 
0.3237 753959.2906 a 
0.0054 215.4067 b 
c 0.6546 753959.2906 
d 0.0054 106.9689 



















Nonnality Test: Passed (P = 0.4877) 












The power of the performed test (0.5970) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. · 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9783 0.0217 
2 0.9730 -0.0046 
3 0.9677 0.0097 
4 0.9625 -0.0364 
5 0.9573 -0.0114 
6 0.9419 -0.0207 
7 0.9268 0.0555 
8 0.8780 -0.0139 
Influence Diagnostics: 
Row Cook'sDist 















































Row Predicted Regr. 5% 
1 0.9783 0.9087 
2 0.9730 0.9236 
3 0.9677 0.9571 
4 0.9625 0.9231 
5 0.9573 0.9115 
6 0.9419 0.8813 
7 0.9268 0.8631 
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- Col 20vCol21 










MANNiToi· ( liii>i.~~;; Fi;s·t:~;ci;; ;;~~ti~~)·································· 
50°C I 20 %moisture 
Nonlinear Regression 
[Variables] 
x =col( I) 
Y = col(2) 
rec~procal_y= 1/ abs(y) 
reciprocal_ysquare= 1 /y"2 
'Automatic Initial Parameter Estimate Functions 
178 
xnearO( q)==max( abs( q) )-abs( q) 
yaixnearO( q,r )==xatymax( q,xnearO( r)) 
[Parameters] 11 • 
== yatxnearO(y,x)/2 Auto {{previous: 0.093512}} 
: == -ln(.5)/(0.5*(x50(~,y)-min(x))). "Auto {{previous: 0.488568}} 
== yatxnearO(y,x)/2 Auto {{previous: 0.921222}} 
~ == -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00453147}} 
[Equation] 
f==a*exp(-b*x)+c*exp(-d*x) 
tit f to Y 
"fit fto y with weight reciprocal_y 





tolerance== 1 e-6 
stepsize=O .1 
iterations= 100 
R == 0.90606896 Rsqr = 0.82096096 Adj Rsqr = 0.68668169 
Standard Error of Estimate= 0.0338 
Coefficient 
a 0.0935 0.0647 
b 0.4886 0.6485 
c 0.9212 0.0623 
d 0.0045 0.0047 
Analysis of Variance: 
DF SS 
Regression3 0.0209 
Residual 4 0.0046 
Total 7 0.0255 
PRESS= 0.1631 










Normality Test: Passed (P = 0.1765) 













R gression Diagnostics: 
Re Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
ow 
-0.4363 -1.4949 -1.9487 1 I.0147 -0.0147 
2 0.9744 0.0333 0.9873 1.2347 1.3593 
3 0.9481 0.0040 0.1170 0.1463 0.1270 
4 0.9304 -0.0247 -0.7307 -0.8608 -0.8259 
5 0.9179 -0.0077 -0.2270 -0.2625 -0.2293 
6 0.8955 -0.0230 -0.6799 -0.9002 -0.8730 
7 0.8811 0.0436 1.2919 1.7180 2.9059 
8 0.8414 -0.0109 -0.3228 -1.8256 -3.8717 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 5.9980 0.9148 -6.3851 
2 0.2149 0.3606 1.0208 
3 0.0030 0.3602 0.0953 
4 0.0718 0.2794 -0.5143 
5 0.0058 0.2523 -0.1332 
6 0.1525 0.4296 -0.7576 
7 0.5668 0.4345 2.5470 
8 25.8207 0.9687 -21.5526 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
l 1.0147 0.9251 1.1044 0.8850 1.1445 
2 0.9744 0.9181 1.0307 0.8651 1.0838 
3 0.9481 0.8918 1.0044 0.8388 1.0574 
4 0.9304 0.8808 0.9799 0.8243 1.0364 
5 0.9179 0.8708 0.9650 0.8130 1.0228 
6 0.8955 0.8341 0.9570 0.7834 1.0076 
7 0.8811 0.8193 0.9429 0.'7688 0.9934 
8 0.8414 0.7491 0.9337 0.7099 0.9730 










10 15 20 25 
- Col 25 v Col 26 
• Time, weeks v O/Do, (Mannitol, 50C/20% Moisture] 
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x == col(l} 
y == col(2) 
reciprocal _y= 1/abs(y) 
reciprocal _ysquare= 1 ly1'2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] ,, . 
a== yatxnearO(y,x)/2 Auto { {prev10us: 0.367652}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.200456}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.668022}} 
d = -ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 3.69366e-010}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.85831342 Rsqr = 0.73670192 Adj Rsqr = 0.53922836 
Standard Error of Estimate = 0.0991 
Coefficient Std. Error t p 
a 0.3677 0.6963 0.5280 0.6254 
b 0.2005 0.4714 0.4253 0.6925 
c 0.6680 0.7276 0.9181 0.4105 
d 0.0000 0.0520 0.0000 1.0000 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.1100 0.0367 3.7306 0.1179 
Residual 4 0.0393 0.0098 
Total 7 0.1493 0.0213 
181 
pRESS == 55.3088 
Durbin-Watson Statistic= 2.4780 
Nonnality Test: Failed (P = 0.0438) 
Constant Variance Test: Passed (P = 0.8849) 
Power of performed test with alpha= 0.0500: 0.8206 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 1.0357 -0.0357 -0.3599 -0.8043 -0.7608 
2 0.9689 -0.0119 -0.1205 -0.1415 -0.1229 
3 0.9142 0.0467 0.4710 0.5537 0.4990 
4 0.8695 0.0409 0.4128 0.4984 0.4457 
5 0.8329 0.0622 0.6272 0.7527 0.7036 
6 0.7584 -0.1674 -1.6892 -2.1065 (+inf) 
7 0.7176 0.0330 0.3330 0.5861 0.5309 
8 0.6747 0.0323 0.3256 4.9393 (+inf) 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.6462 0.7998 -1.5207 
2 0.0019 0.2744 -0.0756 
3 0.0293 0.2763 0.3083 
4 0.0284 0.3141 0.3016 
5 0.0623 0.3056 0.4668 
6 0.6158 0.3570 (+inf) 
7 0.1801 0.6771 0.7687 
8 1397.8128 0.9957 · (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% · Pop. 5% Pop. 95% 
1 1.0357 0.7895 1.2818 0.6664 1.4049 
2 0.9689 0.8247 1.1131 0.6582 1.2796 
3 0.9142 0.7696 1.0589 0.6033 1.2252 
4 0.8695 0.7153 1.0238 0.5540 1.1850 
5 0.8329 0.6808 0.9851 0.5184 1.1474 
6 0.7584 0.5940 0.9228 0.4378 1.0790 
7 0.7176 0.4911 0.9440 0.3611 1.0740 
8 0.6747 0.4001 0.9493 0.2859 1.0635 
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10 15 20 25 
- Col30vCol31 
• Time, weeks v O/Do, (Mannitol, 50C!Ory] 
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y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO(q)=max(abs(q))-abs(q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a =yatxnearO(y,x) "Auto {{previous: 98.7481}} . 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0143815}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit fto y with weight reciprocal_y 




tolerance=O. 000 I 
stepsize= 1 00 
iterations= 100 
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R == 0.85870060 Rsqr = 0.73736673 Adj Rsqr = 0.69359452 























Nonnality Test: Passed (P = 0.6251) 






Power of performed test with alpha= 0.0500: 0.8215 
Regression Diagnostics: 
Row Predicted Residual 
1 98.7481 1.2519 
2 97.3382 -0.4754 
3 95.9483 2.5909 
4 94.5783 7.3974 
5 93.2279 -8.9998 
6 89.2911 -2.6968 
7 85.5206 -1.6393 
8 74.0650 2.6254 
Influence Diagnostics: 
Row Cook'sDist 
1 0.0143 0.2649 
2 0.0015 0.2151 
3 0.0327 0.1773 
4 0.2123 0.1504 
5 0.2687 0.1337 
6 0.0249 0.1369 
7 0.0163 0.2054 











































LACTOSE HYDROUS (First-order reaction) 
25°C /60 %RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
Y = col(2) 
reciprocal_y= 1 I abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO(q)=max(abs(q))-abs(q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 93 .9494}} 




fit fto Y . . 
"fit f toy with we~ght rec~procal_y 





stepsize= 1 00 
iterations= 100 
R == 0.71848585 Rsqr = 0.51622191 Adj Rsqr = 0.43559223 























Normality Test: Passed (P = 0.6128) 










The power of the performed test (0.5249) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
I 93.9494 6.0506 
2 92.6563 1.2016 
3 91.3810 5.7777 
4 90.1233 -3.3359 
5 88.8828 -5.2034 
6 85.2630 -0.0518 


























8 71.2055 8.4481 1.1170 2.1055 3.7615 
Influence Diagnostics: 
Leverage DFFITS Row Cook'sDist 
1 0.1560 0.2641 0.5515 
2 0.0044 0.2148 0.0858 
3 0.0764 0.1772 0.3799 
4 0.0203 0.1505 -0.1874 
5 0.0422 0.1338 -0.2781 
6 0.0000 0.1366 -0.0027 
7 0.4584 0.2046 -1.3721 
8 5.6602 0.7186 6.0107 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 93.9494 84.4385 103.4603 73.1415 114.7573 
2 92.6563 84.0793 101.2334 72.2583 113.0543 
3 91.3810 83.5908 99.1713 71.3012 111.4609 
4 90.1233 82.9448 97.3018 70.2728 109.9738 
5 88.8828 82.1140 95.6517 69.1768 108.5889 
6 85.2630 78.4238 92.1022 65.5327 104.9934 
7 81.7907 73.4201 90.1612 61.4786 102.1027 


















10 15 20 25 
-Col 15vCol16 
• Time, weeks v % Drug [lactose hydrous, 25Cl60%RH) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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LACTOSE HYDROUS (First-order reaction) 





reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y;\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a= yatxnearO(y,x) Auto { {prev10us: 86.3848}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0 .0167549}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 







R = 0.76339834 Rsqr = 0.58277703 Adj Rsqr = 0.51323986 






Analysis of Variance: 
DF SS 
Regression 1 430.8915 
Residual 6 308.4848 
Total 7 739.3762 
PRESS= 837.5987 


















Constant Variance Test: Passed (P = 0.8849) 
power of performed test with alpha= 0.0500: 0.6125 
The power of the performed te~t (0.61~5) is bel_ow the desired power of 0.8000. 
You should interpret the negative findmgs cautiously. 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 86.3848 13.6152 1.8988 2.2217 4.8166 
2 84.9495 -1.5968 -0.2227 -0.2517 -0.2310 
3 83.5380 -4.2025 -0.5861 -0.6463 -0.6116 
4 82.1500 -4.4393 -0.6191 -0.6715 -0.6375 
5 80.7851 -0.1747 -0.0244 -0.0262 -0.0239 
6 76.8248 -6.9567 -0.9702 -1.0455 -1.0553 
7 73.0587 -1.7090 -0.2383 -0.2682 -0.2463 
8 61.7883 5.6432 0.7870 1.4457 1.6349 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.9109 0.2696 2.9261 
2 0.0088 0.2171 -0.1216 
3 0.0451 0.1776 -0.2842 
4 0.0398 0.1500 -0.2678 
5 0.0001 0.1333 -0.0094 
6 0.0881 0.1388 -0.4236 
7 0.0096 0.2100 -0.1270 
8 2.4815 0.7037 2.5193 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 86.3848 77.2752 95.4944 66.6156 106.1540 
2 84.9495 76.7752 93.1238 65.5935 104.3055 
3 83.5380 76.1443 90.9318 . 64.4985 102.5776 
4 82.1500 75.3543 88.9458 63.3347 100.9654 
5 80.7851 74.3789 87.1913 62.1069 99.4633 
6 76.8248 70.2888 83.3608 58.1017 95.5479 
7 73.0587 65.0184 81.0990 53.7589 92.3585 
8 61.7883 47.0707 76.5060 38.8876 84.6891 
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10 15 20 25 
- Col20vCol21 
• Time, weeks v % Drug (Lactose hydrous, 40Cf75%RH) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
LACTOSE HYDROUS (First-order reaction) 
S0°C I 20 %moisture 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal _y= 1 / abs(y) 
reciprocal _ysquare= 1/Y' '2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 80.5994}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0464301}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f to y with weight reciprocal y 





stepsize= 1 00 
iterations= 1 oo 
190 
R == o.83098356 Rsqr = 0.69053367 Adj Rsqr = 0.63895595 























Normality Test: Passed (P = 0.6231) 










The power of the performed test (0.7592) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 80.5994 19.4006 
2 76.9427 -1.7701 
3 73.4519 -12.3742 
4 70.1195 -10.3242 
5 66.9383 -1.0011 
6 58.2347 -4.9448 
7 50.6627 9.4856 
8 31.8453 2.5046 
Influence Diagnostics: 
Row Cook'sDist 
1 1.0988 0.3312 
2 0.0051 0.2386 
3 0.1605 0.1792 
4 0.0841 0.1459 
5 0.0007 0.1332 





































0.1802 0.2704 0.5987 7 0.0583 0.5272 0.3146 8 
95% Confidence: 
Regr. 95% Pop. 5% Pop. 95% Row Predicted Regr. 5% 
1 80.5994 64.7409 96.4579 48.8060 112.3928 
2 76.9427 63.4814 90.4040 46.2746 107.6109 
3 73.4519 61.7883 85.1155 43.5292 103.3746 
4 70.1195 59.5932 80.6458 40.6215 99.6175 
5 66.9383 56.8811 76.9955 37.6044 96.2722 
6 58.2347 46.7322 69.7371 28.3744 88.0950 
7 50.6627 36.3334 64.9921 19.6037 81.7217 
8 31.8453 11.8369 51.8537 -2.2086 65.8992 











20 ~-..---..,-- -,----,----,- --i 
10 15 20 25 
- Col25vCol26 
• Time, weeks v % Drug [Lactose hydrous, 50C/20% Moisture] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 





Y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 95.4743} } 
192 
b==-ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0541414}} 
[Equation] 
f:::a*exp(-b*x) 
fitftoy . . 
"fit f toy with we~ght rec~procal_y 







R == 0.9670 Rsqr == 0.9352 Adj Rsqr == 0.9244 






Analysis of Variance: 
DF SS 
Regression I 2878.0139 
Residual 6 199.5029 
Total 7 3077.5168 
PRESS == 362.9285 








Nonnality Test: Passed (P == 0.4645) 






Power of performed test with alpha== 0.0500: 0.9955 
Regression Diagnostics: 
Row Predicted Residual 
1 95.4743 4.5257 
2 90.4427 6.3309 
3 85.6762 -0.6116 
4 81.1609 -5.7712 
5 76.8836 -8.9200 
6 65.3572 -0.2466 





























8 32.3311 4.9544 0.8592 1.1889 1.2413 
Influence Diagnostics: 
Leverage DFFITS Row Cook'sDist 
I 0.2528 0.3484 0.7072 
2 0.2564 0.2435 0.7627 
3 0.0015 0.1789 -0.0499 
4 0.0996 0.1453 -0.4542 
5 0.2157 0.1349 -0.8167 
6 0.0003 0.1864 -0.0207 
7 0.0091 0.2849 0.1236 
8 0.6463 0.4777 1.1871 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
I 95.4743 87.1455 103 .. 8032 79.0898 111.8589 
2 90.4427 83.4808 97.4046 74.7089 106.1764 
3 85.6762 79.7Q83 91.6441 70.3563 100.9961 
4 81.1609 75.7826 86.5391 66.0609 96.2608 
5 76.8836 71.7011 82.0660 61.8522 91.9149 
6 65.3572 59.2656 71.4489 49.9887 80.7257 
7 55.5589 48.0275 63.0903 39.5650 71.5528 
8 32.3311 22.5792 42.0830 15.1794 49.4828 
20 Graph 26 
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10 15 20 25 
- Col 35 vCol36 
• Time, weeks v % Drug [Lactose hydrous, SOCJOry) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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x == col(l) 
y == col(2) 
reciprocal _y= 1/abs(y) 
reciprocal_ysquare= 1/y"' 2 . . 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 11 • 
a== yatxnearO(y,x)/2 Auto { {prev10us: 0.288768}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0957106}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.722904}} 
d == -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 7.9 l 853e-011}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d *x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.88330073 Rsqr = 0.78022017 Adj Rsqr = 0.61538530 
Standard Error of Estimate= 0.0581 
Coefficient Std. Error t p 
a 0.2888 2.7836 0.1037 0.9224 
b 0.0957 0.7316 0.1308 0.9022 
c 0.7229 2.8101 0.2573 0.8097 
d 0.0000 0.1240 0.0000 1.0000 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.0479 0.0160 4.7333 0.0836 
Residual 4 0.0135 0.0034 
Total 7 0.0613 0.0088 
195 
pRESS == 1.0056 
Durbin-Watson Statistic= 2.6048 
Normality Test: Passed (P = 0.2530) 
Constant Variance Test: Passed (P = 0.1597) 
Power of performed test with alpha= 0.0500: 0.8748 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0117 -0.0117 
2 0.9853 -0.0167 
3 0.9614 0.0240 
4 0.9396 0.0802 
5 0.9198 -0.0775 
6 0.8707 -0.0047 
7 0.8338 0.0050 
8 0.7655 0.0014 
Influence Diagnostics: 
Row Cook'sDist 
1 0.1168 0.7459 
2 0.0106 0.2718 
3 0.0184 0.2452 
4 0.3020 0.3055 
5 0.3328 0.3324 
6 0.0013 0.3369 
7 0.0256 0.7637 


































































































10 15 20 25 
- Col10vCol11 
• Time, weeks v D/Do ( Lactose hydrous, 25C] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 





y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO(q)=max(abs(q))-abs(q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.255963}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.234103}} 
c = yatxnearO{y,x)/2 "Auto {{previous: 0.753922}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 2.42093e-010}} 
[Equation) 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 









R:::: 0.88085926 Rsqr = 0.77591304 Adj Rsqr = 0.60784783 
Standard Error of Estimate= 0.0630 
Coefficient 
a 0.2560 0.3159 
b 0.2341 0.3986 
c 0.7539 0.3323 
d 0.0000 0.0225 



















Normality Test: Passed (P = 0.2432) 






































1 0.1480 0.8159 
2 0.0107 0.2777 
3 0.1172 0.2872 












































2.5431 0.64 77 
2959.1823 0.9942 
95% Confidence: 
Row Predicted Regr. 5% 
1 1.0099 0.8518 
2 0.9565 0.8642 
3 0.9142 0.8204 
4 0.8807 0.7826 
5 0.8543 0.7590 
6 0.8036 0.6976 
7 0.7786 0.6377 
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x = col(l) 
Y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO(r)) 
199 
[Parameters] ,, . 
== yatxnearO(y,x)/2 Auto {{previous: 0.206606}} 
: == -ln(.5)/(0.5*(x50(~,y)-min(x))). "Auto {{previous: 1.381}} 
== yatxnearO(y,x)/2 Auto {{previous: 0.792722}} 
~ == -ln(.5)/(l.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00910134}} 
[Equation] 
f:::a*exp(-b*x)+c*exp(-d*x) 
fit f to Y 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.97241729 Rsqr = 0.94559538 Adj Rsqr = 0.90479192 
Standard Error of Estimate = 0.0317 
Coefficient 
a 0.2066 0.0416 
b 1.3810 0.7609 
c 0.7927 0.0283 
d 0.0091 0.0035 
Analysis of Variance: 
DF SS 
Regression3 0.0699 
Residual 4 0.0040 
Total 7 0.0739 
PRESS = 0.0895 










Normality Test: Passed (P = 0.3537) 











Power of performed test with alpha= 0.0500: 0.9976 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
200 
1 0.9993 0.0007 0.0212 0.4248 0.3765 
2 0.8375 -0.0039 -0.1242 -0.3117 -0.2733 
3 0.7915 0.0019 0.0593 0.0692 0.0599 
4 0.7747 0.0025 0.0775 0.0911 0.0789 
5 0.7652 0.0409 1.2897 1.5544 2.1391 
6 0.7438 -0.0451 -1.4230 -1.6253 -2.4155 
7 0.7238 -0.0103 -0.3236 -0.3666 -0.3230 
8 0.6608 0.0135 0.4263 1.1210 1.1722 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 18.0943 0.9975 7.5397 
2 0.1286 0.8412 -0.6288 
3 0.0004 0.2636 0.0359 
4 0.0008 0.2764 0.0488 
5 0.2734 0.3116 1.4391 
6 0.2012 0.2335 -1.3332 
7 0.0095 0.2208 -0.1719 
8 1.8580 0.8554 2.8508 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9993 0.9114 1.0873 0.8749 1.1238 
2 0.8375 0.7567 0.9182 0.7180 0.9569 
3 0.7915 0.7463 0.8367 0.6925 0.8904 
4 0.7747 0.7284 0.8209 0.6752 0.8741 
5 0.7652 0.7161 0.8144 0.6644 0.8660 
6 0.7438 0.7013 0.7864 0.6460 0.8416 
7 0.7238 0.6824 0.7651 0.6265 0.8210 
8 0.6608 0.5794 0.7422 0.5409 0.7807 










10 15 20 25 
- Col20vCol 21 
• Time, weeks v D/Do [ Lactose hydrous, 40Cf75% RH] 
201 
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LACTOSE HYDROUS (BiPhasic First-order reaction) 
50oc I 20 %moisture 
Nonlinear Regression 
[Variables] 
x == col(l) . 
y == col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x)/2 "Auto {{previous: 0.315899}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 1.61813}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.686347}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0286976}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.96591365 Rsqr = 0.93298917 Adj Rsqr = 0.88273105 
Standard Error of Estimate = 0.0642 
Coefficient Std. Error t p 
a 0.31'59 0.0878 3.5962 0.0228 
b 1.6181 1.3311 1.2157 0.2910 
c 0.6863 0.0616 11.1483 0.0004 
d 0.0287 0.0105 2.7444 0.0517 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.2294 0.0765 18.5639 0.0082 
Residual 4 0.0165 0.0041 
202 
Total 7 0.2459 0.0351 
pR.ESS == 6.4486 
Durbin-Watson Statistic== 2.9292 
Normality Test: Passed (P = 0.2917) 
Constant Variance Test: Passed (P = 0.1196) 
Power of performed test with alpha = 0.0500: 0.9950 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0022 -0.0022 
2 0.7296 0.0222 
3 0.6605 -0.0497 
4 0.6322 -0.0342 
5 0.6124 0.0470 
6 0.5614 -0.0285 
7 0.5151 0.0864 
8 0.3866 -0.0431 
Influence Diagnostics: 
Row Cook'sDist 
1 384.0570 0.9991 
2 2.9478 0.9044 
3 0.0731 0.2640 
4 0.0463 0.3098 
5 0.0846 0.3051 
6 0.0163 0.2076 
7 0.1870 0.2392 
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10 15 20 25 
- Col 25 v Col 26 
• Time, weeks v O/Oo [ Lactose hydrous. SOC/20% Moisture) 
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x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.241149}} 
h = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.398833}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.783533 }.} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0358982}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f to y with weight reciprocal y 









R == 0.98839567 Rsqr = 0.97692600 Adj Rsqr = 0.95962050 
Standard Error of Estimate = 0.0421 
Coefficient 
a 0.2411 0.1465 
b 0.3988 0.3448 
c 0.7835 0.1501 
d 0.0359 0.0134 



















Normality Test: Passed (P = 0.6862) 








Power of performed test with alpha= 0.0500: 0.9999 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0247 -0.0247 
2 0.9177 0.0500 
3 0.8379 0.0128 
4 0.7764 -0.0225 
5 0.7276 -0.0480 
6 0.6242 0.0269 
7 0.5517 0.0143 
8 0.3822 -0.0094 
Influence Diagnostics: 
Row Cook'sDist 
1 6.6056 0.8923 
2 0.2610 0.3314 
3 0.0187 0.3470 
4 0.0424 0.2951 

















































Row Predicted Regr. 5% 
1 1.0247 0.9142 
2 0.9177 0.8504 
3 0.8379 0.7690 
4 0.7764 0.7129 
5 0.7276 0.6673 
6 0.6242 0.5468 
7 0.5517 0.4715 
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Y == col(2) 
reciprocal _y== 1 I abs(y) 
~eciprocal _ysquare= 1 /y"2 
Automatic Initial Parameter Estimate Functions 
xnearO( q)==max( abs( q) )-abs( q) 
YatxnearO( q,r )=xatymax( q,xnearO( r)) 
206 
[Parameters] 11 • 
== yatxnearO(y,x) Auto {{previous: 94.4043}} 
: == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0216548}} 
[Equation] 
f::=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





stepsize= 1 00 
iterations= 100 
R = 0.94008231 Rsqr = 0.88375476 Adj Rsqr = 0.86438055 






Analysis of Variance: 
DF SS 
Regression 1 799 .2164 
Residual 6 105.1254 
Total 7 904.3419 
PRESS= 355.8653 








Normality Test: Passed (P = 0.7290) 






Power of performed test with alpha = 0.0500: 0.9731 
Regression Diagnostics: 
Row Predicted Residual 
1 94.4043 5.5957 
2 92.3820 -0.5158 
3 90.4030 1.2047 
4 88.4664 -0.1959 























6 81.1260 -6.1835 -1.4773 -1.5959 -1.9203 
7 76.0232 -2.3627 -0.5645 -0.6390 -0.6042 
8 61.2211 4.8507 1.1588 2.0389 3.3582 
Influence Diagnostics: 
Leverage Row Cook'sDist DFFITS 
1 0.4802 0.2792 1.1678 
2 0.0028 0.2209 -0.0680 
3 0.0109 0.1782 0.1361 
4 0.0002 0.1493 -0.0194 
5 0.0237 0.1327 -0.2041 
6 0.2127 0.1431 -0.7848 
7 0.0575 0.2197 -0.3206 
8 4.3554 0.6769 4.8612 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 94.4043 88.9924 99.8162 82.8201 105.9885 
2 92.3820 87.5679 97.1960 81.0648 103.6992 
3 90.4030 86.0797 94.7263 79.2856 101.5203 
4 88.4664 84.5091 92.4236 77.4862 99.4465 
5 86.5712 82.8404 90.3021 75.6706 97.4719 
6 81.1260 77.2513 85.0007 70.1753 92.0767 
7 76.0232 71.2225 80.8240 64.7117 87.3348 
8 61.2211 52.7941 69.6481 47.9576 74.4845 












10 15 20 25 
- Col10 v Col 11 
• Time, weeks v % Drug (l actose Anhydrous, 25C] 
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LACTOSE ANHYDROUS (First-order reaction) 




y == col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x) "Auto {{previous: 92.638}} 
b == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0258057}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 







R = 0.91391868 Rsqr = 0.83524736 Adj Rsqr = 0.80778859 






Analysis of Variance: 
DF SS 
Regressionl 994.0183 
Residual 6 196.0702 
Total 7 1190.0885 
PRESS= 598.5089 

















Normality Test: Passed (P = 0.5403) 
Constant Variance Test: Passed (P = 0.8393) 
power of performed test with alpha= 0.0500: 0.9342 
Regression Diagnostics: 
Std. Res. Stud. Res. Stud. Del. Res. Row Predicted Residual 
1 92.6380 7.3620 1.2878 1.5256 1.7802 
2 90.2780 -0.6919 -0.1210 -0.1374 -0.1256 
3 87.9782 3.3852 0.5922 0.6534 0.6189 
4 85.7369 -3.2285 -0.5648 -0.6121 -0.5771 
5 83.5527 -2.4399 -0.4268 -0.4582 -0.4258 
6 77.3283 -8.1106 -1.4188 -1.5364 -1.8009 
7 71.5676 -2.3579 -0.4125 -0.4695 -0.4367 
8 55.2897 6.4973 1.1366 1.9313 2.8661 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.4695 0.2874 1.1307 
2 0.0027 0.2241 -0.0675 
3 0.0464 0.1786 0.2885 
4 0.0327 0.1486 -0.2411 
5 0.0160 0.1323 -0.1663 
6 0.2038 0.1473 -0.7484 
7 0.0326 0.2281 -0.2373 
8 3.5194 0.6536 3.9374 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 92.6380 85.1386 100.1374 76.7667 108.5094 
2 90.2780 83.6568 96.8993 74.8023 105.7538 
3 87.9782 82.0675 93.8888 72.7929 103.1634 
4 85.7369 80.3439 91.1298 70.7455 100.7283 
5 83.5527 78.4646 88.6408 68.6682 98.4371 
6 77.3283 71.9606 82.6960 62.3460 92.3106 
7 71.5676 64.8876 78.2477 56.0667 87.0686 
8 55.2897 43 .9808 66.5985 37.3022 73.2771 
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10 15 20 25 
- Col 15 vCol 16 
• Time, weeks v % Drug [Lactose Anhydrous, 25C/60%RH) 
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LACTOSE ANHYDROUS (First-order reaction) 
40°C /75 %RH 
Nonlinear Regression 
[Variables] 
x == col(l) 
y == col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y;\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x) "Auto {{previous: 84.4599}} 
b == -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0265749}} 
[Equation] 
f==a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 








R == 0.82549980 Rsqr = 0.68144992 Adj Rsqr = 0.62835824 























Normality Test: Failed (P = 0.0173) 










The power of the performed test (0.7469) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 84.4599 15.5401 
2 82.2449 -3.9467 
3 80.0881 -3.5230 
4 77.9878 -1.2118 
5 75 .9425 -5.1174 
6 70.1231 -6.9791 
7 64.7496 -1.2352 
8 49.6391 6.9853 
Influence Diagnostics: 
Row Cook'sDist 
1 1.0440 0.2888 
2 0.0441 0.2246 
3 0.0249 0.1786 
4 0.0023 0.1485 
5 0.0348 0.1323 












































Row Predicted Regr. 5% 
1 84.4599 73.7752 
2 82.2449 72.8227 
3 80.0881 71.6851 
4 77.9878 70.3245 
5 75.9425 68.7112 
6 70.1231 62.4749 
7 64.7496 55.2262 















































LACTOSE ANHYDROUS (First-order reaction) 




Y = col(2) 
reciprocal_y= 1 I abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 




b == -ln(.5)/{x50{x,y)-min(x)) "Auto {{previous: 0.0314973}} 
(Equation] 
[==a*exp(-b*x) 
fit f to Y . . 
"fit f toy with weight rec1procal_y 







R = 0.65684694 Rsqr = 0.43144 790 Adj Rsqr = 0.33668922 






Analysis of Variance: 
DF SS 
Regression 1 811.3322 
Residual 6 1069 .1549 
Total 7 1880.4871 
PRESS= 2492.0799 








Nonnality Test: Passed (P = 0.4898) 










The power of the performed test (0.4209) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 75.7282 24.2718 
2 73.3801 2.5987 
3 71.1049 -9.5538 



















5 66.7638 -12.0277 -0.9010 -0.9672 -0.9610 I 6 60.7441 -1.8355 -0.1375 -0.1495 -0.1367 
7 55.2671 -2.1270 -0.1593 -0.1827 -0.1673 
8 40.3344 10.6059 0.7945 1.2896 1.3847 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 1.0061 0.2990 2.7998 
2 0.0073 0.2283 0.1105 
3 0.0680 0.1789 -0.3556 
4 0.0668 0.1478 -0.3574 
5 0.0712 0.1321 -0.3749 
6 0.0020 0.1537 -0.0582 
7 0.0053 0.2398 -0.0939 
8 1.3591 0.6204 1.7703 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 75.7282 57.8662 93.5902 38.4997 112.9566 
2 73.3801 57.7740 88.9863 37.1799 109.5804 
3 71.1049 57.2882 84.9215 35.6393 106.5704 
4 68.9002 56.3425 81.4578 33.9059 103.8945 
5 66.7638 54.8930 78.6347 32.0101 101.5176 
6 60.7441 47.9395 73.5486 25.6604 95.8277 
7 55.2671 39.2731 71.2611 18.8979 91.6362 
8 40.3344 14.6064 66.0624 -1.2449 81.9136 
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• Time, weeks v % Drug [Lactose Anhydrous, 50C/20% MoistureRH] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
215 




x === col(l) 
y === col(2) 
reciprocal y= 1 I abs(y) 
reciprocal ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a::: yatxnearO(y,x) "Auto {{previous: 87.9779}} 
b::: -ln(.5)/{x50(x,y)-min(x)) "Auto {{previous: 0.057004}} 
[Equation] 
f:::a*exp(-b*x) 
fit f toy 
~'fit f toy with weight reciprocal_y 







R = 0.82517354 Rsqr = 0.68091137 Adj Rsqr = 0.62772993 






Analysis of Variance: 
DF SS 
Regressionl 2286.5353 
Residual 6 1071.5160 
Total 7 3358.0512 
PRESS= 2205 .0436 


















Constant Variance Test: Passed (P = 0.6194) 
power of performed test with alpha= 0.0500: 0.7462 
The power of the performed test (0.7462) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 87.9779 12.0221 0.8996 1.1196 1.1492 
2 83.1031 5.7646 0.4314 0.4964 0.4628 
3 78.4984 -12.3779 -0.9262 -1.0221 -1.0267 
4 74.1488 -9.1772 -0.6867 -0.7427 -0.7115 
5 70.0402 11.7537 0.8795 0.9460 0.9363 
6 59.0307 -15.8898 -1.1890 -1.3217 -1.4331 
7 49.7518 -4.2700 -0.3195 -0.3791 -0.3503 
8 28.1347 15.7308 1.1771 1.6030 1.9353 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.3441 0.3544 0.8514 
2 0.0400 0.2450 0.2636 
3 0.1137 0.1788 -0.4790 
4 0.0468 0.1452 -0.2932 
5 0.0702 0.1357 0.3709 
6 0.2058 0.1907 -0.6957 
7 0.0293 0.2895 -0.2236 
8 1.0978 0.4608 1.7889 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 87.9779 68.5111 107.4447 49.9225 126.0334 
2 83.1031 66.9174 99.2888 46.6169 119.5892 
3 78.4984 64.6728 92.3239 . 42.9961 114.0006 
4 74.1488 61.6906 86.6070 39.1564 109.1412 
5 70.0402 57.9956 82.0848 35.1929 104.8875 
6 59.0307 44.7509 73 .3105 23.3491 94.7123 
7 49.7518 32.1569 67.3466 12.6190 86.8845 
8 28.1347 5.9385 50.3310 -11.3866 67.6561 
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x = col(l) 
y = co1(2) 
reciprocal _y= 1 / abs(y) 
reciprocal _ysq uare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.350559}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.141782}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.640758}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 1.12922e-012}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 









R = 0.9908204 7 Rsqr = 0.98172520 Adj Rsqr = 0.96801910 
standard Error of Estimate = 0.0203 
Coefficient 
a 0.3506 0.3387 
b 0.1418 0.1340 
c 0.6408 0.3469 
d 0.0000 0.0218 



















Normality Test: Passed (P = 0.1963) 








Power of performed test with alpha= 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9913 0.0087 
2 0.9450 -0.0263 
3 0.9048 0.0113 
4 0.8699 0.0128 
5 0.8396 0.0044 
6 0.7707 -0.0213 
7 0.7257 0.0109 
8 0.6613 -0.0006 
Influence Diagnostics: 
Row Cook'sDist 
1 0.6637 0.7699 
2 0.2147 0.2718 
3 0.0363 0.2580 
4 0.0653 0.3108 

















































Row Predicted Regr. 5% 
1 0.9913 0.9418 
2 0.9450 0.9156 
3 0.9048 0.8761 
4 0.8699 0.8384 
5 0.8396 0.8076 
6 0.7707 0.7377 
7 0.7257 0.6775 























20 Graph 21 
• • 
10 15 

























x = col(l) 
Y = col(2) 
reciprocal_y= l/abs(y) 
reciprocal_ysquare=l /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
220 
(Parameters] 11 • 
== yatxnearO(y,x)/2 Auto {{previous: 0.376037}} ~ == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.178844}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.615759}} 




"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.98365048 Rsqr = 0.96756827 Adj Rsqr = 0.94324447 
Standard Error of Estimate= 0.0311 
Coefficient 
a 0.3760 0.2924 
b 0.1788 0.1569 
c 0.6 158 0.3033 
d 0.0006 0.0222 
Analysis of Variance: 
DF SS 
Regression3 0 .1151 
Residual 4 0.0039 
Total 7 0.1190 
PRESS = 0.1794 










Normality Test: Passed (P = 0.7641) 






Power of performed test with alpha= 0.0500: 0.9997 
Regression Diagnostics: 





Stud. Del. Res. 
1 0.9918 0.0082 0.2641 0.5747 0.5196 
2 0.9299 -0.0340 -1.0947 -1.2839 -1.4501 
3 0.8780 0.0356 1.1465 1.3412 1.5658 
4 0.8346 -0.0095 -0.3066 -0.3700 -0.3260 
5 0.7982 0.0129 0.4147 0.4999 0.4471 
6 0.7208 -0.0287 -0.9229 -1.1457 -1.2106 
7 0.6752 0.0169 0.5455 0.9895 0.9860 
8 0.6193 -0.0014 -0.0467 -0.7843 -0.7384 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.3084 0.7888 1.0042 
2 0.1548 0.2730 -0.8887 
3 0.1657 0.2693 0.9506 
4 0.0156 0.3134 -0.2202 
5 0.0283 0.3119 0.3010 
6 0.1776 0.3511 -0.8905 
7 0.5606 0.6961 1.4923 
8 43.3147 0.9965 -12.3919 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9918 0.9152 1.0684 0.8764 1.1071 
2 0.9299 0.8848 0.9749 0.8326 1.0272 
3 0.8780 0.8333 0.9228 0.7809 0.9752 
4 0.8346 0.7863 0.8829 0.7358 0.9334 
5 0.7982 0.7501 0.8464 0.6995 0.8970 
6 0.7208 0.6697 0.7719 0.6206 0.8211 
7 0.6752 0.6032 0.7471 0.5628 0.7875 
8 0.6193 0.5332 0.7054 0.4975 0.7412 
20 Graph 22 
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y == col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1 /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Paramet~rs] 
a== yatxnearO(y,x)/2 "Auto {{previous: 0.232507}} 
b == -ln{.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 1.80374}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.766668}} 
d == -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0170271}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.98001052 · Rsqr = 0.96042061 Adj Rsqr = 0.93073607 
Standard Error of Estimate = 0.0351 
Coefficient Std. Error t p 
a 0.2325 0.0456 5.1038 0.0070 
b 1.8037 1.1450 1.5753 0.1903 
c 0.7667 0.0297 25 .8543 <0.0001 
d 0.0170 0.0042 4.0412 0.0156 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.1194 0.0398 32.3542 0.0029 
Residual 4 0.0049 0.0012 
Total 7 0.1244 0.0178 
223 
pRESS = 3.2448 
Durbin-Watson Statistic = 1.5293 
Normality Test: Passed (P = 0.3720) 
Constant Variance Test: Passed (P = 0.1597) 
Power of performed test with alpha= 0.0500: 0.9993 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9992 0.0008 
2 0.7920 -0.0090 
3 0.7473 0.0183 
4 0.7295 0.0382 
5 0.7164 -0.0081 
6 0.6805 -0.0491 
7 0.6466 -0.0115 
8 0.5454 0.0208 
Influence Diagnostics: 
Row Cook'sDist 
1 651.5372 0.9995 
2 3.1371 0.9299 
3 0.0311 0.2533 
4 0.1830 0.3011 
5 0.0076 0.2887 
6 0.1516 0.1988 
7 0.0097 0.2196 
8 1.9589 0.8090 
95% Confidence: 
Row Predicted Regr. 5% 
1 0.9992 0.9018 
2 0.7920 0.6981 
3 0.7473 0.6983 
4 0.7295 0.6761 
5 0.7164 0.6640 
6 0.6805 0.6371 
7 0.6466 0.6010 
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- Col20 v Col 21 
• Time, weeks v DIDo (Lactose anhydrous, 40Cl75% RH] 
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LACTOSE ANHYDROUS (BiPhasic First-order reaction) 




y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r.)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.437135}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.915575}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.567457}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00496292}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 









R = 0.99237002 Rsqr = 0.98479826 Adj Rsqr = 0.97339695 
Standard Error of Estimate = 0.0267 
Coefficient 
a 0.4371 0.0378 
b 0.9156 0.1858 
c 0.5675 0.0294 
d 0.0050 0.0044 



















Nonnality Test: Failed (P = 0.0080) 








Power of performed test with alpha = 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0046 -0.0046 
2 0.7396 0.0202 
3 0.6319 -0.0164 
4 0.5871 -0.0063 
5 0.5675 -0.0202 
6 0.5488 0.0403 
7 0.5400 -0.0086 
8 0.5138 -0.0044 
Influence Diagnostics: 
Row Cook'sDist 
1 27.4338 0.9837 
2 0.6787 0.6352 
3 0.0718 0.3365 



















































Row Predicted Regr. 5% 
1 1.0046 0.9310 
2 0.7396 0.6805 
3 0.6319 0.5888 
4 0.5871 0.5507 
5 0.5675 0.5266 
6 0.5488 0.5062 
7 0.5400 0.5019 
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x = col(l) 
Y = col(2) 
reciprocal_y= 1 I abs(y) 
~eciprocal_ysquare= 1/y"2 
Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r)=xatymax( q,xnearO( r)) 
227 
[Parameters] " . 
:::: yatxnearO(y,x)/2 Auto { {prev10us: 0.574083}} ~:::: -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.246131}} 
:::: yatxnearO(y,x)/2 "Auto {{previous: 0.415514}} ~:::: -ln(.5)/( l.5*(x50(x,y)-min(x))) "Auto {{previous: 1.41089e-010}} 
[Equation] 
f:::a*exp(-b*x)+c*exp(-d *x) 
fit f to Y 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R=0.91174814 Rsqr = 0.83128468 Adj Rsqr = 0.70474819 
Standard Error of Estimate= 0.1190 
Coefficient 
a 0.5741 0.5398 
b 0.2461 0.3295 
c 0.4155 0.5683 
d 0.0000 0.0714 
Analysis of Variance: 
DF SS 
Regression3 0.2791 
Residual 4 0.0567 
Total 7 0.3358 
PRESS = 8.7426 










Normality Test: Passed (P = 0.0932) 











Power of performed test with alpha= 0.0500: 0.9304 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
228 
1 0.9896 0.0104 0.0874 0.2068 
2 0.8643 0.0243 0.2045 0.2408 
3 0.7664 -0.1052 -0.8840 -1.0500 
4 0.6899 -0.0401 -0.3373 -0.4072 
5 0.6300 0.1879 1.5792 1.8776 
6 0.5180 -0.0866 -0.7277 -0.9174 
7 0.4645 -0.0097 -0.0813 -0.1350 
8 0.4197 0.0190 0.1593 1.9827 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0492 0.8214 0.3863 
2 0.0056 0.2792 0.1307 
3 0.1132 0.2911 -0.6847 
4 0.0190 0.3139 -0.2436 
5 0.3647 0.2927 3.0372 
6 0.1241 0.3709 -0.6865 
7 0.0080 0.6373 -0.1554 
8 151.2061 0.9935 162.1749 
95% Confidence: . 
Row Predicted Regr. 5% Regr. 95% Pop. 5% 
1 0.9896 0.6901 1.2891 0.5436 
2 0.8643 0.6898 1.0389 0.4906 
3 0.7664 0.5881 0.9447 0.3910 
4 0.6899 0.5047 0.8750 0.3111 
5 0.6300 0.4512 0.8088 0.2543 
6 0.5180 0.3168 0.7192 0.1311 
7 0.4645 0.2007 0.7283 0.0417 
8 0.4197 0.0903 0.7491 -0.0469 
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x == col(l) 
y == co1(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1 /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x) "Auto {{previous: 99.589}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0057966}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





step size= 100 
iterations= 100 
R = 0.88627805 Rsqr = 0.78548878 Adj Rsqr = 0.75484432 






Analysis of Variance: 
DF SS 
Regression I 90.6282 
Residual 7 24.7499 
Total 8 115.3781 
PRESS= 35.3794 

















Normality Test: Passed (P = 0.5111) 
Constant Variance Test: Passed (P .= 0.8437) 
power of performed test with alpha= 0.0500: 0.9305 
Regression Diagnostics: 
Std. Res. Row Predicted Residual Stud. Res. Stud. Del. Res. 
I 99.5890 0.4110 0.2186 0.2507 0.2332 
2 99.0134 1.3790 0.7334 0.8191 0.7975 
3 98.4411 1.3947 0.7417 0.8118 0.7897 
4 97.8722 -2.2145 -1.1777 -1.2701 -1.3405 
5 97.3065 -0.3822 -0.2032 -0.2170 -0.2016 
6 96.1849 -0.4487 -0.2386 -0.2531 -0.2354 
7 95.0762 -2.9799 -1.5848 -1.6971 -2.0481 
8 93.9804 2.5533 1.3579 1.4916 1.6719 
9 88.6876 0.2894 0.1539 0.2922 0.2721 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
I 0.0099 0.2400 0.1310 
2 0.0830 0.1984 0.3968 
3 0.0652 0.1653 0.3514 
4 0.1316 0.1403 -0.5414 
5 0.0033 0.1231 -0.0755 
6 0.0040 0.1114 -0.0833 
7 0.2115 0.1280 -0.7848 
8 0.2297 0.1712 0.7598 
9 0.1111 0.7224 0.4390 
95% Confidence: 
Row Predicted Regr. 5% · Regr. 95% Pop. 5% Pop. 95% 
I 99.5890 97.4109 101.7671 94.6379 104.5402 
2 99.0134 97.0329 100.9940 94.1459 103.8809 
3 98.4411 96.6336 100.2487 . 93.6415 103.2408 
4 97.8722 96.2070 99.5373 93.1243 102.6201 
5 97.3065 95.7464 98.8665 92.5944 102.0185 
6 96.1849 94.7011 97.6687 91.4975 100.8723 I I 
7 95.0762 93.4853 96.6672 90.3539 99.7986 
8 93.9804 92.1408 95.8200 89.1685 98.7922 
9 88.6876 84.9085 92.4667 82.8522 94.5229 
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- Col10vCol11 
• Time, weeks 11 % Drug (Starch, 25CJ 
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STARCH (First-order reaction) 




y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1 /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r)=xatymax( q,xnearO(r)) 
[Parameters] 
a=yatxnearO(y,x) "Auto {{previous: 100.491}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0:0037451}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal_y 








R === o.72053762 Rsqr = 0.51917447 Adj Rsqr = 0.45048510 























Normality Test: Passed (P = Q.2828) 










The power of the performed test (0.6049) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Resid.ual Std. Res. Stud. Res. Stud. Del. Res. 
1 100.4908 -0.4908 -0.2134 -0.2441 -0.2270 
2 100.1152 1.5850 0.6891 0:1687 0.7438 
3 99.7410 4.1537 1.8059 1.9758 2.7505 
4 99.3681 -1.7579 -0.7643 -0.8243 -0.8031 
5 98.9967 -2.4960 -1.0852 -1.1591 -1.1937 
6 98.2579 -1.5653 -0.6805 -0.7218 -0.6946 
7 97.5247 -1.5963 -0.6940 -0.7426 -0.7163 
8 96.7970 1.5069 0.6552 0.7184 0.6911 
9 93.2389 0.6621 0.2878 0.5570 0.5275 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0092 0.2360 -0.1262 
2 0.0722 0.1964 0.3678 
3 0.3847 0.1646 1.2210 
4 0.0555 0.1404 -0.3245 
5 0.0946 0.1235 -0.4481 
233 
6 0.0326 0.1112 -0.2457 
7 0.0400 0.1266 -0.2727 
8 0.0522 0.1684 0.3109 












Predicted Regr. 5% Regr. 95% Pop. 5% 
100.4908 97.8488 103.1329 94.4442 
100.1152 97.7045 102.5259 94.1660 
99.7410 97.5341 101.9478 93.8714 
99.3681 97.3304 101.4058 93.5600 
98.9967 97.0854 100.9079 93.2317 
98.2579 96.4441 100.0718 92.5245 
97.5247 95.5896 99.4598 91.7518 
96.7970 94.5653 99.0286 90.9180 
93 .2389 88.5825 97.8952 86.0790 
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. STARCH (First-order reaction) 
40°C I 75 %RH Nonlinear Regression 
[Variables] 
x=col(l) 
Y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
234 
==yatxnearO(y,x) "Auto {{previous: 101.175}} ~ === -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.000653841}} 
[Equation] 
[==a*exp(-b*x) 
fit f to Y 
"fit f toy with weight reciprocal_y 







R === 0.28113767 Rsqr = 0.07903839 Adj Rsqr = 0.00000000 























Normality Test: Passed (P = 0.7798) 










The power of the performed test (0.1052) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 101.1749 -1.1749 
2 101.1088 -0.2626 














4 100.9766 -1.0661 -0.7178 -0.7742 -0.7496 
5 100.9106 0.6437 0.4334 0.4631 0.4354 
6 100.7788 -1.9748 -1.3295 -1.4102 -1.5430 
7 100.6471 1.7310 1.1654 1.2455 1.3070 
8 100.5155 0.1428 0.0961 0.1051 0.0974 
9 99.8605 -0.3619 -0.2437 -0.4858 -0.4576 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.1214 0.2300 -0.4852 
2 0.0046 0.1934 -0.0895 
3 0.2860 0.1636 0.9177 
4 0.0490 0.1405 -0.3031 
5 0.0152 0.1241 0.1639 
6 0.1243 0.1111 -0.5455 
7 0.1104 0.1246 0.4931 
8 0.0011 0.1642 0.0432 
9 0.3511 0.7484 -0.7893 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 101.1749 99.4905 102.8593 97.2796 105.0702 
2 101.1088 99.5640 102.6536 97.2718 104.9457 
3 101.0427 99.6220 102.4634 97.2540 104.8314 
4 100.9766 99.6601 102.2932 97.2258 104.7275 
5 100.9106 99.6736 102.1477 97.1869 104.6344 
6 100.7788 99.6080 101.9495 97.0765 104.4810 
7 100.6471 99.4074 101.8867 96.9225 104.3717 
8 100.5155 99.0921 101.9389 96.7258 104.3053 
9 99.8605 96.8220 102.8990 95.2163 104.5047 
20 Graph 29 













10 15 20 25 
- Col 20vCol 21 
• Time, weeks v % Drug [Starch, 40C/75% RH] 
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STARCH (First-order reaction) 
50oc ; 20 %moisture 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal_ysquare= l /y"2 
'Automatic Initial P::irameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y ,x) "Auto {{previous: 91.2028}} 




"fit fto y with weight reciprocal_y 







R = 0.687983 81 Rsqr = 0.47332173 Adj Rsqr = 0.39808197 






Analysis of Variance: 
DF SS 
Regression I 615.7738 
Residual 7 685. 1887 
Total 8 1300.9624 
PRESS= 2008.9507 

















Normality Test: Passed (P = 0.7679) 
Constant Variance Test: Passed (P = 0.4905) 
power of performed test with alpha= 0.0500: 0.5429 
The power of the performed test (0.5429) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 91 .2028 8.7972 0.8892 1.0400 1.0472 
2 89.3924 7.8634 0.7948 0.8952 0.8808 
3 87.6179 2.8554 0.2886 0.3166 0.2952 
4 85.8786 0.1941 0.0196 0.0211 0.0196 
5 84.1739 -3.8098 -0.3851 -0.4107 -0.3849 
6 80.8653 -1 6.4729 -1.6650 -1.7692 -2.2030 
7 77.6867 -9.1857 -0.9284 -1.0016 -1.0019 
8 74.6331 -2.4393 -0.2466 -0.2744 -0.2554 
9 61.0737 12.7112 1.2848 2.1489 3.4105 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.1991 0.2691 0.6354 
2 0.1077 0.2118 0.4566 
3 0.0102 0.1689 0.1331 
4 0.0000 0.1391 0.0079 
5 0.0116 0.1208 -0.1427 
6 0.2021 0.1144 -0.7917 
7 0.0822 0.1408 -0.4056 
8 0.0090 0.1926 -0.1248 
9 4.1505 0.6425 4.5725 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 91.2028 79.0676 103.3379 64.8480 117.5576 
2 89.3924 78.6258 100.1589 63.6390 115.1457 
3 87.6179 78.0020 97.2337 62.3240 112.9117 
4 85.8786 77. 1545 94.6027 60.9102 110.8471 
5 84.1739 76.0423 92.3055 59.4062 108.9415 
6 80.8653 72.9535 88 .7770 56.1689 105.5616 
7 77.6867 68.9082 86.4651 52.6992 102.6742 
8 74.6331 64.3657 84.9004 49.0844 100.1817 
9 61.0737 42.3208 79.8267 31.0906 91.0569 
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x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal_ysquare= 1/y"2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xa tymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 98.2956}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0556155}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f to y with weight reciprocal_y 







R == 0.97292605 Rsqr = 0.94658509 Adj Rsqr = 0.93895439 
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Normality Test: Passed (P = 0.5334) 






Power ofperfom1ed test with alpha= 0.0500: 0.9995 
Regression Diagnostics: 
Row Predicted Residual 
1 98.2956 1.7044 
2 92.9781 1.6679 
3 87.9482 1.6226 
4 83.1905 4.0165 
5 78.6901 -2.6386 
6 70.406G -7.3276 
7 62.9950 -3.4158 
8 56.3637 -2.5136 
9 32.3195 8.6927 
Influence Diagnostics: 
Row Cook'sDist 
1 0.0471 0.3497 
2 0.0228 0.2408 
3 0.0130 0.1724 
4 0.0569 0.1349 
5 0.0212 0.1204 
6 0.1937 0.1371 
7 0.0643 0.1863 
8 0.0534 0.2455 















































. Row Predicted Regr. 5% 
1 98.2956 91.2315 
2 92.9781 87.1155 
3 87.9482 82.9879 
4 83.1905 78.8036 
5 78.6901 74.5448 
6 70.4066 65.9831 
7 62.9950 57.8392 
8 56.3637 50.4442 
























































y = col(2) 
reciprocal_y= l /abs(y) 
reciprocal _ysqua re= 1 /yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xa tymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.0275784}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.361565}} 
241 
::::: yatxnearO(y,x)/2 "Auto {{previous: 0.979507}} 
~::::: -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00457035}} 
(Equation] 
f:::::a*exp(-b*x)+c*exp(-d *x) 
fit f to Y 
"fit f toy with weight reciprocal_y 





tolerance= l e-6 
stepsize=O .1 
iterations= 100 
R = 0.90054905 Rs.qr = 0.81098859 Adj Rsqr = 0.69758174 
Standard Error of Estimate = 0.0209 
Coefficient 
a 0.0276 0.0485 
b 0.3616 1.1458 
c 0.9795 0.0498 
d 0.0046 0.0033 
Analysis of Variance: 
DF SS 
Regression3 0. 0094 
Residual 5 0.0022 
Total 8 0.0115 
PRESS= 0.0580 










Normality Test: Passed (P = 0.7524) 








Power of perfom1ed test with alpha = 0.0500: 0.9509 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0071 -0.0071 
2 0.9943 0.0097 

















4 0.9755 -0.0189 -0.9056 -1.0750 
5 0.9683 0.0010 0.0472 0.0540 
6 0.9562 0.0012 0.0574 0.0662 
7 0.9459 -0.0249 -1.1926 -1.4792 
8 0.9365 0.0288 1.3813 1.7851 
9 0.8940 -0.0042 -0.2008 -1.4659 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 1.4614 0.8692 -2.3823 
2 0.0334 0.3028 0.3375 
3 0.0839 0.3237 0.5589 
4 0.1181 0.2902 -0.7012 
5 0.0002 0.2344 0.0267 
6 0.0004 0.2471 0.0339 
7 0.2945 0.3500 -1.2945 
8 0.5340 0.4013 2.1707 
9 28.0975 0.9812 -12.5570 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% 
1 1.0071 0.9570 1.0571 0.9337 
2 0.9943 0.9647 1.0238 0.9330 
3 0.9840 0.9534 1.0145 0.9222 
4 0.9755 0.9466 1.0044 0.9145 
5 0.9683 0.9423 0.9942 0.9086 
6 0.9562 0.9295 0.9829 0.8962 
7 0.9459 0.9141 0.9776 0.8835 
8 0.9365 0.9025 0.9705 0.8729 
9 0.8940 0.8408 0.9471 0.8184 

















• Time, weeks v D/Do, [Starch, 25C] 
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x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1/y''2 
. 'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xa tymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.0463895}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.200272}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.970291}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00152882}} 
[Equation] 
f=a*exp(-b* x)+c*exp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.75880383 Rsqr = 0.57578325 Adj Rsqr = 0.32125321 
Standard Error of Estimate = 0.0256 
Coefficient Std. Error t p 
a 0.0464 0.1746 0.2657 0.8011 
b 0.2003 0.9406 0.2129 0.8398 
c 0.9703 0.1830 5.3014 0.0032 
d 0.0015 0.0090 0.1694 0.8722 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.0044 0.0015 2.2621 0.1989 
Residual 5 0.0033 0.0007 
Total 8 0.0077 0.0010 
244 
pRESS = 20.5658 
ourbin-Watson Statistic= 1.9522 
Normality Test: Passed (P = 0.2124) 
Constant Variance Test: Passed (P = 0.2852) 
Power of performed test with alpha= 0.0500: 0.6820 
The power of the performed test (0.6820) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 1.0167 -0.0167 -0.6525 -1.4311 -1.6659 
2 1.0068 0.0102 0.3999 0.4694 0.4294 
3 0.9984 0.0405 1.5858 1.8609 3.0017 
4 0.9913 -0.0152 -0.5941 -0.7130 -0.6728 
5 0.9852 -0.0202 -0.7898 -0.9341 -0.9196 
6 0.9754 -0.0085 -0.3307 -0.3770 -0.3421 
7 0.9678 -0.0086 -0.3348 -0.4081 -0.3712 
8 0.9618 0.0212 0.8296 1.1842 1.2486 
9 0.9419 -0.0029 -0.1137 -4.4912 (+inf) 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 1.9509 0.7921 -3.2518 
2 0.0208 0.2742 0.2639 
3 0.3263 0.2737 1.8429 
4 0.0560 0.3057 . -0.4464 
5 0.0870 0.2851 -0.5807 
6 0.0107 0.2306 -0.1873 
7 0.0202 0.3270 -0.2588 
8 0.3636 0.5092 1.2717 
9 7857.7743 0.9994 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0167 0.9582 1.0752 0.9287 1.1046 
2 1.0068 0.9724 1.0412 0.9326 1.0810 
3 0.9984 0.9640 1.0328 0.9242 1.0726 
4 0.9913 0.9550 1.0276 0.9162 1.0664 
5 0.9852 0.9501 1.0203 0.9107 1.0597 
6 0.9754 0.9438 1.0069 0.9025 1.0483 
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7 0.9678 0.9303 1.0054 0.8921 1.0435 
8 0.9618 0.9149 1.0087 0.8811 1.0426 
9 0.9419 0.8762 1.0076 0.8490 1.0348 
• 
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x = col(l) 
y = col(2) 
reciprocal_y= 1 /abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=rnax( abs( q))-abs( q) 
yatxnearO( q,r)=xatymax( q,xnearO(r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.284321}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.000676696}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.727428}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.000644927}} 
[Equation] 
f=a*exp(-b*x)+c*cxp(-d*x) 
fit f toy 
"fit f toy with weight reciprocal_y 






tolerance= 1 e-6 
stepsize=O. l 
iterations= 100 
R = 0.28113749 Rsqr = 0.07903829 Adj Rsqr = 0.00000000 
Standard Error of Estimate= 0.0176 
Coefficient 
a 0.2843 285635.0184 
b 0 . .0007 23.9808 
c 0.7274 285635.0184 
d 0.0006 9.3552 



















Normality Test: Passed (P = 0.7798) 












The power of the performed test (0.1052) is below the desired power of0.8000. 
You should interpret the negative findings cautiously. 
Regression Di8gnostics: 
Row Predicted Residual 
1 1.011 7 -0.0117 
2 1.0 11 1 -0.0026 
3 1.010-+ 0.0232 
4 1.0098 -0.0107 
5 1.009 l 0.0064 
6 1.0078 -0.0197 
7 1.0065 0.0173 
8 1.0052 0.0014 

































Row Cook'sDist Leverage DFFITS 
1 0.1073 0.3750 -0.6329 
2 0.0027 0.2647 -0.0938 
3 0.0470 0.0893 0.4940 
4 0.0094 0.0857 -0.1 812 
5 0.0040 0.0967 0.1145 
6 0.0569 0.1 349 -0.5070 
7 0.0704 0.1904 0.5445 
8 0.0015 0.3667 0.0696 
9 2.6632 0.9389 -3. 1456 
95% Confidence: 
Row Pred icted Rcgr. 5% Regr. 95% Pop. 5% 
1 1.0117 0.9841 1.0394 0.9588 
2 1.011 1 0.9878 1.0343 0.9603 
3 1.01 04 0.9969 1.0239 0.9633 
4 1.0098 0.9965 1.0230 0.9627 
5 1.0091 0.9951 1.0232 0.9618 
6 1.0078 0.9912 1.0244 0.9597 
7 1.0065 0.9868 1.0262 0.9572 
8 1.0052 0.9778 1.0325 0.9523 
9 0.99SG 0.9548 1.0424 0.9357 
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STARCH (BiPhasic First-order reaction) 




y == col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysq u are= 1 l/'2 
'Automatic In iti al Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r)= xa ty max( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x)/2 "Auto {{previous: 0.346976}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.307337}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.68886}} 
d == -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 2.12148e-010}} 
[Equation] 
f==a*exp(-b* x)+c*cx p(-d *x) 
fit f toy 
"fit f toy with weigbt reciprocal_y 





tolerance= 1 e-6 
stepsize=O. l 
iterations= 100 
R == 0.92855729 Rsqr = 0.86221864 Adj Rsqr = 0.77954983 
Standard Error of Estimate= 0.0599 
Cocfficien t Std. Error •t p 
a 0.3 -+ 70 0.1666 2.0828 0.0917 
b 0.3073 0.2517 1.2208 0.2766 
c 0.6889 0.1751 3.9336 0.0110 
d 0.0000 0.0149 0.0000 1.0000 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.1122 0.0374 10.4298 0.0136 
Residual 5 0.0 179 0.0036 
Total 8 0. 1301 0.0 163 
249 
pRESS = 16.6152 
Durbin-Watson Statistic= 1.4125 
Nonnality Test: Failed (P = 0.0446) 
Constant Variance Test: Passed (P = 0.8094) 
Power of perfo rmed test with alpha= 0.0500: 0.9811 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 1.0358 -0.0358 -0.5985 -1.5159 -1.8443 
2 0.9440 0.0285 0.4765 0.5644 0.5217 
3 0.8765 0.0282 0.4714 0.5648 0.5221 
4 0.8269 0.0339 0.5657 0.6739 0.6322 
5 0.7903 0.0133 0.2221 0.2560 0.2305 
6 0.7-B7 -0.0998 -1.6672 -1.9075 -3.2699 
7 0.7185 -0.0335 -0.5600 -0.6951 -0.6542 
8 0.7049 0.0170 0.2843 0.3823 0.3470 
9 O. GS 9G 0.0482 0.8058 7.3977 (+inf) 
Influence Diagnostics: 
Row Cook' sDist Leverage DFFITS 
1 3.1104 0.8441 -4.2915 
2 0.032 1 0.2872 0.3311 
3 0.034 8 0.3036 0.3447 
4 0.0-+76 0.2955 0.4094 
5 0.0054 0.2477 0.1323 
6 0.2S 12 0.2361 -1.8181 
7 0.0653 0.3509 -0.4810 
8 0.0295 0.4468 · o.3119 
9 11 39.L15 17 0.9881 (+inf) 
95% Confidence: 
Row J>r edicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 l .035S 0.8944 1.1772 0.8268 1.2448 
2 o.9-+-:o 0.86 15 1.0265 0.7694 1.1186 
3 0.8765 0.79 17 0.9613 0.7008 1.0522 
4 0.8269 0.7432 0.9105 0.6517 1.0020 
5 0. 7903 0.7137 0.8669 0.6184 0.9623 
6 0. 7-+37 0.6690 0.8185 0.5726 0.9149 
7 0.7 185 0.6274 0.8097 0.5397 0.8974 
8 0.70! 9 0.6020 0.8078 0.5198 0.8900 
9 0.08% 0.5366 0.8426 0.4726 0.9066 
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y = col(2) 
reciprocal _y= 1 / abs(y) 
·reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.687449}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.12064}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.338624}} 




"fit f to y with weight reciprocal_y 









R = 0.99125473 Rsqr = 0.98258593 Adj Rsqr = 0.97213749 
Standard Error of Estimate= 0.0341 
Coefficient 
a 0.6874 0.8355 
b 0.1206 0.1314 
c 0.3386 0.8503 
d 0.0000 0.0922 



















Normality Test: Passed (P = 0.4066) 








Power of performed test with alpha= 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0261 -0.0261 
2 0.9479 -0.0015 
3 0.8787 0.0170 
4 0.8173 0.0548 
5 0.7629 -0.0024 
6 0.6720 -0.0412 
7 0.6005 -0.0047 
8 0.5444 -0.0059 
9 0.4002 0.0099 
Influence Diagnostics: 
Row Cook'sDist 
1 1.7186 0.7480 
2 0.0002 0.2706 
3 0.0259 0.2405 




















































Row Predicted Regr. 5% 
1 1.0261 0.9502 
2 0.9479 0.9023 
3 0.8787 0.8357 
4 0.8173 0.7706 
5 0.7629 0.7157 
6 0.6720 0.6290 
7 0.6005 0.5502 
8 0.5444 0.4763 
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x == col(l) 
Y == col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal_ysquare= 1/y'''2 
253 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] " . 
a= yatxnearO(y ,x) Auto {{previous: 102.241}} 




"fit f toy with weight reciprocal_y 







R = 0.94669224 Rsqr = 0.89622621 Adj Rsqr = 0.88140138 






Analysis of Variance: 
DF SS 
Regression! 413.6188 
Residual 7 47.8928 
Total 8 461.5116 
PRESS = 81.3825 








Normality Test: Passed (P = 0.7689) 






Power of performed test with alpha = 0.0500: 0.9928 
Regression Diagnostics: 
Row Predicted Residual 
1 102.2411 -2.2411 











Stud. Del. Res. 
-0.9909 
1.1194 
3 99.6308 3.4156 1.3058 1.4310 1.5751 
4 98.3507 -0.9936 -0.3798 -0.4095 -0.3838 
5 97.0870 -2.0161 -0.7708 -0.8225 -0.8012 
6 94.6082 1.9769 0.7558 0.8022 0.7794 
7 92.1927 -3 .7668 -1.4401 -1.5474 -1.7662 
8 89.8389 -0.1307 -0.0500 -0.0552 -0.0511 
9 78.9410 1.2093 0.4623 0.8219 0.8006 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.1679 0.2543 -0.5787 
2 0.1561 0.2052 0.5688 
3 0.2057 0.1673 0.7060 
4 0.0136 0.1397 -0.1547 
5 0.0469 0.1219 -0.2985 
6 0.0408 0.1124 0.2774 
7 0.1851 0.1339 -0.6944 
8 0.0003 0.1816 -0.0241 
9 0.7298 0.6836 1.1767 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 102.2411 99. 1219 105.3604 95 .3140 109.1683 
2 100.9275 98.1255 103.7295 94.1373 107.7177 
3 99.6308 97.1010 102.1605 92.9483 106.3132 
4 98.3507 96.0386 100.6628 91.7475 104.9538 
5 97.0870 94.9278 99.2462 90.5358 103.6382 
6 94.6082 92.5342 96.6822 88.0846 101.1318 
7 92.1927 89.9295 94.4559 85.6065 98.7789 
8 89.8389 87.2029 92.4748 83.1155 96.5622 
9 78.9410 73.8272 84.0549 70.9156 86.9664 
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• Time, weeks v % Drug [Talc, 25C] 
255 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
TALC (First-order reaction) 
2s0 c /60%RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal _y= 1/abs(y) 
reciprocal _ysquare= 1 /y''2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 101.384}} 




"fit f toy with weight reciprocal_y 





step size= 100 
iterations= 100 
R = 0.78307565 Rsqr = 0.61320747 Adj Rsqr = 0.55795139 






Analysis of Variance: 
DF SS 
Regressionl 44.8811 
Residual 7 28.3096 
Total 8 73 .1907 
PRESS= 41.1859 

















Normality Test: Passed (P = 0.7028) 
Constant Variance Test: Passed (P = 0.9477) 
p0wer of performed test with alpha= 0.0500: 0.7324 
The power of the performed test (0. 7324) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 101.3838 -1.3838 -0.6881 -0.7874 -0.7636 
2 100.9866 1.6822 0.8365 0.9332 0.9234 
3 100.5909 -0.7303 -0.3631 -0.3973 -0.3721 
4 100.1968 -1.9726 -0.9809 -1.0579 -1.0686 
5 99.8042 1.6896 0.8401 0.8974 0.8831 
6 99.0237 2.9685 1.4761 1.5657 1.7983 
7 98.2493 0.0724 0.0360 0.0385 0.0357 
8 97.4810 -2.7063 -1.3457 -1.4759 -1.6464 
9 93.7284 0.3804 0.1891 0.3654 0.3415 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0959 0.2363 -0.4248 
2 0.1066 0.1966 0.4568 
3 0.0156 0.1647 -0.1652 
4 0.0914 0.1404 -0.4318 
5 0.0567 0.1234 0.3314 
6 0.1534 0.1112 0.6362 
7 0.0001 0.1267 0.0136 
8 0.2209 0.1686 -0.7414 
9 0.1823 0.7320 . 0.5645 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% · Pop. 5% Pop. 95% 
1 101.3838 99.0720 103.6955 96.0963 106.6712 
2 100.9866 98.8779 103.0952 95.7847 106.1884 
3 100.5909 98.6611 102.5207 95.4589 105.7229 
4 100.1968 98.4153 101.9783 95.1187 105.2749 
5 99.8042 98.1334 101.4750 94.7639 104.8445 
6 99.0237 97.4378 100.6097 94.0109 104.0365 
7 98.2493 96.5566 99.9420 93.2017 103.2969 
8 97.4810 95.5284 99.4336 92.3404 102.6216 
9 93.7284 89.6598 97.7969 87.4701 99.9867 
257 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
TALC (First-order reaction) 
40°C I 75%RH 
NO OUTPUT 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
TALC (First-order reaction) 




y = col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters) 
a= yatxnearO(y,x) "Auto {{previous: 84.9833}} 
b = -ln(.5)/(x50(x,y)-min(x)) "Auto {{previous: 0.0272392}} 
[Equation] 
f=a*exp(-b*x) 
fit f toy 
"fit f toy with weight reciprocal__y 








R == 0.7685 Rsqr = 0.5906 Adj Rsqr = 0.5321 






Analysis of Variance: 
DF SS 
Regression 1 872.5961 
Residual 7 604.8367 
Total 8 1477.4328 
PRESS = 1511.2094 








Normality Test: Passed (P = 0.6711) 










The power of the performed test (0.7021) is below the desired power of0.8000. 
You should interpret the negative findings cautiously . . 
Regression Diagnostics: 
Row Predicted Residual 
1 84.9833 15.0167 
2 82.6997 4.4898 
3 80.4774 -1.3672 
4 78.3149 -11.6707 
5 76.2105 -2.7199 
6 72.1697 -8.1631 
7 68.3432 0.3788 
8 64.7196 -5.8232 
9 49.2876 10.6308 
Influence Diagnostics: 
Row Cook'sDist 



































2 0.0416 0.2182 0.2731 
3 0.0027 0.1703 -0.0679 
4 0.1467 0.1383 -0.5836 
5 0.0066 0.1200 -0.1074 
6 0.0580 0.1172 -0.3370 
7 0.0002 0.1487 0.0171 
8 0.0632 0.2040 -0.3413 
9 2.4371 0.5991 2.7971 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 84.9833 73.2623 96.7044 60.0733 109.8934 
2 82.6997 72.4326 92.9668 58.4398 106.9596 
3 80.4774 71.4074 89.5475 56.6994 104.2555 
4 78.3149 70.1420 86.4878 54.8644 101.7654 
5 76.2105 68.5966 83.8243 52.9489 99.4720 
6 72.1697 64.6451 79.6943 48.9372 95.4022 
7 68.3432 59.8670 76.8194 44.7853 91.9011 
8 64.7196 54.7927 74.6465 40.6017 88.8375 
9 49.2876 32.2752 66.3000 21.4927 77.0824 















10 15 . 20 25 
- Col25vCol26 
• Time, weeks v % Drug (Talc, 50C/20% Moisture] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 




x == col(l) 
Y == col(2) 
260 
reciprocal _y= 1/abs(y) 
reciprocal _ysquare= 1/yJ\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
(Parameters] 
a== yatxnearO(y,x) "Auto {{previous: 98.224}} 




"fit f toy with weight reciprocal_y 







R = 0.98210601 Rsqr = 0.96453222 Adj Rsqr = 0.95946539 






Analysis of Variance: 
DF SS 
Regression 1 2963.6243 
Residual 7 108.9784 
Total 8 3072.6027 
PRESS = 198.1004 








Normality Test: Passed (P = 0.6137) 






Power of performed test with alpha= 0.0500: 0.9999 
Regression Diagnostics: 





Stud. Del. Res. 
1 98.2240 1.7760 0.4501 0.5537 0.5242 
2 93.3357 6.8087 1.7256 1.9764 2.7523 
3 88.6906 -1.4945 -0.3788 -0.4163 -0.3903 
4 84.2768 -4.6651 -1.1823 -1.2715 -1.3423 
5 80.0826 -2.2969 -0.5821 -0.6205 -0.5909 
6 72.3099 -3.4261 -0.8683 -0.9326 -0.9227 
7 65.2917 -0.8959 -0.2271 -0.2508 -0.2332 
8 58.9547 1.0517 0.2666 0.3058 0.2850 
9 35.3850 4.0678 1.0310 1.3805 1.4982 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0787 0.3391 0.3755 
2 0.6089 0.2377 1.5368 
3 0.0181 0.1724 -0.1781 
4 0.1265 0.1353 -0.5310 
5 0.0262 0.1199 -0.2181 
6 0.0668 0.1332 -0.3617 
7 0.0069 0.1801 -0.1093 
8 0.0148 0.2400 0.1602 
9 0.7556 0.4423 1.3342 
95% Confidence: 
Row Predicted Regr. 5% . Regr. 95% Pop. 5% Pop. 95% 
1 98.2240 92.7907 103.6573 87.4272 109.0208 
2 93.3357 88.7871 97.8843 82.9559 103.7154 
3 88.6906 84.8167 92.5646 78.5883 98.7930 
4 84.2768 80.8446 87.7089 74.3355 94.2181 
5 80.0826 76.8524 83.3127 70.2092 89.9559 
6 72.3099 68.9051 75.7148 62.3781 82.2418 
7 65.2917 61.3317 . 69.2518 55.1561 75.4274 
8 58.9547 54.3837 63.5256 48.5651 69.3442 
9 35.3850 29.1801 41.5898 24.1801 46.5899 
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10 15 20 25 
- Col30vCol31 
• Time, weeks v % Drug [Talc, 50C/Dry] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 




x = col(l) 
y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y1'2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a=yatxnearO(y,x)/2 "Auto {{previous: 0.411743}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.0412329}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.618745}} 




"fit f to y with weight reciprocal_y 









R = 0.95072798 Rsqr = 0.90388369 Adj Rsqr = 0.84621390 
Standard Error of Estimate= 0.0298 
Coefficient 
a 0.4117 15.0848 
b 0.0412 0.9213 
c 0.6187 15.0995 
d 0.0000 0.4174 
Analysis of Variance: 
DF SS 
Regression3 0.0417 
Residual 5 0.0044 
Total 8 0.0462 
PRESS = 6.9041 










Normality Test: Passed (P = 0.7024) 








Power of performed test with alpha = 0.0500: 0.9945 
Regression Diagnostics: 
Row Predicted Residual 
2 1.0305 -0.0305 
3 1.0139 0.0211 
4 0.9979 0.0326 
5 0.9826 -0.0090 
6 0.9679 -0.0172 
7 0.9402 0.0256 
8 0.9148 -0.0305 
9 0.8914 0.0057 
10 0.7992 0.0023 
Influence Diagnostics: 
Row Cook'sDist 
2 2.0886 0.7031 
3 0.0645 0.2728 








































5 0.0114 0.2679 -0.1937 
6 0.0501 0.2974 -0.4207 
7 0.0866 0.2581 0.5884 
8 0.1758 0.3144 -0.9007 
9 0.0555 0.6670 0.4260 
10 1938.9740 0.9991 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
2 1.0305 0.9663 1.0947 0.9306 1.1304 
3 1.0139 0.9739 1.0538 0.9275 1.1002 
4 0.9979 0.9620 1.0338 0.9133 1.0825 
5 0.9826 0.9430 1.0222 0.8964 1.0688 
6 0.9679 0.9261 1.0096 0.8807 1.0551 
7 0.9402 0.9013 0.9791 0.8544 1.0261 
8 0.9148 0.8719 0.9577 0.8270 1.0026 
9 0.8914 0.8288 0.9539 0.7925 0.9902 
10 0.7992 0.7227 0.8758 0.6910 0.9075 












10 15 20 25 
------"-l:l.oJa 
- Col 10v Col 11 
• Time, weeks v D/Do, [Talc, 25C] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
TALC (BiPhasic First-order reaction) 
2s0 c I 60%RH 
Nonlinear Regression 
[Variables] 
x == col(l) 
Y == col(2) 
reciprocal_y== 1/abs(y) 
reciprocal_ysquare= l /y"2 
265 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x)/2 "Auto {{previous: 0.45219}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00453869}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.561641}} 




"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.78307374 Rsqr = 0.61320448 Adj Rsqr = 0.38112716 
Standard Error of Estimate= 0.0238 
Coefficient 
a 0.4522 736579.2042 
b 0.0045 358.6938 
c 0.5616 736579.2032 
d 0.0034 289.4781 
Analysis of Variance: 
DF SS 
Regression3 0.0045 
Residual 5 0.0028 
Total 8 0.0073 
PRESS = 0.0134 










Normality Test: Passed (P = 0.7009) 













The power of the performed test (0.7324) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 1.0138 -0.0138 -0.5813 -0.7352 -0.6963 
2 1.0099 0.0168 0.7071 0.8204 0.7888 
3 1.0059 -0.0073 -0.3069 -0.3128 -0.2825 
4 1.0020 -0.0197 -0.8291 -0.9171 -0.8994 
5 0.9980 0.0169 0.7098 0.6890 0.6477 
6 0.9903 0.0297 1.2469 1.3606 1.5335 
7 0.9825 0.0007 0.0294 0.0341 0.0305 
8 0.9748 -0.0271 -1.1389 -1.3111 -1.4476 
9 0.9374 0.0037 0.1555 0.7867 0.7517 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0811 0.3750 -0.5394 
2 0.0582 0.2571 0.4641 
3 0.0009 0.0374 -0.0557 
4 0.0470 0.1826 -0.4250 
5 -0.0069 -0.0613 (+inf) 
6 0.0883 0.1602 0.6697 
7 0.0001 0.2569 0.0179 
8 0.1398 0.2455 -0.8257 
9 3.8057 0.9609 3.7281 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0138 0.9764 1.0513 0.9421 1.0856 
2 1.0099 0.9788 1.0409 0.9413 1.0784 
3 1.0059 0.9941 1.0177 0.9436 1.0682 
4 1.0020 0.9758 1.0281 0.9355 1.0685 
5 0.9980 0.9980 0.9980 0.9980 0.9980 
6 0.9903 0.9658 1.0147 0.9244 1.0561 
7 0.9825 0.9515 1.0135 0.9139 1.0511 
8 0.9748 0.9445 1.0052 0.9066 1.0431 
9 0.9374 0.8774 0.9973 0.8517 1.0230 
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10 15 20 25 
-Col15 v Col16 
• Time, weeks v O/Do, (Talc, 25C/60% RH] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
TALC (BiPhasic First-order reaction) 
40°C I 75%RH 
NO OUTPUT 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
TALC (BiPhasic First-order reaction) 




y = col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.341123}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.516044}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.66249}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00541061}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d *x) 
fit f toy 
"fit f to y with weight reciprocal_y 






tolerance= 1 e-6 
stepsize=O. l 
iterations= 100 
R = 0.9666 Rsqr = 0.9342 Adj Rsqr = 0.8948 
Standard Error of Estimate= 0.0441 
Coefficient 
a 0.3411 0.0746 
b 0.5160 0.2261 
c 0.6625 0.0694 
d 0.0054 0.0078 
Analysis of Variance: 
DF SS 
Regression3 0.1380 
Residual 5 0.0097 
Total 8 0.1477 
PRESS = 0.0343 










Normality Test: Passed (P = 0.7948) 








Power of performed test with alpha~ 0.0500: 0.9988 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0036 -0.0036 
2 0.8625 0.0094 
3 0.7769 0.0142 
4 0.7244 -0.0579 
5 0.6916 0.0433 
6 0.6568 -0.0167 
7 0.6399 0.0473 
8 0.6296 -0.0406 




































Row Cook'sDist Leverage DFFITS 
1 0.2443 0.9205 -0.8917 
2 0.0104 0.3673 0.1835 
3 0.0230 0.3612 0.2758 
4 0.2093 0.2632 -1.1226 
5 0.0833 0.2136 0.5944 
6 0.0188 0.2759 -0.2506 
7 0.2063 0.3259 1.0013 
8 0.1401 0.3125 -0.7714 
9 1.6491 0.9599 2.3632 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0036 0.8949 1.1123 0.8466 1.1607 
2 0.8625 0.7938 0.9312 0.7300 0.9950 
3 0.7769 0.7088 0.8450 0.6447 0.9091 
4 0.7244 0.6662 0.7825 0.5970 0.8517 
5 0.6916 0.6392 0.7440 0.5668 0.8164 
6 0.6568 0.5972 0.7163 0.5287 0.7848 
7 0.6399 0.5752 0.7046 0.5094 0.7704 
8 0.6296 0:5662 0.6929 0.4997 0.7594 
9 0.5946 0.4835 0.7056 0.4359 0.7532 
2D Graph 39 
1 . 1 ~-----------, 
1.0 
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10 15 20 25 
- Col 25 v Col 26 
• Time, weeks v O/Do, (Talc, SOC/20% Moisture] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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x == col(l) 
y == col(2) · 
reciprocal _y== 1/abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a== yatxnearO(y,x)/2 "Auto {{previous: 0.194689}} 
b == -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.296141}} 
c == yatxnearO(y,x)/2 "Auto {{previous: 0.83071}} 




"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.99183104 Rsqr = 0.98372882 Adj Rsqr = 0.97396611 
Standard Error of Estimate= 0.0316 
Coefficient Std. Error . t p 
a 0.1947 0.1710 1.1384 0.3065 
b 0.2961 0.3061 0.9675 0.3777 
c 0.8307 0.1778 4.6722 0.0055 
d 0.0366 0.0129 2.8352 0.0365 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.3023 0.1008 100.7639 <0.0001 
Residual 5 0.0050 0.0010 
Total 8 0.3073 0.0384 
271 
pRESS = 0.0905 
Durbin-Watson Statistic= 2.5529 
Normality Test: Passed (P = 0.4865) 
Constant Variance Test: Passed (P = 0.0988) 
Power of performed test with alpha= 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0254 -0.0254 
2 0.9456 0.0558 
3 0.8797 -0.0077 
4 0.8243 -0.0282 
5 0.7770 0.0009 
6 0.6997 -0.0108 
7 0.6378 0.0061 
8 0.5859 0.0142 
9 0.3997 -0.0051 
Influence Diagnostics: 
Row Cook'sDist 
1 5.9275 0.8481 
2 0.4534 0.2918 
3 0.0096 0.3091 
4 0.1186 0.2961 
5 0.0001 0.2485 
6 0.0129 0.2481 
7 0.0080 0.3548 
8 0.0648 0.4258 
9 13.1347 0.9778 
95% Confidence: 
Row Predicted Regr. 5% 
1 1.0254 0.9505 
2 0.9456 0.9017 
3 0.8797 0.8345 
4 0.8243 0.7801 
5 0.7770 0.7365 
6 0.6997 0.6592 
7 0.6378 0.5894 
8 0.5859 0.5329 





















































































10 15 20 25 
- Col 30vCol31 
• Time, weeks v D/Do, [Talc. SOC/Ory 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 





y = col(2) 
reciprocal_y=l/abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters) 
a= yatxnearO(y,x) "Auto {{previous: 95.3049}} 




"fit f toy with weight reciprocal_y 





step size= 100 
iterations= 100 
R = 0.73300110 Rsqr = 0.53729062 Adj Rsqr = 0.47118928 
273 






Analysis of Variance: 
DF SS 
Regression 1 126.2918 
Residual 7 108.7613 
Total 8 235.0531 
PRESS = 326.1659 








Normality Test: Passed (P = 0.2642) 










The power of the performed test (0.6296) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 95.3049 4.6951 
2 94.6075 -4.5163 
3 93.9153 3.5307 
4 93.2281 0.5700 
5 92.5459 0.5543 
6 91.1966 0.0533 
7 89.8669 -4.3953 
8 88.5565 -4.3463 
9 82.2861 3.8744 
Influence Diagnostics: 
Row Cook'sDist 
1 0.3008 0.2430 
2 0.2049 0.1999 
3 0.0955 0.1657 
4 0.0020 0.1402 
5 0.0016 0.1228 















































Row Predicted Regr. 5% 
1 95.3049 90.7103 
2 94.6075 90.4404 
3 93.9153 90.1208 
4 93 .2281 89.7386 
5 92.5459 89.2793 
6 91.1966 88.0838 
7 89.8669 86.5167 
8 88.5565 84.6759 












































• Time, weeks v % Drug {Ferric oxide, 25CJ 
• 












FERRIC-OXIDE (First-order reaction) · 
2s0 c I 60 %RH 
Nonlinear Regression 
[Variables] 
x == col(l) 
Y == col(2) 
reciprocal_y==l /abs(y) 
reciprocal _ysquare= l /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)==max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
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[Parameters] 
a=== yatxnearO(y,x) "Auto {{previous: 94.6625}} 




"fit f toy with weight reciprocal_y 







R = 0.49034996 Rsqr = 0.24044308 Adj Rsqr = 0.13193495 






Analysis of Variance: 
DF SS 
Regression 1 26.8925 
Residual 7 84.9533 
Total 8 111.8458 
PRESS= 245.4569 








Normality Test: Passed (P = 0.3652) 










The power of the performed test (0.2592) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 94.6625 5.3375 








Stud. Del. Res. 
2.1641 
-0.3560 
3 94.0444 2.8383 0.8147 0.8913 0.8764 
4 93.7368 -2.1949 -0.6300 -0.6796 -0.6510 
5 93.4303 -3.4791 -0.9987 -1.0668 -1.0792 
6 92.8202 1.5619 0.4483 0.4756 0.4476 
7 92.2141 -3.5891 -1.0302 -1.1022 -1.1224 
8 91.6119 -2.3332 -0.6697 -0.7341 -0.7074 
9 88.6596 3.0512 0.8758 1.7026 2.0594 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.4714 0.2350 1.1996 
2 0.0176 0.1960 -0.1758 
3 0.0782 0.1645 0.3889 
4 0.0377 0.1404 -0.2631 
5 0.0802 0.1236 -0.4052 
6 0.0141 0.1112 0.1583 
7 0.0878 0.1263 -0.4267 
8 0.0543 0.1677 -0.3176 
9 4.0280 0.7354 3.4331 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 94.6625 90.6688 98.6562 85.5078 103.8172 
2 94.3530 90.7062 97.9998 85.3442 103.3617 
3 94.0444 90.7035 97.3853 85.1551 102.9337 
4 93 .7368 90.6503 96.8234 84.9399 102.5337 
5 93.4303 90.5346 96.3260 84.6985 102.1621 
6 92.8202 90.0733 95.5671 84.1366 101.5038 
7 92.2141 89.2870 95.1412 83.4719 100.9563 
8 91.6119 88.2385 94.9854 82.7103 100.5136 
9 88.6596 81.5955 95.7238 77.8079 99.5114 














10 15 20 25 
- Col15vCol 16 
• Time, weeks v % Drug !Ferric oxide, 25C/60% RH) 
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••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
FERRIC-OXIDE (First-order reaction) 
40°C I 15 %RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 97.0328}} 




"fit f toy with weight reciprocal_y 





step size= 100 
iterations= 100 
R = 0.52010303 Rsqr = 0.27050716 Adj Rsqr = 0.16629390 
Standard Error of Estimate= 3.8442 
Coefficient 
a 97.0328 1.8682 
b 0.0038 0.0024 
Analysis of Variance: 
DF SS 
Regression 1 38.3596 
Residual 7 103 .4468 
Total 8 141.8064 
PRESS= 380.7332 

















Normality Test: Passed (P = 0.2819) 
Constant Variance Test: Passed (P = 0.1243) 
p0 wer of performed test with alpha= 0.0500: 0.2919 
The power of the performed test (0.2919) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 97.0328 2.9672 0.7719 0.8832 0.8674 
2 96.6603 -2.0478 -0.5327 -0.5943 -0.5646 
3 96.2892 1.4408 0.3748 0.4101 0.3843 
4 95.9196 3.2910 0.8561 0.9233 0.9122 
5 95.5514 1.8261 0.4750 0.5074 0.4786 
6 94.8191 -1.4809 -0.3852 -0.4086 -0.3829 
7 94.0925 -5.4011 -1.4050 -1.5034 -1.6915 
8 93.3715 -4.9135 -1.2782 -1.4017 -1.5301 
9 89.8483 4.3244 1.1249 2.1748 3.5354 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.1206 0.2362 0.4823 
2 0.0432 0.1965 -0.2793 
3 0.0166 0.1647 0.1706 
4 0.0696 0.1404 0.3686 
5 0.0181 0.1235 0.1796 
6 0.0104 0.1112 -0.1355 
7 0.1639 0.1267 -0.6441 
8 0.1991 0.1685 -0.6887 
9 6.4738 0.7324 . 5.8495 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% · Pop. 5% Pop. 95% 
1 97.0328 92.6153 101.4503 86.9261 107.1395 
2 96.6603 92.6304 100.6902 86.7169 106.6037 
3 96.2892 92.6006 99.9779 86.4792 106.0993 
4 95 .9196 92.5140 99.3252 86.2124 105.6268 
5 95.5514 92.3573 98.7454 85.9164 105.1863 
6 94.8191 91.7875 97.8507 85.2368 104.4015 
7 94.0925 90.8575 97.3275 84.4439 103.7412 
8 93.3715 89.6402 97.1027 83.5453 103.1976 
9 89.8483 82.0686 97.6279 77.8836 101.8130 
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88 • • 
86~-~-~-~--~-~--; 
10 15 20 25 
- Col 20 v Col 21 
• Time, weeks v % Drug [Ferric oxide, 40Cl75% RH] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
FERRIC-OXIDE (First-order reaction) 
50°C I 20 %moisture 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y=l/abs(y) 
reciprocal_ysquare= 1/yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 92.2681}} 




"fit f to y with weight reciprocal_y 





step size= 100 
iterations= 100 
R = 0.54301341 Rsqr = 0.29486356 Adj Rsqr = 0.19412978 
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Analysis of Variance: 
DF SS 
Regression I 81 .1015 
Residual 7 193.9459 
Total 8 275.0474 
PRESS = 424.2674 








Normality Test: Passed (P = 0.4458) 










The power of the performed test (0.3193) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 92.2681 7.7319 
2 91.7159 -6.6647 
3 91.1669 0.2321 
4 90.6213 6.4185 
5 90.0790 -1.6415 
6 89.0040 -4.7380 
7 87.9418 -2.9907 
8 86.8924 -1.7186 
9 81 .8298 3.3844 
Influence Diagnostics: 
Row Cook'sDist 
1 0.4492 0.2403 
2 0.2478 0.1986 
3 0.0002 0.1653 
4 0.1411 0.1402 
5 0.0078 0.1231 








































7 0.0272 0.1282 -0.2219 
8 0.0133 0.1714 -0.1524 
9 1.9234 0.7215 2.0457 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% 
1 92.2681 86.1667 98.3694 78.4064 
2 91.7159 86.1694 97.2623 78.0893 
3 91.1669 86.1062 96.2277 77.7308 
4 90.6213 85.9601 95.2825 77.3305 
5 90.0790 85.7124 94.4456 76.8886 
6 89.0040 84.8500 93.1580 75.8824 
7 87.9418 83.4860 92.3976 74.7216 
8 86.8924 81.7393 92.0454 73.4211 
9 81.8298 71.2572 92.4025 65.4989 






































x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
282 
a== yatxnearO(y,x) "Auto {{previous: 93.9272}} 




"fit f toy with weight reciprocal_y 







R == 0.97200797 Rsqr == 0.94479949 Adj Rsqr = 0.93691370 






Analysis of Variance: 
DF SS 
Regression I 2194.7751 
Residual 7 128.2311 
Total 8 2323.0062 
PRESS= 287.4305 








Normality Test: Passed (P = 0. 7036) 






Power of performed test with alpha= 0.0500: 0.9994 
Regression Diagnostics: 
Row Predicted Residual 
1 93.9272 6.0728 
2 89.9254 -2.0340 
3 86.0940 1.8044 
4 82.4258 1.0546 
5 78.9140 -5.2288 


























7 66.3004 -4.2779 -0.9995 -1.0971 -1.1162 
8 60.7712 -0.0489 -0.0114 -0.0130 -0.0121 
9 39.3191 5.7103 1.3342 1.8711 2.4503 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.7040 0.3217 1.4475 
2 0.0444 0.2320 -0.2820 
3 0.0223 0.1721 0.1987 
4 0.0055 0.1362 0.0980 
5 0.1149 0.1194 -0.5098 
6 0.0210 0.1272 -0.1935 
7 0.1232 0.1700 -0.5051 
8 0.0000 0.2297 -0.0066 
9 1.6927 0.4916 2.4095 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 93 .9272 88.1865 99.6679 82.2918 105.5627 
2 89.9254 85 .0501 94.8006 78.6916 101.1591 
3 86.0940 81.8952 90.2928 75.1369 97.0511 
4 82.4258 78.6909 86.1608 71.6380 93.2137 
5 78.9140 75.4171 82.4108 68.2062 89.6217 
6 72.3328 68.7228 75.9427 61.5876 83.0780 
7 66.3004 62.1282 70.4727 55.3535 77.2474 
8 60.7712 55.9201 65.6222 49.5479 71.9944 
9 39.3191 32.2231 46.4151 26.9586 51.6796 
20 Graph 41 












10 15 20 25 
- Col 30vCol31 
• Time. weeks v % Drug {Ferric oxide, 50C/2Dry] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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y == col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.141982}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.164601}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.840774}} 
d = -ln(.5)/(1.5*(x50(x,y)-min(x))) "Auto {{previous: 1.87663e-010}} 
[Equation] 
f=a*exp(-b*x)+c*exp(-d *x) 
fit f toy 
"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.83352356 Rsqr = 0.69476153 Adj Rsqr = 0.51161844 
Standard Error of Estimate = 0.0379 
Coefficient Std. Error t p 
a 0.1420 0.4079 0.3480 0.7420 
b 0.1646 0.5184 0.3175 0.7637 
c 0.8408 0.4224 1.9905 0.1032 
d 0.0000 0.0218 0.0000 1.0000 
Analysis of Variance: 
DF SS MS F p 
Regression3 0.0163 0.0054 3.7935 0.0927 
Residual 5 0.0072 0.0014 





Durbin-Watson Statistic= 2.5793 
Normality Test: Failed (P = 0.0160) 
Constant Variance Test: Passed (P = 0.5198) 
Power of performed test with alpha= 0.0500: 0.8361 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 0.9828. 0.0172 0.4552 0.9542 0.9437 
2 0.9612 -0.0603 -1.5917 -1.8642 -3.0196 
3 0.9429 0.0315 0.8324 0.9637 0.9552 
4 0.9274 0.0106 0.2786 0.3308 0.2991 
5 0.9143 0.0167 0.4416 0.5211 0.4792 
6 0.8937 0.0188 0.4974 0.5679 0.5252 
7 0.8788 -0.0241 -0.6364 -0.7809 -0.7454 
8 0.8682 -0.0260 -0.6876 -1.0426 -1.0542 
9 0.8461 0.0156 0.4106 6.8933 (+inf) 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.7725 0.7724 1.7385 
2 0.3230 0.2710 -1.8411 
3 0.0790 0.2540 0.5574 
4 0.0112 0.2903 0.1913 
5 0.0266 0.2818 0.3002 
6 0.0245 0.2330 0.2895 
7 0.0771 0.3359 -0.5302 
8 0.3531 0.5650 -1.2015 
9 3337.0459 0.9965 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9828 0.8972 1.0683 0.8531 1.1124 
2 0.9612 0.9105 1.0119 0.8514 1.0710 
3 0.9429 0.8939 0.9920 0.8339 1.0520 
4 0.9274 0.8750 0.9799 0.8168 1.0380 
5 0.9143 0.8626 0.9660 0.8040 1.0245 
6 0.8937 0.8466 0.9407 0.7855 1.0018 
7 0.8788 0.8224 0.9353 0.7663 0.9914 
8 0.8682 0.7950 0.9413 0.7463 0.9900 
9 0.8461 0.7489 0.9433 0.7085 0.9836 
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20 Graph 1 




















10 15 20 25 
- Col10vCol 11 
• Time, weeks v D/Do, [Ferric oxide, 25C) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
FERRIC-OXIDE (BiPhasic First-order reaction) 




y = col(2) 
reciprocal _y= 1 I abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r)=xatymax( q,xnearO(r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.087789}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.531831}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.905793}.} 




"fit f to y with weight reciprocal_y 









R = 0. 79886257 Rsqr = 0.63818141 Adj Rsqr = 0.42109026 
Standard Error of Estimate= 0.0284 
Coefficient 
a 0.0878 0.0450 
b 0.5318 0.5658 
c 0.9058 0.0407 
d 0.0000 0.0033 
Analysis of Variance: 
DF SS 
Regression3 0.0071 
Residual 5 0. 0040 
Total 8 0.0112 
PRESS= 0.1041 










Normality Test: Passed (P = 0.3683) 












The power of the performed test (0.7653) is below the desired power of 0.8000. 
Yo~ should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 0.9936 0.0064 
2 0.9574 -0.0257 
3 0.9361 0.0327 
4 0.9236 -0.0082 
5 0.9163 -0.0167 
6 0.9094 0.0344 
7 0.9070 -0.0208 
8 0.9062 -0.0134 
9 0.9058 0.0113 
Influence Diagnostics: 
Row Cook'sDist 



































2 0.1951 0.3740 -0.9194 
3 0.2959 0.3630 1.2729 
4 0.0098 0.2597 -0.1790 
5 0.0293 0.2108 -0.3206 
6 0.1915 0.2751 1.0139 
7 0.0941 0.3230 -0.5979 
8 0.0359 0.3082 -0.3505 
9 26.2892 0.9620 22.3428 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9936 0.9233 1.0639 0.8921 1.0950 
2 0.9574 0.9126 1.0021 0.8716 1.0431 
3 0.9361 0.8920 0.9802 0.8507 1.0215 
4 0.9236 0.8863 0.9609 0.8415 1.0057 
5 0.9163 0.8827 0.9498 0.8358 0.9967 
6 0.9094 0.8710 0.9478 0.8268 0.9920 
7 0.9070 0.8655 0.9486 0.8229 0.9912 
8 0.9062 0.8656 0.9468 0.8226 0.9899 
9 0.9058 0.8341 0.9775 0.8034 1.0082 
















10 15 ?O 25 
- Col 15vCol 16 
• T ime, weeks 11 O/Oo, [Ferric oxide, 25C/60% RH] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
FERRIC-OXIDE (BiPhasic First-order reaction) 
40°C /75 %RH 
Nonlinear Regression 
[Variables] 
x = col(l) 




'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.0903676}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.210639}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.907939}} 




"fit f to y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O. l 
iterations= 100 
R = 0.71054287 Rsqr = 0.50487117 Adj Rsqr = 0.20779387 
Standard Error of Estimate= 0.0375 
Coefficient 
a 0.0904 0.2259 
b 0.2106 0.6808 
c 0.9079 0.2377 
d 0 .0000 0.0128 
Analysis of Variance: 
DF SS 
Regression3 0.0072 
Residual 5 0.0070 
Total 8 0.0142 
PRESS = 36.0903 










Normality Test: Passed (P = 0.2873) 












Power of performed test with alpha= 0.0500: 0.5855 
The power of the performed test (0.5855) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 0.9983 0.0017 0.0452 0.1000 0.0896 
2 0.9811 -0.0350 -0.9345 -1.0962 -1.1249 
3 0.9672 0.0101 0.2685 0.3140 0.2836 
4 0.9560 0.0361 0.9642 1.1481 1.1967 
5 0.9469 0.0269 0.7185 0.8422 0.8131 
6 0.9335 -0.0001 -0.0024 -0.0028 -0.0025 
7 0.9247 -0.0378 -1.0082 -1.2436 -1.3384 
8 0.9189 -0.0344 -0.9168 -1 .3336 -1.4860 
9 0.9093 0.0324 0.8659 11.7811 (+inf) 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 0.0098 0.7960 0.1769 
2 0.1129 0.2732 -0.6897 
3 0.0091 0.2687 0.1719 
4 0.1377 0.2948 0.7736 
5 0.0663 0.2722 0.4973 
6 0.0000 0.2303 -0.0014 
7 0.2016 0.3427 -0.9665 
8 0.4962 0.5274 -1.5699 
9 6387.8017 0.9946 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9983 0.9124 1.0842 0.8692 1.1274 
2 0.9811 0.9308 1.0315 0.8724 1.0898 
3 0.9672 0.9173 1.0172 0.8587 1.0757 
4 0.9560 0.9037 1.0083 0.8464 1.0656 
5 0.9469 0.8966 0.9971 0.8382 1.0555 
6 0.9335 0.8872 0.9797 0.8266 1.0403 
7 0.9247 0.8683 0.9811 0.8131 1.0363 
8 0.9189 0.8490 0.9889 0.7999 1.0380 
9 0.9093 0.8132 1.0053 0.7732 1.0453 
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10 15 20 25 
- Col20vCol21 
• Time. weeks v D/Oo, [Ferric oxide, 40Cl75% RHJ 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
FERRIC-OXIDE (BiPhasic First-order reaction) 




y = col(2) 
reciprocal_y=l/abs(y) 
reciprocal_ysquare= 1fyA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.118032}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.284503}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.845865}} 




"fit f to y with weight reciprocal_y 









R = 0.68453483 Rsqr = 0.46858793 Adj Rsqr = 0.14974069 
Standard Error of Estimate= 0.0541 
Coefficient 
a 0.1180 0.1725 
b 0.2845 0.6735 
c 0.8459 0.1825 
d 0.0000 0.0122 
Analysis of Variance: 
DF SS 
Regression3 0.0129 
Residual 5 0.0146 
Total 8 0.0275 
PRESS = 0.4189 










Normality Test: Passed (P = 0.2163) 












The power of the performed test (0.5365) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 0.9639 0.0361 0.6677 1.6347 2.1430 
2 0.9347 -0.0842 -1.5566 -1.8376 -2.8849 
3 0.9127 0.0013 0.0242 0.0288 0.0258 
4 0.8961 0.0743 1.3735 1.6375 2.1509 
5 Q.8837 0.0007 0.0127 0.0147 0.0131 
6 0.8673 -0.0246 -0.4553 -0.5200 -0.4782 
7 0 .8580 -0.0085 -0.1567 -0.1944 -0.1745 
8 0.8527 -0.0010 -0.0183 -0.0250 -0.0224 
9 0.8463 0.0059 0.1087 1.0876 1.1133 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 3.3361 0.8332 4.7888 
293 
2 0.3324 0.2825 -1.8103 
3 0.0001 0.2952 0.0167 
4 0.2825 0.2965 1.3963 
5 0.0000 0.2537 0.0077 
6 0.0206 0.2334 -0.2639 
7 0.0051 0.3501 -0.1281 
8 0.0001 0.4655 -0.0209 






















0.8370 1.0908 0.7757 
0.8608 1.0085 0.7773 
0.8372 0.9882 0.7545 
0.8205 0.9718 0.7379 
0.8137 0.9537 0.7281 
0.8001 0.9344 0.7129 
0.7758 0.9402 0.6965 
0.7579 0.9476 0.6845 


















10 15 20 25 
- Col 25 v Col 26 
















x = col(l) 
Y = col(2) 
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reciprocal_y=l/abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
(Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.278258}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.21828}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.709415}} 




"fit f to y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.99107522 Rsqr = 0.98223009 Adj Rsqr = 0.97156814 
Standard Error of Estimate= 0.0287 
Coefficient 
a 0.2783 0.2471 
b 0.2183 0.2021 
c 0.7094 0.2563 
d 0.0230 0.0178 
Analysis of Variance: 
DF SS 
Regression3 0.2282 
Residual 5 0.0041 
Total 8 0.2323 
PRESS = 0.0203 










Normality Test: Passed (P = 0.2977) 












Power of performed test with alpha= 0.0500: 1.0000 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 0.9877 0.0123 0.4290 0.9777 0.9724 
2 0.9170 -0.0380 -1.3239 -1.5562 -1.9382 
3 0.8573 0.0217 0.7546 0.8879 0.8653 
4 0.8066 0.0282 0.9811 1.1699 1.2279 
5 0.7632 -0.0263 -0.9167 -1.0712 -1.0915 
6 0.6930 0.0089 0.3 109 0.3553 0.3219 
7 0.6386 -0.0183 -0.6385 -0.7911 -0.7565 
8 0.5948 0.0124 0.4310 0.6098 0.5669 
9 0.4511 -0.0008 -0.0277 -0.2942 -0.2654 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 1.0023 0.8075 1.9914 
2 0.2310 0.2762 -1.1973 
3 0.0758 0.2778 0.5366 
4 0.1444 0.2967 0.7976 
5 0.1048 0.2676 -0.6597 
6 0.0096 0.2340 0.1779 
7 0.0837 0.3485 -0.5532 
8 0.0932 0.5006 0.5676 
9 2.4198 0.9911 -2.8071 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9877 0.9213 1.0540 0.8884 1.0870 
2 0.9170 0.8781 0.9558 o.8335 1.0004 
3 0.8573 0.8184 . 0.8962 0.7738 0.9408 
4 0.8066 0.7664 0.8468 0.7225 0.8907 
5 0.7632 0.7250 0.8014 0.6800 0.8463 
6 0.6930 0.6572 0.7287 . 0.6109 0.7750 
7 0.6386 0.5950 0.6822 0.5528 0.7243 
8 0.5948 0.5426 0.6471 0.5044 0.6853 
9 0.4511 0.3776 0.5246 0.3469 0.5553 
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10 15 20 25 
- Col30vCol31 
• Time, weeks v D/Oo, [Ferric oxide, SOC/Dry] 
************************************************************************ 




x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal_ysquare= 1 /y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 88.5058}} 




"fit f toy with weight reciprocal_y 







R = 0.53591830 Rsqr = 0.28720842 Adj Rsqr = 0.04961123 
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Analysis of Variance: 
DF SS 
Regression 1 111 .104 7 
Residual 3 275.7389 
Total 4 386.8436 
PRESS= 684.7905 








Normality Test: Passed (P = 0.5885) 










The power of the performed test (0.1327) is below the desired power of0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 88.5058 11.4942 
2 87.1765 -3.9248 
3 85.8672 -11.0416 
4 79.6098 2.0661 
5 76.0764 1.4259 
Influence Diagnostics: 
Row Cook'sDist 
1 0.9557 0.4308 
2 0.0585 0.3214 
3 0.2921 0.2487 
4 0.0177 0.3363 
5 0.0645 0.6628 
95% Confidence: 
Row Predicted Regr. 5% 
1 88.5058 68.4800 
2 87.1765 69.8791 



























































- Col9 v Col10 
97.3024 
100.9165 
20 Graph 46 







L-4 Tablets (First-order reaction) 
25°C I 60 % RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal_ysquare= 1/y"2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 90.9752}} 




"fit f to y with weight reciprocal_y 








R = 0.36269390 Rsqr = 0.13154686 Adj Rsqr = 0.00000000 






Analysis of Variance: 
DF SS 
Regression 1 41.2269 
Residual 3 272.1737 
Total 4 313.4006 
PRESS = 768.9416 








Normality Test: Passed (P = 0.1734) 










The power of the performed test (0.0774) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 90.9752 9.0248 
2 90.2004 -6.7429 
3 89.4322 -7.0152 
4 85.6883 8.8798 
5 83.5175 -4.1468 
Influence Diagnostics: 
Row Cook'sDist 
1 0.5754 0.4245 
2 0.1751 0.3216 
3 0.1213 0.2509 
4 0.3192 0.3299 




























Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 90.9752 71.2248 110.7257 54.7961 127.1544 
2 90.2004 73.0112 107.3896 55.3534 125.0475 
3 89.4322 74.2480 104.6164 55.5293 123.3352 
4 85.6883 68.2786 103.0979 50.7319 120.6446 















- Col 14vCol15 
• Time, weeks v % Drug [L4 Tablets, 25C/60% RH] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
L-4 Tablets (First-order reaction) 
40°C /75 % RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y=l/abs(y) 
reciprocal_ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a = yatxnearO(y,x) "Auto {{previous: 93.395}} 




"fit f to y with weight reciprocal_y 








R = 0.77076136 Rsqr = 0.59407308 Adj Rsqr = 0.45876410 






Analysis of Variance: 
DF SS 
Regression 1 263.6055 
Residual 3 180.1202 
Total 4 443.7258 
PRESS= 697.1267 








Normality Test: Passed (P = 0.4144) 










The power of the performed test (0.3035) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 93.3950 6.6050 
2 91.2621 0.1846 
3 89 .1778 -6.5428 
4 79.4491 -6.9326 
5 74.1290 6.7522 
Influence Diagnostics: 
Row Cook'sDist 
1 0.5060 0.4388 
2 0.0002 0.3211 
































Row Predicted Regr. 5% 
1 93.3950 77.0612 
2 91.2621 77.2884 
3 89.1778 76.9482 
4 79.4491 64.9746 




















20 Graph 48 
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x = col(l) 
y = col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal_ysquare= 1/yA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x) "Auto {{previous: 88.9987}} 





"fit f toy with weight reciprocal_y 







R = 0.90949854 Rsqr = 0.82718759 Adj Rsqr = 0.76958346 






Analysis of Variance: 
DF SS 
Regression 1 1231.8276 
Residual 3 257.3480 
Total 4 1489.1757 
PRESS = 821.6253 








Normality Test: Passed (P = 0.4730) 










The power of the performed test (0.5778) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual 
1 88.9987 11.0013 
2 83.5396 -9.8140 
3 78.4152 -3.1642 
4 57.1402 -2.4821 





















Row Cook'sDist Leverage DFFITS 
1 1.2451 0.4790 4.1309 
2 0.3838 0.3180 -1.0650 
3 0.0236 0.2360 -0.1821 
4 0.0370 0.3870 -0.2265 
5 0.4566 0.5799 0.8837 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 88.9987 68.5982 109.3992 53.1521 124.8453 
2 83.5396 66.9176 100.1615 49.7004 117.3787 
3 78.4152 64.0957 92.7347 45.6457 111.1848 
4 57.1402 38.8039 75.4766 22.4268 91.8536 
5 47.2571 24.8103 69.7038 10.2077 84.3064 











- Col 24 v Col 25 
• Time, weeks v % Drug [l4 Tablets, SOC/Ory] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 





y = col(2) 
reciprocal _y= 1/ abs(y) 
reciprocal_ysquare= 1fyA2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
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a= yatxnearO(y,x)/2 "Auto {{previous: 0.219076}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 1.7807}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.782068}} 




"fit f to y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=O .1 
iterations= 100 
R = 0.95990266 Rsqr = 0.92141311 Adj Rsqr = 0.68565244 
Standard Error of Estimate= 0.0551 
Coefficient 
a 0.2191 0.1165 
b 1.7807 2.8185 
c 0.7821 0.1039 
d 0.0000 0.0168 
Analysis of Variance: 
DF SS 
Regression3 0.0356 
Residual 1 0.0030 
Total 4 0.0387 
PRESS = 55.5621 










Normality Test: Passed (P = 0.6010) 












The power of the performed test (0.7853) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
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Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 1.0011 -0.0011 -0.0207 -1.6711 (+inf) 
2 0.8190 0.0135 0.2454 1.6706 (+inf) 
3 0.7883 -0.0400 -0.7261 -1.6699 (+inf) 
4 0.7821 0.0347 0.6292 0.8277 0.0000 
5 0.7821 -0.0070 -0.1278 -0.2779 0.0000 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 4532.0189 0.9998 (+inf) 
2 31.6346 0.9784 (+inf) 
3 2.9906 0.8110 (+inf) 
4 0.1252 0.4222 0.0000 
5 0.0720 0.7886 0.0000 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 1.0011 0.3006 1.7017 0.0104 1.9919 
2 0.8190 0.1260 1.5120 -0.1664 1.8044 
3 0.7883 0.1574 1.4192 -0.1545 1.7311 
4 0.7821 0.3268 1.2373 -0.0534 1.6176 
5 0.7821 0.1599 1.4042 -0.1549 1.7190 













- Col 9vCol10 
• Time, weeks v DfDo, (l-4 Tablets, 25C] 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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L-4 Tablets (BiPhasic First-order reaction) 
25°C I 60 %RH 
Nonlinear Regression 
[Variables] 
x = col(l) 
y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.408332}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.00882357}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.501416}} 




"fit f toy with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.36269364 Rsqr = 0.13154668 Adj Rsqr·= 0.00000000 
Standard Error of Estimate= 0.1650 
Coefficient Std. Error 
a 
b 
0.4083 6871896.7094 0.0000 
0.0088 14244.6038 0.0000 
c 
d 
0.5014 6871896.6285 0.0000 
0.0083 11689.2197 0.0000 
Analysis of Variance: 
DF SS 
Regression3 0.0041 
Residual 1 0.0272 

















Durbin-Watson Statistic = 2.4654 
Normality Test: Passed (P = 0.1730) 
Constant Variance Test: Passed (P = 0.0500) 
Power of performed test with alpha= 0.0500: 0.0774 
The power of the performed test (0.0774) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously. 
Regression Diagnostics: 
Row Predicted Residual Std. Res. Stud. Res. Stud. Del. Res. 
1 0.9097 0.0903 0.5471 0.7737 0.0000 
2 0.9020 -0.0674 -0.4087 -1.4294 (+inf) 
3 0.8943 -0.0702 -0.4253 -0.6540 0.0000 
4 0.8569 0.0888 0.5381 0.5649 0.0000 
5 0.8352 -0.0415 -0.2516 -0.3298 0.0000 
Influence Diagnostics: 
Row Cook'sDist Leverage DFFITS 
1 -0.4489 1.5000 (+inf) 
2 -6.7584 1.0818 (+inf) 
3 -0.3598 1.4229 (+inf) 
4 -0.1677 1.9072 (+inf) 
5 -0.0739 1.5822 (+inf) 
95% Confidence: 
Row Predicted Regr. 5% Regr. 95% Pop. 5% Pop. 95% 
1 0.9097 -1.6576 3.4771 -2.4047 4.2242 
2 0.9020 -1.2782 3.0822 -2.1225 3.9265 
3 0.8943 -1.6061 3.3948 -2.3686 4.1572 
4 0.8569 -2.0380 3.7518 . -2.7173 4.4311 
5 0.8352 -1.8015 3.4719 -2.5332 4.2037 
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- Col 14vCol15 
• Time. weeks v D/Do, [L-4 Tablets, 25C/60% RH) 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
L-4 Tablets (BiPhasic First-order reaction) 




y = col(2) 
reciprocal_y=l/abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a= yatxnearO(y,x)/2 "Auto {{previous: 0.24046}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 0.606988}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.765575}} 




"fit f to y with weight reciprocal_y 












R = 0.95135409 Rsqr = 0.90507461 Adj Rsqr = 0.62029845 
Standard Error of Estimate= 0.0649 
Coefficient 
a 0.2405 0.3286 
b 0.6070 1.1249 
c 0.7656 0.3293 
d 0.0000 0.0472 
Analysis of Variance: 
DF SS 
Regression3 0.0402 
Residual 1 0.0042 
Total 4 0.0444 
PRESS= 2.7170 










Normality Test: Passed (P = 0.6964) 












The power of the performed test (0.7423) is below the desired power of 0.8000. 
You should interpret the negative findings cautiously . . 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0060 -0.0060 
2 0.8966 0.0178 
3 0.8370 -0.0106 
4 0.7690 -0.0438 
5 0.7661 0.0427 
Influence Diagnostics: 
Row Cook'sDist 
1 2.6970 0.9721 
2 0.0610 0.5772 
3 0.0227 0.5841 
4 9.0114 0.8936 






























Row Predicted Regr. 5% 
1 1.0060 0.1930 
2 0.8966 0.2701 
3 0.8370 0.2068 
4 0.7690 -0.0105 




























- Col 19vCol20 













y = col(2) 
reciprocal_y= 1/abs(y) 
reciprocal _ysquare= 1/y/\2 
'Automatic Initial Parameter Estimate Functions 
xnearO( q)=max( abs( q) )-abs( q) 
yatxnearO( q,r )=xatymax( q,xnearO( r)) 
[Parameters] 
a = yatxnearO(y,x)/2 "Auto {{previous: 0.209693}} 
b = -ln(.5)/(0.5*(x50(x,y)-min(x))) "Auto {{previous: 19542.4}} 
c = yatxnearO(y,x)/2 "Auto {{previous: 0.790307}} 




fit f toy 
"fit f to y with weight reciprocal_y 





tolerance= 1 e-6 
stepsize=0.1 
iterations= 100 
R = 0.99169616 Rsqr = 0.98346127 Adj Rsqr = 0.93384507 










Analysis of Variance: 
DF SS 
Regression3 0.1465 
Residual 1 0.0025 
Total 4 0.1489 
PRESS = 0.0000 
Durbin-Watson Statistic = 3 .4872 











Normality Test: Passed (P = 0.7092) 
Constant Variance Test: Passed (P = 0.0500) 
Power of performed test with alpha= 0.0500: 0.9723 
Regression Diagnostics: 
Row Predicted Residual 
1 1.0000 0.0000 
2 0.7555 -0.0182 
3 0.7222 0.0304 
4 0.5764 -0.0298 

























Row Cook'sDist Leverage DFFITS 
1 (+inf) 1.0000 (+inf) 
2 0.1119 0.5817 0.0000 
3 0.1064 0.4041 0.0000 
4 0.0831 0.3679 0.0000 














0.3694 1.6306 0.1082 
0.2745 1.2364 -0.0376 
0.3213 1.1230 -0.0250 
0.1939 0.9589 -0.1611 
-0.0035 1.0104 -0.3056 











- Col 24 v Col 25 











This appendix includes the residual plots for the output generated in Appendix A. Using a 
suitable graphical procedure (Microsoft® Excel 97), residual plots are drawn for the 
degradation data to fit first order and biphasic first order reactions. This was done for all 
the drug-excipient mixtures for all conditions. Residuals are plotted against 
experimentally determined values (observed) and model fitted values (predicted values). 
Essentially what is considered important while looking at residual plots is a random 
scatter around the baseline with no significant trend in the plot. 
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1) Drug + Dextrose 
dextrose. first order (25 C) 
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dextrose, biphasic first order (25 C/60 o/.RH) 
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=.~ : :o~ +)·-·.·--~----..----__,· ;;; - I • Series 1 I 
& -001 : 0:5 15 
-0.02 +-- --------~· 
Predicted Values 
dextrose, biphasic first order (50 C/20 % 
moisture) 
o~ !· ., 
•15 
iO 







dextrose, biphasic first order (50 C) 
'' j 1 l•soon•I "' iO * ::I • "C o~ : "Ill 





2) Drug + DiCalcium Phosphate Dihydrate 
DCPD, first order (25 C) 
-~I • 1~ Ill iii ::I ·~· I• Series1 I 'C ·111 8! 50 . ~ • 
-40 
Actual Value 
DCPD, first order (40 C/75 %RH) 
-~ l • ,~ ..!!! • 1: .. ::I • I• Series1 I 'C ;; ·111 • 8! •• • 
-20 
Actual Value 
DCPD, first order (50 C/20 o/.moisture) 
Ill -~l • ,~ iii ::I • • I• Series1 I 'C ~~Q ·111 • 8! 50 . 
·20 
Actual Value 
DCPD, first order (50 C) 






















DCPD, Blphasic First Order (25 C) 
::~ • 
,1. ~· J • Series1 I 0:5 • * ·~ -0.2 
-0.4 
Actual Values 
DCPD, Biphasic First Order (40 C/75 '%RH) 
:; l • 





DCPD, Biphasic First Order (50 C/20 % 
moisture) 
:; I 1 • I• Series1 I • • 0:5 • •• • • 1 -0.1 
Actual Values 
DCPD, Biphasic First Order (50 C) 














DCPD, first order (40 C/75 %RH) 
20 1·----------~ 
1.:: .... ----~~-~'-----',_____...,. 
-20 ~-----------~ 
• 1~ • • • I• Series1 I • 50 • • • 
Predicted Values 
DCPD, first order (50 C/20 %moisture) 
20 ----------~ I :~ \ ~ .. :j; 1~ 1 .,~1 1 
Predicted Values 
DCPD, first order (50 C) 
20 -i---------.--1 i T • ; • :. 1;0 l•soo .. 11 
Predicted Values 
319 
DCPD, Biphasic First Order (25 C) 
0.4 1 . f (/) 0.2 _,_ ________ __J i ~:,:, !; 'o• • ,; ; u 1.s ... 11 
-0.4 J_ ________ __, 
Predicted Values 
DCPD, Biphasic First Order (40 C/75 %RH) 
0.2 
• 
"' 0.1 • • ~ 0 
.., ·-.-




































_O.i: 1 1 5 
Predicted Values 



























Calcium Sulfate, first order (25 C) 
10 l ,j, 5 • • I• Series1 I 0 =~~Q -5 50 
-10 
Actual Values 




• I• Series1 I 
_.._ 0 
·1100 50 1po 
-5 
Actual Value 
Calcium Sulfate, first order (40 C/75 %RH) 




Calcium Sulfate, first order (50 C/20 % 
moisture) 
:1 • .~ • I• Series1 I .. ... • 50 • 100 
-20 
Actual Value 
Calcium Sulfate, first order (50 C) 







































Calcium Sulfate, Biphasic first order (25 C) 
'~ j • 










: I• Series1 I '': ·~· 0 5 1 
-0.05 
Actual Value 








Calcium Sulfate, Blphaslc first order (50 C/20 
%moisture) 
:; j • 1 I• Series1 I •• • l!.5 • -0.1 
Actual Values 








Calcium Sulfate, first order (25 C) 
l.ll +-----5~0--·-·.-':lo--,  I ·"'~' 
Predicted Values 
Calcium Sulfate first order (25 C/60 %RH) 
-.ci:~ .. ~ 1o:t~. ~---------·-1 ;;; ~ • • 
95 
I •Series 1 I 
'• 85 9t> •• 
-5 ~-------~--'-- ~ 
Predicted Values 
Calcium Sulfate first order (40 C/75 %RH) 
"' ] ... :1 iii " I • Series1 I ,, • "Ill • ., Cl: 80 as. 
Predicted Values 
Calcium Sulfate first order (50 C/20 '/dnoisture) 
20 
1-:: f 
• '~ .. ~ •• I • Series1 I • • 
-20 
Predicted Values 
Calcium Sulfate first order (50 C) 
1.:~ 1·------.-so--.--.-~-.. -,~ 
-20 - . 
Predicted Values 
321 
Calcium Sulfate, Biphasic first order (25 C) 
=.~ ~ :01 +---~------·.-%--'<-: ~ ------li :;; • • I •Series1 1 




Calcium Sulfate, Biphasic first order (25 C/60 
%RH) 
~ 0.05 • 
., 0.1 • I 
i --0 0~o,Jla.__0 _ _..o.,..~,,5_·_.__,o~~s"'• 5 
Predicted Values 
Calcium Sulfate, Biphasic first order (40 C/75 
%RH) 
·ii --0.05 .,._ --Uco'."-s -~~__,_: _ ..:u'\.5 I• Series1 I i 00~ t I 







Calcium Sulfate, Biphasic first order (50 C/20 
'!.moisture) 
:; 1 · • J. I • Series1 I ... • 
--0.1 09 • 
Predicted Values 
Calcium Sulfate, Biphasic first order (50 C) 
r~ .._j--0_. .• -=--·.-:~· -~-_____Ji l •series1 I t}.--005 ~ _5. .1 15 
--0.1 _,__ ________ __J_ 
Predicted Values 
4) Drug + Mannitol 
Mannilol, first order (25 C) 
5 
Ill • 
"' . l ii 0 




Mannitol, first order (25 C/60 %RH) 
J • • 't Ill • ii • :I • I• Series1 I ,, 95 100 OJ •• ., a: 
Actual Values 




I • Series1 I 
~· • . -..-90 • 95 100 1 p: 5 
-5 
Actual Value 
Mannitol, first order (50 C/20 '!.moisture) 
j ~ +j---50---·-;-~-~----',~ I•,,_, I 
Actual Value 
Mannitol, first order (50 C) 




Mannitol, Biphasic first order (25 C) 
0.1 
Ill 
~ 0.05 • 
• • _., 
,, 
·111 0 & 0 






























0 • I •Series1 I 
""'"" 
-.-
1f 5 • 09 0.95 1 • 
-0.05 • 
Actual Values 







.~5· • • • 1.p 0.9 • 0.95 1 5 
Actual Values 
Mannitol, Biphaslc first order (50 C/20 
'!.moisture) 
':I •• ,j, I• Series1 I ,. •• I 0.5 ... 1 
-0.05 
Actual Values 
Mannltol, Biphaslc first order (50 C) 




Mannltol, first order (25 C) 
5 ~------------
., . . 
~ 0 +-- -~--~.~.,.::•c.._ .,,._ _ --i 
~ _5 $ 90 95 100 1 ~5 I• Series1 I 
& 
-10 J_ _________ __J 
Predicted Values 
Mannltol, first order (25 C/60 %RH) 
! ~'j+-'-· _oo_•----1._.~.-+-~ ·_=:----!~ 
-10 ~- ----------_J 
I• Series1 I 
Predicted Values 









. . ....... 
95 • 1~0 
~-----------___) 
• 90 
I• Series1 I 
Predicted Values 
Mannltol, first order (50 C/20 %moisture) 
5 
• ., • • Oi 
:;J • I• Series1 I ,, 0 ..-
"ill 1'i & 85 90 .95 1,0 
-5 • • 
Predicted Values 
Mannitol, first order (50 C) 




Mannltol, Blphasic first order (25 C) 
0.1 
., 
• Oi 0.05 
:;J I• Series1 I ,, 
• • "ill _._ 
.. 0 
........ ci:: o.~5 0.9 • 0.95 1.p5 1 
-0.05 
Predicted Values 






0 • I• Series1 I ,, --.- ... 111 
& o.p.i • 0.96 o.!18 1 1.p2 
-0.05 • 
Predicted Values 
Mannitol, Blphasic first order (40 C/75 o/cRH) 
0.1 ~---------~ 
., 













•• 0 +---.-~---~.--'-.-'.r- -
0.~5 0.9 t .95+ 
-0.05 ~-----------
Predicted Values 
Mannltol, Biph;islc first order (50 C/20 
%moisture) 
,,: I •• 
,1, I• Series1 I .. .. ' 0.5 .. r 
-0.05 
Predicted Values 
Mannitol, Biphasic first order (50 C) 
:: j • J I• Series1 I . ... •• 0.5 1 
-0.2 • 
Predicted Values 
5) Drug + Lactose Anhydrous 
Lactose Anhydrous, First Order (25 C) 
~ ..i -11_0;5 +j------_..,. ___ ---1 ~ ¥~ ~s~a_·~:-• .. _~ll:wnc_ _ __._.,,f o l•O•O••> ! 
Actual Values 
Lactose Anhydrous, First Order (25 C/60 
%RH) 


















Lactose Anhydrous, First Order (40 C/75 
%RH) 
:~ I • 1 • I • Series1 I ' . ' 50 •• 100 
Actual Values 
Lactose Anhydrous, First Order (50 C/20 
%moisture) 
30 ~1 • .t ;:: I • Series1 I • 1~0 
-20 
Actual Values 
Lactose Anhydrous, First Order (50 C) 
:} l • ,f, • • • I• Series1 I • 1 ~0 50 . • • 
Actual Values 
324 
Lactose Anhydrous, Blphasic First Order (25 C) 
i OO: j 0.5 • • ... • 115 I •Series1 I 








Lactose Anhydrous, Blphasic First Order (25 
C/60 %RH) 
0.05 
J • • • • I •Series1 I 0 




















Lactose Anhydrous, Biphasic First Order (40 
C/75 %RH) 




Lactose Anhydrous, Blphasic First Order (50 
C/20 %moisture) 
'': ! • ,j, • I• Series1 I oT• • 
-0.05 
Actual Values 




I •Series1 1 :· . . : ~ -0.1 
-0.2 
Actual Values 
Lactose Anhydrous, First Order (25 C) 
w - .: j I • Series 1 I 
l:t:
-:o .. ~ 1-5~0 1+-----------.:r.~'l'- ----~50u_ __ •_. _._. JJll1t0 
-10 ~--------------'-
Predicted Values 
Lactose Anhydrous, First Order (25 C/60 %RH) 
Predicted Values 
Lactose Anhydrous, First Order (40 C/75 %RH) 
:ol:t:~ .. ::0 +--j ~·---11 w _ • l •Series1I 
• • 50 • ... 1,0 
-10 ~-------------'-
Predicted Values 
Lactose Anhydrous, First Order (50 C/20 
°lcmoisture) 
• • J•Series1 1 -:oa::'"~= :o~ .... J--------~---''--i 
-20 20 40 ·; ..,.· . 
Predicted Values 
Lae1ose Anhydrous, First Order (50 C) 
i'.l +!-----~----~ 
-20 ~----------------' 























Lactose Anhydrous, Blphasic First Order (25 C) 
'': j ..... l • I• Series1 I 0.5 • • -0.02 
-0.04 
Predicted Values 
Lactose Anhydrous, Blphaslc First Order (25 
C/60 %RH) 
,,: I • 
,j, • • I• Series1 I • ~ • 0.5 • .1 
-0.05 
Predicted Values 
Lactose Anhydrous, Biphaslc First Order (40 
C/75%RH) 
,,: I • 
.j, • • ' ••• J • Series1 I 0.5 +--0.05 
-0.1 
Predicted Values 
Lactose Anhydrous, Biphaslc First Order (50 
C/20 %moisture) 
': l • ,j, • I• Series1 I ¥ • o.'"!• 
-0.05 
Predicted Values 
Lactose Anhydrous, Biphaslc First Order (SOC) 
-:0~ ::01 f-- ==·===~I ., ~ • • ~ J+Series1 1 ~ -0. 1 ;;; • • 4 1 5 
-0.2 ~--------------' 
Predicted Values 













Lactose Hydrous, First Order (25 C) 
'l j • ·~ • •• I• Series1 I ;; ·1~0 ' 
-10 • 
Actual Values 
Lactose Hydrous, First Order (25C/60%RH) 
Actual Values 







• • 50. • 100 1po 
Actual Values 
Lactose Hydrous, First Order (50C/ 
20'!.molsture) 
I• Series1 I 
I ~~ lr---50~~~4 •.---1~~------<,l I•""'' 
Actual Values 
Lactose Hydrous, First Order (SOC) 
I ] +j---#~~-~----l 
-10 -'- ----~---__J 




Lactose Hydrous, Biphasic first order (25 C) 
=.~ 00~501 1 +-----,---_, __ • .---------l  ;; •• :+ 15 l +series1 I ~ -0.05 .,._ __ ~0~5 _ __ ~1 ___ _.,_, 














Lactose Hydrous, Blphasic first order (25 C/60 
%RH) 
,: I 
,j, l·-"I •• • #+. 0.5 1 
-0.1 • 
Actual Values 




• I• Series1 I 
' • ' 0.5 . 
-0.05 
Actual Values 
Lactose Hydrous, Blphaslc first order (50 C/20 
%moisture) 
Actual Values 
Lactose Hydrous, Biphaslc first order (50 C) 
I ~'~j +---·~~·5-:~-.·-1---,[. I-'""' I 
-0.1 
Actual Values 
Lactose Hydrous, First Order (25C) 




• • • ::i I• Series1 I 't:I •• ·111 
"' 
50 •mo 0:: 
• -10 
Predicted Values 
Lactose Hydrous, First Order (25C/60%RH) 
10 l . ..1 .; 0 •• -6 50 • I 1 , o I • Series 1 I ~ -10 +- ----------<-
·20 -'- ------------' 
Predicted Values 
Lactose Hydrous, First Order (40C/75%RH) 
I : l 
-10 -
. . l I· 5.,;,,1 
50 ·.'.: 10 
Predicted Values 
Lactose Hydrous, First Order (SOC/ 
20%moisture) 
=~~~ :~o t----'L- ~~--~----j! ~ _ • • • l +Series11 : ... 
-20 ~-----5!) _ __ ._. __ ~1 ' 0 
Predicted Values 
Lactose Hydrous, First Order (SOC) 










Lactose Hydrous, Blphasic first order (25 C) 
, 1 I • 
115 






Lactose Hydrous, Biphasic first order (25 C/60 
"/.RH) 
r: 1----o~.5 __ ._• .~·~.~;~---<1 15 I• s"""1 I 
-0.1 ~- ----~·~----~. 
Predicted Values 
Lactose Hydrous, Biphasic first order (40 C/75 
"/.RH) 
!!!. 0.05 ~------.-----~ 
.. 
-6 0 -+------·_ ..... __ __,_..,_._ _ __, 
·111 .-. 
&! ~ 
-0.05 -'-- -- - -'•'---- - - ---' 
0.5 1 5 
Predicted Values 
Lactose Hydrous, Biphasic first order (SO C/20 
%moisture) 
.. 
, 1 I • 
15 
iii • ::i • I• Series1 I 't:I o~ ' : ·111 •a.t•. &! -0.05 
-0.1 
Predicted Values 
Lactose Hydrous, Biphasic First Order (SOC) 
=-~111 00~501 +--1 ----r--r'-----'---r-. - I ~ - • • • 
1 5 
I • Series 1 I ~ -0.05 '1'- -·~0~:~5-+ .. ·-~r----'.j-
-0.1 -'--- ----------' 
Predicted Values 
7) Drug + Starch 
Starch, First Order (25 C) 
Actual Values 
Starch, First Order (25 C/60 %RH) 
i ~ t + • • • j I • Series 1 I ~ j ~+---~9~5-.-l-.--1-i:~a--__,1 5 
Actual Values 
Starch, First Order (40 C/75 %RH) 
.. 
a 
• '~ iU • ::J .. • I• Series1 I 'C • ~o 1~2 "ill ., • a:: 
Actual Values 
Starch, First Order (50 C/20 %moisture) 
_:i \ 
• l [•SMM' .. iU ... ·: ::J 'C "ill 




Starch, First Order (50 C) 
I _J ~l---·~5~~-: ·-~~~~o~ _ _...,,,~ 
Actual Values 
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Starch, Biphasic First Order (25 C) 
OM l .!! • ' ~ .. •• ::J I• Series1 I 'C '~f • ' o;• ! 1ll .. 09 a:: -a.o:P s • 
-0.04 
Actual Values 
Starch, Blphasic First Order (25 C/60 %RH) 
















Starch, Biphasic First Order (40 C/75 %RH) 
OM l • ' ~ .j ;~ . I• Series1 I :;~ . ·~ • 
-0.04 
Actual Values 









Starch, Blphasic First Order (50 C) 
j 00~1 +--~•~ ... ~--.+...-·· • .,,~---11 I • Series1 I 
~ 0.5. , 15 
-0.05 ~---~~-----~ 
Actual Values 
Starch, First Order (25 C) 
Predicted Values 
Starch, First Order (25 C/60 %RH) 
i H_._ ._;4 __ s_~_·_._;_~ _._.:_~ _ __,'2 I• Series1 I 
Predicted Values 
Starch, First Order (40 C/75 °/cRH) 
Predicted Values 
Starch, First Order (50 C/20 °/cflloisture) 
i ~: t---· _ _.._;-----"l l•Series1 1 ~ -10 50 ··: 1 10 
-20 J_~ ________ ___: _ __J_ 
Predicted Values 
Starch, First Order (50 C) 





Starch, Biphasic First Order (25 C) 
=-~ 0.020 +--~-~->---·-·~---' 0.04 f . ~ :;; ~ ~.._ ' • l •Series1 I 






-0 . 04 ~-----------'· 
Predivted Values 
Starch, Biphasic First Order (25 C/60 o/cRH) 
0061 • 
,t • I• Series1 I ~i. • :~ .. ~ ~ . 5- • * 
-0.04 
Predicted Values 
Starch, Biphasic First Order (40 C/75 °/cRH) 
Predicted Values 
· Starch, Biphasic First Order (50 C/20 
0/cmoisture) 
i o; I \~~· .  I & .-0.1 "'"l ___ 0,,,."""5- ••- --'-1 __ ---'-1 5 I • Series 1 I 
-0.2 ~------------'· 
Predicted Values 
Starch, Biphasic First Order (50 C) 
0' 1 !.! 1 ., * :I I •Series1 I i:i 0.0: • "ill • & ... • ., 0.5 • t 
-0.05 
Predicted Values 
8) Drug + Talc 




.. ~ "' :I ; "O 'Ill /}, 
Actual Value Actual Values 
Talc, First Order (25 C/60 %RH) Talc,Biphasic First Order (25 C/60 %RH) 
Actual Value Actual Values 
Talc, First Order (50 C/20 %moisture) Talc, Biphasic First Order (50 C/20 %moisture) 
-~ l ,1, 01 j ,j, • ..!!! • :~·· "' • I• Series1 I J • Series1 J :I "O ' ~·· 1~0 i oo: 'Ill a' • ; "' so•+ 0:: &! -0.05 
-20 -0.1 
Actual Values Actual Values 
Talc, First Order (50 C) Talc, Biphasic First Order (50 C) 
'l I 01 l ., • 1~ J iU • .. : iU :I • • I• Series1 I :I I• Series1 I "O ' . . ~ "O o~ •• 'Ill 50 • ~ j=Q 'Ill /}, &! • • ••• 0.5 • , 
-10 
-0.05 
Actual Values Actual Values 
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Talc, First Order (25 C) Talc, Biphasic First Order (25 C) 
~! • 110 OM l ,1, .!!! ·~ • .:~ "' ::I ;;;; I• Series1 j [ • Series1 I ..., ·111 r~ ~ 05 • ti -0.02 • • 
-0.04 
Predicted Values Predicted Values 
Talc, First Order (25 C/60 %RH) Talc, Biphasic First Order (25 C/60 %RH) 
j H+--~·-9~5-.-· .. ·-;~-·-·.----1,~ I·'"'"' I ii~::1~· .. f -5 0 +---"•'-rr------<•>-~ .• - .----i1 5 I• Series1 I ;! -0 02-.,0 ~9 _ _ ~0~9~5~.---<-+----~-'">'. 
-0.04 ~---------~ 
Predicted Values Predicted Values 
Talc, First Order (50 C/20 "/cmoisture) Talc, Biphasic First Order (50 C/20 %moisture) 
j J .... !----:--.....  -.. -:-· ----',~ I•'""' I 
Predicted Values Predicted Values 
Talc, First Order (50 C) Talc, Biphasic First Order (50 C) 
":I 01 l • 1 ., 1 • Oi • • • I• Series1 I ::I [ • Series1 I ! ~ ; ••• ;;o ..., ·~ •• '111 •• • • j ti • • • J 0.5 • t 
-10 -0.05 
Predicted Values Predicted Values 
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9) Ferric Oxide 
Ferric Oxide, First Order (25 C) 
10 
.!!. ~ "' 5 :I • • I • Series1 I 'ti ·115 0 --*-Cl> 
0:: 
-5 ap .a~ 90 95 100 1 ' 5 • 
Actual Values 







• • I• Series1 I 'ti 
·115 • 
&! 0 • 
-5$ .~· 95 100 * 
Actual Values 
Ferric Oxide, First Order (40 C/75 °lcRH) 
5 
• •• .. .. iU 0 
:I 
•!ls I• Series1 I 'ti 
-5* 





Ferric Oxide, First Order (50 C/20 %moisture} 
1t 
• • 




Ferric Oxide, First Order (50 C} 




Ferric Oxide, Biphasic First Order (25 C) 
0.05 
• 
• ••• • 
5 I +series1 I 
~ 0 


















• • I• Series1 I 0 
• • 
1 rs 0 ~5 •0•9 •0.95 
-0.05 
Actual Values 
Ferric Oxide, Biphasic First Order (40 C/75 
%RH) 
0.05 
• • • 
. -"'. I • Series1 I 0 
0.~5 .o.9 0.95 1.p5 
-0.05 
Actual Values 
Ferric Oxide, Biphasic First Order (50 C/20 
o/c111oisture} 
"' 0.1 • • J 
~ 0 +----/---~_...,._,._.....--~-~-_,1 l +Series1 1 
~ o a o.a5 o.9 o.95 1.b5 
-0.1 ~-~·----·--·-.J 
Actual Values 
Ferric Oxide, Biphasic First Order (50 C) 
0.04 
0.02 • 
"' •• • fti 0 
















Ferric Oxide, First Order (25 C) 
• : 1 1 • Series 1 I 
... 
• ~ ~o 
Predicted Values 
Ferric Oxide, First Order (25 C/60 %RH) 
10 
-<IL 5 




90 •9· ~ 
Predicted Values 















• 95• I• Series1 [ 90 92 94 9.8 
Predicted Values 
Ferric Oxide, First Order (50 C/20 
%moisture) 
• • ~ • • • • • 85 •90 • 
Predicted Values 
Ferric Oxide, First Order (50 C) 
I• Series1 I 
=·=§ 




Ferric Oxide, Biphasic First Order (25 C) 
0.05 
• • 
"' • • • • «i 0 
:I 
08 0.85•. 0.9 'O 0.95 
·115 
-0.05 ~ • 

























I• Series1 I • 0 • 
0 9, • 0.95' 
• 
-0.05 _,_ _________ ______, 
Predicted Values 




0 • . I• Series1 [ 









..... I• Series1 I 0 
08 0.85 0.9 0.95 
-0.1 • 
Predicted Values 
Ferric Oxide, Biphaslc First Order (50 C) 
OM j •• 
.J, •• 
• 






10) Levothyroxine Sodium Tablets 
L-4 Tablets, First Order (25 C) L-4 Tablets, Biphasic First Order (25 C) 
-~ t 1~ 0.05 .!!! 1:0 • .. IV Oi • :I I• Series1 I I• Series1 I "O .. :I 0 "O 'ill • 'ill • & 50 • &! 4J 0.5 1 5 
• -20 
-0.05 
Actual Values Actual Values 
L-4 Tablets, First Order (25 C/60 °lcRH) L-4 Tablets, Biphasic First Order (25 C/60 "I.RH) 
.. 
1t ~ 1~ 01 1 ·~ 115 1•5"511 ;; :I I •Series1 I "O 'ill ; r~ 0:5 & ~ ~ ~· &! -0.05 • 
-10 -0.1 
Actual Values Actual Values 
L-4 Tablets, First Order (40 C/75 %RH) L-4 Tablets, Biphasic First Order (40 C/75 %RH) 
I 1~ +j~~~w~-.-:-·~1~:,~~--j1~ 
-10 _,_ __________ __,_ 





0 0.5 • 1 1 5 
-0.05 +----~·----_J 
Actual Values Actual Values 
L-4 Tablets, First Order (50 C) L-4 Tablets, Biphasic First Order (50 C) 
_1 j 
0.04 




0.5 • 1 _j 
• 
5 
Actual Values Actual Values 
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"' ,~I • I iii • :I I• Series1 I ,, 
• • ~5 ill "' 0.5 a:: 
• 
-0.05 
Predicted Values Predicted Values 
L-4 Tablets, First Order (25 C/60 o/.RH) L-4 Tablets, Biphasic First Order (25 C/60 °/.RH) 
1 1r.ffi· ./l 1 · 5'"~' 
-10 .L _ ____ ________ J
Predicted Values Predicted Values 
L-4 Tablets, First Order (40 C/75 o/.RH) L-4 Tablets, Biphasic First Order (40 C/75 °/.RH) 
-.a::~"'~ 1-~~ 1-----~----~1 :;; ~ • : I • Series 1 j 50 •• 1~ 0 
-10 -'--- - - --- -------' 
--a::~ ..~ 0.050 i~-· ·~____;I :;; ~ • + I •Series 1 I 0.5 1 115 
-0.05 . . 
Predicted Values Predicted Values 
L-4 Tablets, First Order (50 C) L-4 Tablets, Biphasic First Order (50 C) 
~ 20 F 
; _ :: :f===========:=~=·======·=•===~c\}6l0 [.-se-OOSt] 
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